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Turn your face toward the sun and the shadows will fall behind you. 
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 LIST OF ABBREVIATIONS 
AP-1 Activator Protein-1 
APC Antigen-Presenting Cell 
ASC Apoptosis-Associated speCk-like protein 
C/EBP CAAT Box Enhancer Binding Protein 
caspase cysteine-aspartic protease 
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h hour 
i.p. intraperitoneal 
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IL-1R IL-1Receptor 
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IMI IntraMammary Infection 
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LTA LipoTeichoic Acid 
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MCP-1 Monocyte Chemoattractant Protein-1 
MDP Muramyl DiPeptide 
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MIP Macrophage Inflammatory Protein 
MMPs Matrix MetalloProteinase 
NF-kappaB Nuclear Factor-kappa B 
NLR NOD-like receptors 
p.i. post-induction   
 
 
 
PD Protective Dose 
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PMN PolyMorphoNuclear 
PRR Pathogen Recognition Receptor 
RANTES Regulated on Activation Normal T Cell Expressed and Secreted 
S. aureus Staphylococcus aureus 
S. chromogenes Staphylococcus chromogenes  
S. fleurettii Staphylococcus fleurettii 
S. uberis Streptococcus uberis 
SCC Somatic Cell Count 
SD Standard Deviation 
TA Teat Apex 
TF Transcription Factor 
TLR Toll-Like Receptor 
TNF-alpha Tumor Necrosis Factor-alpha 
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GENERAL INTRODUCTION 
 
I. MASTITIS, AN INFLAMMATORY DISEASE AFFECTING MAMMALS 
 
BACKGROUND: MAMMALIAN MILK PRODUCTION RESULTS FROM A CONSERVED MAMMARY 
GLAND ONTOGENY 
 
Milk production is a mammalian hallmark wherein neonates are nourished postpartum through a very 
effective and adaptable organ (Kuruppath, Bisana et al. 2012). Hundred millions of years ago, 
evolutionary reprogramming of apocrine cutaneous glands associated with either hair follicles or 
evolutionary merging of different skin glands, resulted in a new excretion organ to support altricial 
offspring (Oftedal 2002; Olsson and Oldenborg 2008). The Eutherian (Placentalia) mammary gland 
provided for modern mammals is a result of morphological, physiological, biochemical, ecological and 
behavioral adaptations (Lefevre, Sharp et al. 2010).  
Proteome analysis of different mammalian genomes confirms the conserved ontogeny of the 
mammary gland (Lemay, Lynn et al. 2009). The mammary gland is rudimental at birth and develops 
further into a post-pubertal quiescent gland in a process called mammogenesis (Lombardi 1998). At 
the onset of lactation, the slumber state of the exocrine gland differentiates with parturition due to 
female sex hormonal signaling (Lamote, Meyer et al. 2004). Morphologically, the mammary gland 
generally enlarges due to extensive branching of ducts and alveolar formation. Once fully functional, 
lactogenesis is initiated and sustained in the galactopoietic stage. Alveolar secretion starts with the 
highly protein- and fat-rich colostrum leading to the production of copious mature milk with a relative 
stable constitution under the influence of prolactin (Lacasse, Lollivier et al. 2012). Mammary 
secretions contain a diversity of constituents synthesized and secreted by several cellular pathways. 
Milk proteins such as casein are produced in the endoplasmic reticulum and are guided by the Golgi 
system to the cellular membrane. Budding of this membrane results in micelles loaded with proteins 
encoded in the mammary epithelial cells and is perceived as a mildly invasive apocrine secretion 
method. These membrane remnants, together with both de novo mammary triglyceride formation and 
ex novo liver or diet lipids locally released, render milk its characteristic fatty nature (Neville 2009). 
Milk saccharides such as lactose are also produced by the mammary cell compartment, while minerals 
such as calcium ions can be released through transepithelial transport from the bloodstream. The 
latter have important implications creating a hormonally-regulated osmotic gradient and eventually 
fluid excretion (Anantamongkol, Ao et al. 2012). In lactating animals that lose their milking stimuli, 
regression of the complete mammary gland to its state prior to pregnancy is introduced either through 
weaning of the litter or through entering the dry-off period. This involution process involves 
programmed cell death programs of specific epithelial cell populations and is reversible at its onset. 
Dead mammary cells are first discarded from their originating epithelial layer (anoikis) and 
subsequently released in the alveolar lumen (Watson and Kreuzaler 2011). In each state (embryonic, 
prepregnant, fully functional gestational and involutional) the mammary gland is compartmentalized in 
a parenchymal and a stromal portion. The ductal parenchym of pseudo-stratified cuboidal architecture 
consists of contractile myoepithelial cells and encircles another layer of epithelial cells that encloses 
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the lumen. The alveolar parenchyma concentrated in lobuli has a similar structure consisting of the 
same cell types. These different cell layers can be identified by means of their specific cytokeratin 
expression (Sleeman, Kendrick et al. 2006). The luminal mammary epithelial cells have a secretory 
potential which depends on the mammary stage. When alveoli are full of secretion, the myoepithelial 
cells contract and guide the milk through the ducts which collects in sinuses towards the orifice, where 
it gets released. Embedded in both layers of epithelia from this alveo-lobular structure, reside stem 
cells responsible for the morphological dynamicity of the post-natal mammary gland. These two layers 
contain several functionally distinct subpopulations, including stem, progenitor and differentiated cells 
(Smith, Welm et al. 2012). This complex cellular framework is supported by an elaborate stromal 
compartment called the Extra-Cellular Matrix (ECM). Based on its position in the gland, the ECM is 
subdivided in basal lamina, intra- and inter-lobular stroma and fibrous connective tissue. These ECM 
molecules actively participate in the organization of the complex mammary gland architecture and 
furthermore in cell functions including adhesion, survival, apoptosis, proliferation and differentiation of 
the mammary gland (Brownfield, Venugopalan et al. 2013). Although they are not yet fully understood, 
alterations in ECM constituents likely have implications in mammary gland diseases due to their 
influence on internalization of bacteria in hosts’ epithelia following a mammary infection 
(Dziewanowska, Patti et al. 1999; Dziewanowska, Carson et al. 2000), on infiltration and activation of 
immune cells and on tumor development (Lochter and Bissell 1995; Van Laere, Van den Eynden et al. 
2006). 
I.1. What is Mastitis? 
Although milk production by the mammary gland is essential for all mammals, cow milk is of key 
importance for the dairy industry. Dairy cow milk differs in composition of milk derived from other 
Mammalian species (Lemay, Lynn et al. 2009) but has no fixed composition per se. Cow milk 
composition depends on breed, stages of lactation, and composition of the ration. Similar as other 
mammals, the composition of cow milk stays relatively constant during mid-lactation, with most 
significant changes occurring in early and late lactation (Ilves, Harzia et al. 2012). 
The interest for cow milk dates back from human civilizations that finally developed agriculture. Men 
selected dairy animals characterized by relatively dilute milks containing modest levels of fat, caseins, 
and whey proteins, and relatively high levels of lactose. The reason why men specifically selected 
cows or other dairy species is still a matter of speculation. Some people claim that dairy milk 
resembles human milk, in being dilute, or perhaps such species were easier to milk because their 
dilute milk accumulated in substantial storage cisterns between bouts of suckling (Oftedal 2012). 
Nevertheless, improvements in efficiencies of production and technological advances in milk removal 
still continues today with lower number of dairy herds and ever higher total milk production 
(Thompson-Crispi, Atalla et al. 2014). In the 80’ies, the US needed around 350,000 herds to produce 
60,000 million kg/year while in 2010 less than 100,000 herds were able to produce 90,000 million 
kg/year (von Keyserlingk, Martin et al. 2013). These yields far surpass the one needed to nourish the 
newborn calf and not surprisingly, such a high production is associated either directly or indirectly with 
  13 
 
 
GENERAL INTRODUCTION 
an increased rate of reproduction-related health problems, i.e. mainly mastitis but also metritis (Roche 
2006).  
In essence mastitis (mast = breast; itis = inflammation), can be defined as an inflammatory disease of 
the (lactating) udder in ruminant species (Rauw, Kanis et al. 1998; Contreras and Rodriguez 2011). 
Mastitis is characterized by typical changes which can be either directly observed i.e. clinical 
symptoms of udder tissue inflammation and organoleptic loss of milk quality, or lack visual symptoms 
i.e. subclinical mastitis. Alongside with other parameters, the latter can be detected by the 
measurement of Somatic Cell Count (SCC). Milk SCC levels of individual quarters above a well-
defined threshold (200,000 - 250,000 cells/ml) give an indication of udder inflammation (Smith, 
Hillerton et al. 2001). From an economical perspective, the consequences of mastitis are not only 
limited to the compromised milk quality (e.g. lower production and inadequate composition) and health 
traits of the animal (lameness, metabolic or reproductive disorders), but also to the lower economic 
value of milk, increased veterinary and labour costs, and an increased need for cow replacement 
(Asaf, Leitner et al. 2014; Ducrocq and Wiggans 2014). 
Because of its substantial economic and animal welfare impact, mastitis was mainly recognized as a 
relevant pathological process for cows and other dairy animals. However, an increasing number of 
researchers from veterinary and human medicine have recently intensified the sharing of their 
knowledge on mammary gland inflammation. This interdisciplinary communication resulted in a major 
added value for the field of mastitis research. Consequently, the now accepted concept is that not only 
ruminants but probably all mammals and certainly also humans suffer from mammary gland 
inflammation (Contreras and Rodriguez 2011). 
I.2. Major versus Minor Mastitis Udder Pathogens  
The movement of leukocytes and serum proteins from the blood to the affected udder can be due to 
amalgam of causes. Indeed, mastitis is a complex disease associated with a variable origin, severity 
and outcome depending on the environment, pathogen or host (Schukken, Gunther et al. 2011; De 
Vliegher, Fox et al. 2012). Mammary gland inflammation can be elicited by infectious (bacteria, 
viruses, mycoplasmas, algae, yeast, …) and non-infectious agents (chemical and physical factors, 
trauma, obstruction lymph vessels, ...). The most common etiological agent of mastitis in dairy cattle 
are bacteria and these will therefore be the main focus of this PhD thesis (Pyorala 2003). 
Mastitis-causing bacteria can be discriminated based on the severity of their induced symptoms 
(Viguier, Arora et al. 2009). Major mastitis pathogens such as Staphylococcus aureus (S. aureus), 
Streptococcus uberis (S. uberis), and the coliforms such as Escherichia coli (E. coli) are usually 
considered more damaging to the udder of dairy cows than minor mastitis pathogens such as 
coagulase-negative staphylococci (CNS) (Reyher, Haine et al. 2012; Watts 1988). In addition to the 
virulence feature, mastitis pathogens can also be categorized based on their epidemiology i.e. as 
being either contagious or environmental. The host is the main source of contagious mastitis 
pathogens and transmission occurs primarily from one dairy cow to another. On the other hand, 
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environmental mastitis pathogens are more likely to be transmitted from the habitat to the dairy cow 
(e.g. bedding in the stable).  
Staphylococcus aureus is a Gram-positive pathogen that can be isolated from quarters of dairy cows 
with either clinical or subclinical mastitis. In Flanders, a Belgian region with about 280,000 dairy cows, 
S. aureus could be isolated in 25% of the infected milk samples that had a composite SCC of 250,000 
cells/ml in three consecutive years (Piepers, De Meulemeester et al. 2007). In addition, S. aureus was 
the most frequently isolated pathogen from quarters that had visible signs of clinical mastitis in a 
nationwide study conducted in Canada (Olde Riekerink, Barkema et al. 2008; Sol, Sampimon et al. 
2000). Besides S. aureus, that is generally recognized as a contagious major pathogen, the coliform 
E. coli is often considered as an environmental major pathogen. In Flanders, E. coli is isolated in about 
15% of the mastitis cases and the likelihood of isolation of this pathogen has been associated with the 
increase in severity of the mastitis symptoms (Verbeke, Piepers et al. 2014). Nevertheless, reports 
have emerged on E. coli isolates that are capable of inducing chronic mastitis due to internalization 
into the mammary epithelial cells (Almeida, Dogan et al. 2011; Döpfer, Barkema et al. 1999). These 
major mastitis pathogens may infect the udder despite the presence of antibacterial mechanisms in 
the milk environment (Barrio, Rainard et al. 2003; Rainard 2003; Benkerroum 2010). It has been 
increasingly reported that a number of mastitis-associated isolates may have actively adapted to thrive 
in milk. For example, mastitis-associated E. coli grown in milk are known to up- and down-regulate 
hundreds of proteins in contrast to the same strains grown in conventional culture media (Lippolis, 
Bayles et al. 2009). This observation indicates that bacteria that cause mastitis have a higher fitness in 
this environment. Fitness of bacteria is defined as the ability of a germ to adjust its metabolism to 
environmental conditions, in order to survive and grow (Laurent, Lelievre et al. 2001). Although proper 
confirmation of this hypothesis is still lacking and thus warrants in-depth research, the term “Mammary 
Pathogenic E. coli (MPEC)” was introduced suggesting distinct E. coli with specific mammary 
pathogenicity and inherent local inflammatory potential (Shpigel, Elazar et al. 2008). Interestingly, 
similar indications are also accumulating for S. aureus mastitis-associated isolates. It is known that the 
mastitis-associated S. aureus-suppressing activity of antibiotics in milk cultures is lower than in broth 
cultures (Louhi, Inkinen et al. 1992). 
A variety of CNS species have been isolated from milk samples of bovine mastitis cases, the most 
commonly being S. chromogenes, S. haemolyticus, S. simulans or S. epidermidis (Capurro, Artursson 
et al. 2009; Piessens, Van Coillie et al. 2011; Taponen, Koort et al. 2007). CNS species can be 
retreived in either milk samples of dairy cows with clinical or subclinical symptoms but, contrary to the 
symptoms inflicted by major mastitis pathogens, CNS mastitis is usually associated with much milder 
symptoms (Jarp 1991). Besides the difference in virulence, the fitness of a CNS species may also 
differ from major mastitis pathogens. The challenge dose of S. chromogenes to experimentally induce 
mastitis in dairy cows has been reported to be 100 to 1000 times higher than those generally used to 
induce S. aureus or E. coli mastitis (Simojoki, H., T. Orro, et al. 2009). Once CNS colonization is 
established in the udder, the infection may either be transient and disappear spontaneously or persist 
in the mammary gland. Studies on CNS species are complicated by the fact that they are abundantly 
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present and are not always implicated in an udder infection. It was demonstrated that S. chromogenes 
may colonize the teat apex pre-partum without being associated with an intramammary infection (De 
Vliegher, Laevens et al., 2003). Furthermore, several CNS species such as S. fleurettii, S. sciuri, and 
S. equorum were retrieved in the environment but rarely in mastitis samples (Piessens, Van Coillie et 
al. 2011). Furthermore, this seemingly contradictory result is probably due to the fact that CNS are 
most commonly referred to as one group of bacterial species, while in reality a high diversity exists 
between species and even between strains or isolates within one species (Thorberg, Danielsson-
Tham et al., 2009). Lastly, it should be remarked that emerging reports also attribute beneficial 
features of CNS isolates which gains increasing interest. CNS isolates may inhibit major mastitis 
pathogens either by competitive exclusion and/or the production of antibacterial substances (Braem, 
Stijlemans et al. 2014). 
The reason why pathogens with low fitness or low virulence features still can induce inflammation in 
the udder of dairy cows is a subject for ongoing research. Interestingly, many minor or major 
pathogens share Microbe-Associated Molecular Patterns (MAMPs) that can each on an individual 
basis induce sterile mastitis. For example, peptidoglycan (PGN) and lipoteichoic acid (LTA) (see 
section II.1 of the general introduction) both elicit an inflammatory response when exposed to 
mammary epithelia. Although MAMPs are present on both CNS and S. aureus mastitis-associated 
isolates, they induce different mastitis symptoms. It is suggested that subtle variations of these 
MAMPs may be responsible for the observed different degrees in pathogenicity. Next to the MAMPs 
that may be similar between minor an major pathogens, some features are restricted to pathogens 
such as invasion in the host tissue, secretion of toxins, etc. and have to be detected by the host 
differently (see section II.3. of the general introduction). Although this latter host response is not yet 
characterized during mastitis, mastitis in the udder will be more complex and could be explained by a 
specific combination rather than a synergy of MAMPs (Shpigel, Elazar et al. 2008). 
I.3. Insights in the Current Curative and Preventive Mastitis Strategies 
For almost 50 years the use of antibiotics against mastitis has been standard practice as dictated by 
the 10-point management program of the National Mastitis Council (NMC_Guidelines 2014). 
Routinely, these antibiotics are infused in the udder rather than parenterally and the panel of 
antimicrobial agents is limited to a few classes (Table 1). The intramammary antibiotics are delivered 
intracisternally through the teat canal and can be given during the dry period as well as in the milking 
period. During the dry period, higher doses can be used than in a milking cow. Furthermore, antibiotics 
remain in the udder for longer during dry cow therapy as a lot of antibiotic is lost at each milking with 
lactating cow therapy. At last, dry cow therapy uses long lasting antimicrobial compounds (Gruet, 
Maincent et al. 2001). In the UK, the use of intramammary administered antibiotics was about 0.95 
g/infected dairy cow in 2013 (Pyorala, Taponen et al. 2014). The intensive use of antibiotics is 
predominantly due to their activity against subclinical mastitis pathogens (such as S. aureus), while it 
sometimes has limited benefits in shortening the duration of a clinical mastitis infection (typically 
caused by E. coli). Hence, if recovery is not really expected from treatment with antibiotics it rather is 
from anti-inflammatory drugs (Hogan and Larry Smith 2003).  
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Such use of antibiotics may lead to antibiotic resistance in bacterial isolates of mastitis cases. A 
Canada-wide study has determined that the prevalence of antibiotic resistance in bovine mastitis 
pathogens isolated from milk samples is low (Saini, McClure et al. 2012). Nevertheless, multi-
resistance strains (e.g. livestock-associated multi-resistant S. aureus) have started to emerge in 
mastitic udders and may cause significant problems for the human health (Vanderhaeghen, Cerpentier 
et al. 2010; Vanderhaeghen, Hermans et al. 2010). Moreover, the prevalence of antibiotic-resistant 
mastitis-associated isolates may peak after selective culling or segregation of persistent infected cows 
from the herd. This can be explained as follows: major mastitis pathogens have more severe 
symptoms compared to the mild CNS-induced mastitis. Elimination of the animals suffering from a 
major mastitis pathogen such as S. aureus due to culling, may positively select for animals with minor 
pathogens such as CNS (Barlow 2011). Consequently, CNS species that inherently contain a 
antimicrobial resistance panel far exceeding the one of S. aureus mastitis isolates, will become the 
main infectious species in that herd (Frey, Rodriguez et al. 2013; Owens and Watts 1988; Piessens, 
De Vliegher et al. 2012; Pyorala and Taponen 2009). 
Complementary to curative antibiotic treatment, increasing efforts have been done to develop 
vaccines for mastitis over the recent years. These vaccines can systemically be administered during 
the prepartus and aim to enhance the cows’ immunologic resistance to mastitis-causing bacteria. The 
main commercially available vaccines against E. coli-induced mastitis are J-5 Bacterin (Zoetis), 
Endovac-Bovi (IMMVAC) and J Vac (Merial). J-5 based vaccines (J-5 and J Vac) contain an 
inactivated mutant strain of E. coli 0111:B4 strain while Endovac-Bovi contains a killed re-17 mutant 
Salmonella typhimurium (Talbot and Lacasse 2005). The former bacterins induce a non-specific 
immune response in the host and claim reduction in severity of symptoms, LPS opsonisation and 
enhanced bacterial clearance (Dosogne, Vangroenweghe et al. 2002). Two commercial vaccines are 
on the market against S. aureus. While Lysingin (Boehringer Ingelheim Vetmedica) contains lysates of 
different S. aureus strains, Startvac (Hipra) contains a mixture of inactivated E. coli J5 strain and the 
S. aureus SP 140 strain expressing a Slime Associated Antigenic Complex. However, field trials or 
experimental challenge carried out with Lysigin in adult cows showed only limited effectiveness in 
reducing infection duration and severity (Camussone, Veaute et al. 2014). Startvac efficacy was 
estimated in two herds and was associated with a moderate reduction in incidence and duration of 
new S. aureus and CNS infections (Schukken, Bronzo et al. 2014). Next to the antibacterial effect, the 
vaccine was suggested to reduce the severe inflammatory reaction after inoculation compared to non-
vaccinated dairy cows (Deberdt, Piepers et al. 2012). 
Despite the development of various vaccines, few have claimed satisfactory outcomes. The 
development for anti-mastitis vaccines seems much more difficult compared to anti-viral vaccines. It is 
suggested that the immunogenic antigens of mastitis pathogens are capsular polysaccharides that can 
vary between strains (Talbot & Lacasse 2005). As such, it is preferable to consider multiple pathogens 
at once and the host-associated inflammatory response they induce (Tiwari, Babra et al. 2013).   
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Table 1: Antimicrobial agents commonly used as curative therapy for bovine mastitis. 
Mechanism of action Antibiotic Antibiotic class 
DNA gyrase 
  
 
Novobiocin aminocoumarins 
dihydropteroate synthetase 
  
 
Sulfamethoxazole sulfonamide 
 
Trimethoprim/sulfatrimethoprim sulfonamide 
30S subunit of the ribosome 
  
 
Gentamicin aminoglycoside 
 
Neomycin aminoglycoside 
 
Streptomycin aminoglycoside 
 
Oxytetracycline tetracycline 
 
Tetracycline tetracycline 
50S subunit of the ribosome 
  
 
Chloramphenicol amphenicol 
 
Florfenicol amphenicol 
 
Clindamycin lincosamide 
 
Erythromycin macrolide 
 
Lincomycin lincosamide 
 
Pirlimycin lincosamide 
 
Spiramycin macrolide 
 
Tylosin macrolide 
beta-lactamase 
  
 
Amoxicillin aminopenicillin 
 
Ampicillin aminopenicillin 
 
Cefalexin cephalosporin (1
th
 gen) 
 
Cefalonium cephalosporin (1
th
 gen) 
 Cefapirin cephalosporin (1
th
 gen) 
 Cefazolin cephalosporin (1
th
 gen) 
 Cefquinome cephalosporin (4
th
 gen) 
 Ceftiofur cephalosporin (3
th
 gen) 
 Cefuroxime cephalosporin (2
th
 gen) 
 
Cephalothin cephalosporin (1
th
 gen) 
 
Cephaparin cephalosporin (1
th
 gen) 
 
Cloxacillin aminopenicillin 
 
Hetacillin aminopenicillin 
 
Oxacillin aminopenicillin 
peptidoglican synthesis 
  
 
Vancomycin glycopeptide 
topoisomerase ligase inhibitor 
  
 
Enrofloxacin fluoroquinolone 
Table adapted from (Guerin-Faublee, Carret et al. 2003; Sawant, Sordillo et al. 2005; Marshall and 
Levy 2011; Ruegg 2012) 
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Although it is hypothesized that the extreme heterogeneity of pathogens that are able to induce 
mastitis limit the efficacy of a single-bacterin-based vaccine in the field, alternative strategies to protect 
the udder against severe mastitis have been proposed that exploit the richness of bovine-associated 
bacterial isolates to circumvent severe clinical mastitis (Lohuis, Kremer et al. 1990). These kind of 
protective strategies are based on recurrent infections of the dairy cows’ udder. Experimental and 
observational studies involve the inoculation of the dairy cow with minor or major pathogens or utilize 
natural infection prior to an infection with major pathogens. It is suggested that colonization of the first 
infectious agent prevents the colonization and virulence of the second infection (Suojala, Orro et al. 
2008). Furthermore, it is proposed that the colonization of the first infectious agent not only has an 
effect on the local macrophages, but also on the epithelia cells in the udder. This would subsequently 
result in a change of the immune response towards the second infectious agent that enters the udder 
(Gunther, Petzl et al. 2012; Petzl, Gunther et al. 2012). Ideally, the first infectious agent would be an 
commensal or minor mastitis pathogen that could circumvent the infection of a major mastitis 
pathogen (Rainard and Poutrel 1988). In that respect, CNS species have been suggested as 
colonizing agent as they exhibit a wide range of different bacterial species that contain properties such 
as milk promoting factors, production of anti-bacterial molecules and mild virulence (Piepers, Opsomer 
et al. 2010; Piessens, De Vliegher et al. 2012; Vanderhaeghen, Piepers et al. 2014). 
Overall, this research area is characterized by an intense debate due to the high diversity of results 
among studies (especially between experimental and observatory studies) and the relatively low 
number of reports. The difficulty to study this subject has been suggested to be due to confounding 
dairy cow factors such as breed, season of calving, age, and stage of lactation but also herd-level 
factors such as overall microbiome in the herd or the environment (Reyher, Haine et al. 2012).  
 
II. HOST INNATE IMMUNE SIGNALING OF INTEREST FOR MASTITIS 
 
BACKGROUND: THE UNIQUE AND COMPLEX IMMUNOBIOLOGY OF THE MAMMARY GLAND 
 
Milk is an unique liquid with a dual role in nourishment and in immunological protection of the newborn 
(Ward and German 2004). Based on phylogenetic tree data, scientists discovered the mammary gland 
as an organ that has evolved from antimicrobial glands into milk-producing entities (Fig.1). Many milk 
nutrients are now considered as an evolutionary bypass of these original antimicrobial molecules. To 
illustrate this remarkable modification the documented transition of lysozyme into α-lactalbumin is a 
nice example. Whereas α-lactalbumin is a prototypical mammalian protein that enables lactose 
production in the mammary gland, lysozyme is an anti-bacterial peptide producing enzyme that dates 
back already to non-vertebrate species. Despite their functional differences, both proteins share a 
40% amino acid identity and have a nearly identical three-dimensional structure (Irwin, Biegel et al. 
2011). Moreover, xanthine oxido-reductase (XOR) is crucial for the formation and secretion of milk fat 
from the lactating epithelium. It has an antimicrobial function through the production of both Reactive 
Oxygen Species (ROS) and Reactive Nitrogen species (RNS). The remnants of the innate immune 
system in the mammary gland are not only restricted to lysozyme and XOR but are also represented 
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by a vast array of antibacterial proteins of lactoperoxidase, lactoferrins and beta-defensins (Huang, 
Morimoto et al. 2012), oligosaccharides (Moon, Kim et al. 2007), fatty acids (Batovska, Todorova et al. 
2009), mucins (Sando, Pearson et al. 2009) and secreted milk antibodies such as Immunoglobulins 
(Igs) (Boumahrou, Chevaleyre et al. 2012). 
 
Figure 1: Initially, the mammalian skin enhanced its surface and produced mucus as protection 
against infectious diseases. This mucosal skin gland evolved into a mammary gland organ 
with an additional nutritional function beside its more ancient innate immune function. The 
relics from its innate immune history are still inherently present in Xanthine OxidoReductase 
(XOR) and Lysozyme. Adapted from (Vorbach, Capecchi et al. 2006). 
Complementary to this large group of secreted molecules, the immunobiology of the mammary gland 
also contains an extensive cellular component that aids the host to fight intramammary infections. In 
general, the prevailing leukocyte populations of a healthy mammary gland sensing infectious bacteria 
consist of both innate and acquired immune cells i.e. macrophages and lymphocytes, respectively. 
During mammary gland infection, macrophages function as Antigen-Presenting Cells (APC) but also 
act as professional phagocytes against invading microorganisms. They trigger the innate immune 
response through prostaglandin-, leukotriene- and cytokine-mediated signaling (Elazar, Gonen et al. 
2010). Moreover, these macrophage-derived chemokines partly guide polymorphonuclear leucocytes 
(PMN) from blood into the infected udder, which either nullify or at least weaken bouts of microbial 
agents (Sordillo and Streicher 2002). This is supported by the possibility of inducing mammary 
inflammation with a major cell wall component derived from Gram-negative bacteria, i.e. 
lipopolysaccharide (LPS). In the latter sterile mastitis model, macrophages were shown to be the key 
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cell type responsible for efficient neutrophil infiltration (Elazar, Gonen et al. 2010). Upon an 
inflammatory insult, phagocytic macrophages also neutralize leukocytes including neutrophils, dead 
cells and cellular debris that form a potential pro-inflammatory threat. In contrast to live cells, dead 
cells generally expose extracellular phosphatidylserine, efficiently recognized as an “eat me” signal to 
phagocytize cellular remains (Schwertfeger, Rosen et al. 2006). Through this elegant strategy, dead 
immune cells decompose safely, a crucial process supporting homeostasis.  
Lymphocytes are organized in Lymph Nodes (LN) and are part of an elaborate lymphatic system (Van 
den Broeck, Derore et al. 2006). T-lymphocytes become activated in these mammary-associated LNs 
by antigens captured either by mammary dendrocytes, by macrophages or by B-lymphocytes or other 
resident APCs. In contrast to other mammals, dairy cow udders do not have mammary LN but are 
drained by retro-mammary LNs and contain a Furstenberg’s Rosette where lymphocytes are 
numerous. Moreover, bovine lymphocytes are predominantly cytotoxic T-cells (CD8
+
) compared to a 
lower number of T-helper cells (CD4
+
). Both these subtypes are released in different ratios in milk 
depending on the lactational stage (Taylor, Dellinger et al. 1994; Asai, Kai et al. 1998). Overall, 
lymphocytes have important implications for all mammals in the mammary defense against exogenous 
agents (Denis, Lacy-Hulbert et al. 2011), protection of the milk-fed offspring (Sabbaj, Ibegbu et al. 
2012) and also in breast cancer metastasis (Tan, Zhang et al. 2011). The number of lymphocytes 
increases following bacterial infection of the mammary gland (Cao, Jing et al. 2012). Interaction with 
antigens such as S. aureus enterotoxins induces T-lymphocyte activation, immunosuppression (i.e. 
decreased T-cell proliferation) or influences cell viability (Park, Fox et al. 1993; Webb and Gascoigne 
1994; Slama, Sladek et al. 2009). Activated T-lymphocytes secrete a specific panel of pro-
inflammatory cytokines aiding the efficient clearance of bacteria (Persson Waller, Colditz et al. 2003; 
Riollet, Mutuel et al. 2006). This potential makes them key players in chronic mammary gland 
infections and therefore suggests innovative prevention perspectives in the context of staphylococcal 
mastitis vaccination (Wallemacq, Bedoret et al. 2012). 
The most prominent cell type in the mammary gland is the epithelial cell which is perceived as an 
imminent part of the mammary gland innate immune system (Monks, Rosner et al. 2005). As the 
mammary gland regresses very fast during its involution post-weaning, a scary accumulation of dead 
cells occurs in the lumen. These might expose their intracellular compounds and thus imply an 
inflammatory danger (Monks, Smith-Steinhart et al. 2008). Mammary epithelial cells can act as (non-
professional) phagocytes and engulf either partly damaged or already dead cells to resolve or prevent 
such undesired inflammatory conditions. Although less efficient in this elimination function than the two 
professional leukocytes (macrophages and neutrophils), they again utilize specific receptors such as 
the phosphatidylserine receptor, CD36, vitronectin receptor, CD91 to scavenge the vast lumen for 
damaged cells. Upon the detection hereof, they respond by excreting anti-inflammatory mediators like 
Transforming Growth Factor (TGF)-β1, while reducing the amount of pro-inflammatory mediators like 
Tumor Necrosis Factor (TNF)-α and IL-8/CXCL8 thus bridging the critical time frame before massive 
influx of both the innate immune cells (Monks, Rosner et al. 2005). Mammary epithelial cells should 
undoubtedly be considered as non-professional immune cells as they express Pathogen Recognition 
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Receptors (PRRs) embedded in their membrane, which enable them not only to sense exogenous 
bacterial ligands but moreover to react against this threat as an essential part of the innate immunity 
(Gunther, Koczan et al. 2009). 
In healthy functional mammary glands, other leukocytes besides the predominating macrophages and 
lymphocytes are only present in low amount (e.g. neutrophils, natural killer-cells, dendritic cells, 
eosinophils, basophils, B-lymphocytes). Nevertheless, they rapidly become the principal innate 
immune cell type found in the inflamed udder and in its secretions. The numerical values of immune 
cells in bovine milk have been reported by differentiating the SCC in normal cows and in mastitis 
cases (Schwarz, Diesterbeck et al. 2011). Indeed, the non-speciﬁc innate immune cells called 
neutrophils are initially recruited to the site of infection. This recruitment is a result of a cocktail of 
inﬂammatory mediators which are orchestrated by the activated PRR-expressing cells (described in 
detail in Section II.1). Furthermore, stimulated local endothelial cells become fenestrated so that blood 
neutrophils leak in the infected mammary tissue further guided by the latter chemoattractants. Once 
directly exposed to pathogens, neutrophils also use the process of phagocytosis now complemented 
by bactericidal means (both oxygen-dependent as mediated by the respiratory burst involving ROS 
and RNS and oxygen-independent via small antibacterial molecules like cathepsins and calpains) to 
eliminate the bacterial hazard as rapidly as possible (Paape, Mehrzad et al. 2002). 
II.1. Toll-like Receptors, Pathogen Recognition Receptors for the Host Innate Immunity 
The resident innate defense system has evolutionary roots and comprises the unique anatomy of the 
gland (e.g. the teat canal with its keratin plug) as well as an extensive humoral and cellular component 
to protect the host against mastitis pathogens such as E. coli or S. aureus (Craven 1985). To prevent 
their excessive activation, these defense systems have to be appropriately controlled both in time and 
space. For this purpose, antigens expressed by pathogens are distinguished from host factors by 
PRRs (Fig. 2). The main PRR expressed by mammary cells to recognize bacteria are Toll-Like 
Receptors (TLRs). These receptors are evolutionary conserved protecting even invertebrates from 
pathogenic assaults. The specificity of a certain TLR is determined by the MAMP it recognizes. For 
example, TLR2 recognizes LTA of Gram-positive bacteria, TLR4 recognizes LPS from Gram-negative 
bacteria and TLR5 interacts with bacterial flagellin (Rainard and Riollet 2006). Furthermore, PGN is 
expressed by both Gram-negative and -positive bacteria and is suggested to bind bovine TLR2 
although this is a matter of debate (Girardin, Travassos et al. 2003; Farhat, Sauter et al. 2008). 
Remark that each of these MAMPs does not bind a fully designated TLR, but that rather binding is 
possible to several TLRs (Yang, Mark et al. 1998; Takeuchi, Hoshino et al. 2000). Furthermore, the 
formation of lipid rafts within clathrin-coated pits is required for the endocytosis of stimulators and their 
subsequent intracellular signal transduction. Consequently, blockage of these lipid rafts inhibits the 
TLR response by the mammary epithelium (Kim, Im et al. 2011). 
The intensity with which a mammary resident cell type reacts to a MAMP is typically coordinated by its 
co-receptors. A well-known example is that of CD14, a receptor with a soluble (sCD14) and a 
membrane bound (mCD14) isoform (Zanoni and Granucci 2013). LPS is recognized by its LPS-
binding protein (LBP) and these LPS/LBP complexes interact with (s or m)CD14 to trigger TLR4 
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(Oviedo-Boyso, Valdez-Alarcon et al. 2007). Cell types bearing mCD14 in the vicinity of their TLR4, 
such as macrophages or neutrophils, have an advantage over cell types lacking mCD14 and relying 
on less easy accessible sCD14 such as endothelial or epithelial cells (Frey, Miller et al. 1992; Sohn, 
Paape et al. 2004). Moreover, CD14 expression is not restricted to Gram-negative bacteria because it 
also recognizes PGN (Rainard and Riollet 2006).  
 
 
Figure 2: Pathogen Recognition Receptors (PRR) of interest for bacterial induced mastitis in 
dairy cows. Toll-like receptors (TLR) recognize extracellular MAMPs while Nod-Like Receptors 
(NLR) recognize intracellular MAMPs. Agonists of TLRs are LipoTeichoic Acid (LTA), 
Lipopolysaccharide (LPS) and Flagellin. Agonists of NLRs are PeptidoGlycaN constituents 
gamma-D-glutamyl-meso-diaminopimelic acid (iE-DAP), N-acetylmuramyl-L-alanyl-g-D-
glutamyl-meso-diaminopimelic acid (mur-TriDAP) and MuramylDiPeptide (MDP). Made with 
software from www.proteinlounge.com. 
In the context of this PhD thesis, the focus lies on the TLRs as main PRR during the host innate 
immune response. However this host defense process is so crucial that important “back-up” PRRs 
exist with overall signaling pathways that appear partially redundant. Furthermore, MAMPs are not 
only detected extracellularly. There are also intracellular PRRs such as Absent In Melanoma 2 (AIM2) 
and NOD-like receptors (NLR) (Takeuchi and Akira 2010). For instance, microbial DNA can be 
detected by the extracellular part of the TLR9 but the intracellular receptor HIN200 can also bind this 
MAMP. Reports on this other group of PRRs are scarce in the context of mastitis, but nevertheless 
have already been stated as important (Bercot, Kannengiesser et al. 2009). More specifically, 
Muramyl DiPeptide (MDP) and LTA are both essential constituents of the cell wall of S. aureus. When 
these MAMPs are injected in bovine udders, they synergistically and selectively increase several local 
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chemoattractants and recruit neutrophils. A comparable neutrophil influx ensues when LTA triggers 
TLR2 signaling or when MDP triggers NOD2, but the cooperation of both receptors raises a synergetic 
response (Bougarn, Cunha et al. 2010). Based on other infection models, these intracellular PRRs are 
not just characterized as back-up PRRs but seem important to sense intracellular bacteria and toxins. 
This property is suggested to discriminate between commensal and invasive pathogens (Franchi, 
Kamada et al. 2012). Next to their function to mediate the antimicrobial defense, the presence of these 
PRRs and downstream effectors have recently also been implicated in the homeostasis of gut 
microbiota. NLR-deficient mice may develop a dysregulation of the gut flora (dysbiosis) and make 
them more susceptible to persistent pathogenic infections (Gagliani, Palm et al. 2014).  
II.2. NF-kappaB, a Transcription Factor for Pro- and Anti-Inflammatory Signaling 
Interaction between MAMPs and PRRs of either professional or non-professional innate immune cells 
initiates signaling pathways. These eventually lead to the production of cytokines and other 
endogenous mediators, which are essential in the host protection against pathogens. The nuclear de 
novo production of cytokines occurs through Transcription Factors (TFs) activated downstream of 
PRRs (Fig. 3).  
Most of the inflammatory proteins involved in neutrophil influx and activation have been shown to 
contain kappaB sites within their promoter (Pahl 1999). The latter are necessary for the Nuclear 
Factor-kappaB (NF-kappaB) TF to bind, activate and transcribe the accommodating gene. NF-kappaB 
is the best described TF in mastitis, mammary gland development, the lactation cycle and even 
mammary tumorigenesis (Safieh-Garabedian, Mouneimne et al. 2004; Notebaert, Duchateau et al. 
2005; Lerebours, Vacher et al. 2008; Notebaert, Carlsen et al. 2008; Connelly, Barham et al. 2010; 
Demeyere, Remijsen et al. 2013; Matusik, Jin et al. 2014). As a plethora of genes can be induced by a 
handful of TFs such as NF-kappaB, strict regulatory systems are hence required. 
Interference of the TF to bind its promoter can be effectuated on many levels. First, the TF can be 
prevented to translocate to the nucleus by influencing several upstream mediators in a post-
translational way. Indeed, NF-kappaB is a dimer comprising 5 TFs that have to coordinate an 
adequate inflammatory response i.e. RelA/p65, RelB, c-Rel, p50, and p52. The variable composition 
of the NF-kappaB dimer induces a differential gene expression. Furthermore, two subunits (i.e. p50 
and p52) are expressed as p105 and p100 protein precursors, respectively, that contain ankyrin 
repeats which need to be post-translationally cleaved and unlike the former 3 TFs (RelA/p65, RelB, c-
Rel) have no transcriptional activation domain. All NF-kappaB subunits contain a highly conserved Rel 
Homology Domain (RHD) necessary to bind DNA, other subunits and the Inhibitor of NF-kappaB 
(IkappaB). Through the RHD binding of these IkappaB subunits, NF-kappaB can be kept inactive in 
the cytoplasm. Only when a stimulus such as a complexed TLR triggers the canonical pathway the 
IkappaB Kinase (IKK) complex can phosphorylate IkappaBalpha. This phosphorylation induces 
ubiqitination and subsequent degradation of the IkappaB in turn releasing NFkappaB for translocation 
to the nucleus (Bradford and Baldwin 2014).  
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Secondly, a TF can be hindered to bind its promoter. NF-kappaB activity can be regulated at the 
promotor-site either by the local presence of modulating TFs or by the chromatin density. NF-kappaB 
co-operates with other factors to fine-tune the expression of genes such as IL-8 and a beta-defensin 
upon TLR triggering of bovine mammary epithelial cells (Liu, Shi et al. 2011). IL-8 is very fastly and 
transiently expressed while beta-defensin is slowly upregulated. The kinetics of this enhancement 
occur simultaneously with a fast DNA binding activity of the CAAT Box Enhancer Binding Proteins 
(C/EBP) TF concomitant with a slower and more steady NF-kappaB activity. Remarkably, both IL-8 
and the beta-defensin have a composite promotor (Liu, Shi et al. 2011). On the other hand, the beta-
defensin /EBPbeta a.k.a. NF-IL-6, a member of the TF C/EBP, interacts with the NF-kappaB subunit 
RelA/p65 (Zwergal, Quirling et al. 2006) and is induced by RelA/p65 but inhibited by C/EBPbeta. IL-8 
is inhibited with increasing NF-kappaB activity while increased with C/EBPbeta activity. Furthermore, 
chromatin accessibility is also important for NF-kappaB transcription (Liu, Shi et al. 2011).  
Other inflammatory signaling of key importance to mastitis is the induction by PRRs of two additional 
TFs i.e.Activator Protein-1 (AP-1) and Interferon Regulatory Factor (IRF). These are also known to 
induce cytokine and chemokine production with both inflammatory and microbicidal properties. 
Although MyD88-dependent NF-kappaB signaling is generally accepted, MAPK signaling (AP-1), 
cAMP response element-binding protein (CREB) and IRF3 are only occasionally suggested for E. coli 
and S. aureus mastitis (Kim, Im et al. 2011; Wang, Song et al. 2014). Clearly, some signaling induced 
by these different TFs is redundant, but marked differences also exist. NF-kappaB is proven to be 
important for internalization of S. aureus bacteria in epithelial cells (Wei, Fu et al. 2014). In contrast, 
although activated, inhibition of MAPK kinases does not change the internalization of the latter 
(Oviedo-Boyso, Barriga-Rivera et al. 2008). 
At last, different TFs and resulting cytokines can also be indirectly activated by PRR. For example, the 
InterLeukin (IL)-receptor can bind MyD88 and thus activate both NF-kappaB and MAPK pathways to 
induce antimicrobial defensins (Froy 2005). This latter strategy is suggested for cells that require 
activation by a secondary signal different from but related to either the initial infection, or redundant 
systems or additional stimuli next to the MAMPs. This can be demonstrated by supplementing IL-
1beta or TNF-alpha to a S. aureus inoculum resulting in a synergetic internalization of the bacterium in 
bovine cells by additional NF-kappaB activation of the cytokines compared to that of the MAMPs alone 
(Oviedo-Boyso, Barriga-Rivera et al. 2008). 
II.3. Caspases, Mediators of Inflammation and Cell Death  
Inflammatory mediators, such as cytokines and chemokines sometimes need additional regulation to 
perform their activity. A well-known example is the pro-inflammatory cytokine IL-1beta (Fig. 3). 
Following bacterial infection, PRRs in bovine epithelial cells get triggered, internalized and express the 
proIL-1beta gene through activation of multiple TFs such as NF-kappa, AP-1 and CRE (Kim, Im et al. 
2011). Despite its fast transcription, IL-1beta is not always detected in milk post-exposure to a mastitis 
pathogen (Bougarn, Cunha et al. 2010).  
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Transcription of the IL-1beta gene results in an inactive 31kDa proform that needs processing into an 
active form detectable by the IL-1Receptor (IL-1R). Following infection with mastitis-associated E. coli 
or S. aureus isolates, transcripts of IL-1beta are enhanced in mammary epithelial cells and protein 
levels are detected in milk of infected cows. Remarkably, the kinetics of this increase in milk differ 
between E. coli and S. aureus (Bannerman, Paape et al. 2004; Lahouassa, Moussay et al. 2007). 
Based on other models, IL-1beta is hypothesized to be a product of the inflammasome (Thacker, Balin 
et al. 2012). Inflammasomes are intracellular multiproteins that mediate activation of inflammatory 
cysteine-aspartic proteases (caspases) -1. This latter protein is a zymogen (procaspase) that contains 
a large prodomain to recruit caspase-1 into an activating complexes such as the inflammasome. 
Following this recruitment the inactivating prodomain is released through autocleavage. Different 
inflammasomes exist depending on the cytosolic Damage-Associated Molecular Pattern molecules 
(DAMPs) and MAMPs they detect and their name reflects the receptor bound. Furthermore, these 
receptors can either directly or indirectly bind procaspases-1 the latter through an adaptor protein such 
as Apoptosis-associated SpeCk-like protein (ASC) (Lamkanfi and Dixit 2012).This canonical pathway 
activates caspase-1 and IL-1beta as well as IL-18 but not IL-1 alpha, nevertheless this inflammasome 
activity is important for the secretion of all these proteins. A redundant system is caspase-11 which 
can also induce the release of IL-1beta/IL-18 through non-canonical inflammasomes (Vanden Berghe, 
Demon et al. 2014). Indeed, functional caspase-11 activates caspase-1 in the absence of NLR NLrp3 
or ASC, thus also activating IL-18. Moreover, the latter pathway has unique features as IL-1alpha 
release in vivo is fully dependent on caspase-11 activity (Vigano and Mortellaro 2013).  
Both caspase 1 and -11 do not only influence the production and secretion of cytokines, they also 
induce an unique cell death program called pyroptosis which is already suggested in infected bovine 
neutrophils (Demeyere, Remijsen et al. 2013). Clearly, PRR signaling is not merely related to 
inflammation. Indeed, it has been shown in mice that TLR4 triggering reduces the milk secreting 
epithelium and inhibits the nuclear localization of phosphorylated STAT5 which is important for the 
production of milk proteins (Glynn, Hutchinson et al. 2014). Furthermore, this shrinking of the 
mammary epithelial cell number is associated with shedding of the alveolar epithelial cells into the 
lumen. This process happens cleanly without disrupting the blood milk barrier or distorting the tight 
junctions (Kobayashi, Oyama et al. 2013). The increase in mammary epithelial cell death seen during 
E. coli and S. aureus mastitis is believed to be an enhanced involution that is accompanied by high 
levels of pro-apoptotic caspases such as caspase-3 (Wesson, Deringer et al. 2000; Long, Capuco et 
al. 2001). Similar to inflammatory caspases, these pro-apoptotic caspases are assembled in a 
multiprotein complex (apoptosome) with adaptor proteins (apaf together with cyt c and ATP) inducing 
(auto)cleavage of the involving procaspases (Bao and Shi 2007). 
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Figure 3: Hypothetic scheme of pathogen dependent processing of proIL-1beta in resident 
mammary cells (e.g. epithelia, macrophages, …) . Membrane bound Pathogen Recognition 
Receptors (PRRs) get triggered and induce pro-IL-1beta production through several 
transcription factors (NF-kappaB, CREB or AP-1). Intracellular PRRs also get triggered and 
cleave pro-caspase-1 in the inflammasome. As a resulting caspase-1 may cleave pro-IL-1beta 
into IL-1beta. E. coli and S. aureus are believed to trigger different PRRs and to induce different 
transcription factors that result in different IL-1beta levels in the milk. Made with software from 
www.proteinlounge.com.  
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III. MOUSE MODELS CONTRIBUTE TO NOVEL INSIGHT IN MASTITIS 
 
To study the molecular mechanism of bovine mastitis and improve therapies, several experimental 
infection models have been developed. In vitro models typically characterize mastitis-associated 
bacterial isolates (i.e. their MIC, biofilm production, antibiotic resistance genes; Section I) and/or their 
interaction with host cells. Inflammatory signaling data obtained from such model studies using either 
mammary epithelial cell lines or isolated udder/blood cells exposed to mastitis-associated bacteria or 
MAMPs are of great value for elucidating the pathogenesis of bovine mastitis. Although these models 
are of high interest to the field, in the context of this PhD thesis the focus will be mainly on the in vivo 
mouse model while in vitro models are only briefly mentioned.  
III.1. Mastitis Models 
Dairy cows have been genetically selected for their unique linked or pleiotropic traits to achieve high 
production efficiency. However, the heritability of these features brings along a negative energy 
balance as body reserves are in a major part being used for milk anabolism. Moreover they affect 
other highly energy-dependent anabolism, more specifically also the animals’ immunity (Rauw, Kanis 
et al. 1998). Generally, it is well recognized that a high milk yield and suboptimal management 
predisposes dairy cows to mastitis by impairing their defense system (Sordillo and Streicher 2002). 
The unique milk composition, the high milk production and the immune system of the cow (Werling, 
Jungi 2003) and the possible bacterial adaptation to the milk environment of the udder (see Section 
I.2) imply that confirmatory mastitis studies should always be performed within the target-animal 
species. Nevertheless, such experiments are severely limited with respect to research tools and 
infrastructure, and are also very expensive and labour-intensive. As a result, more specific culture 
models and in vivo mouse models have been developed to tackle these major drawbacks of in vivo 
bovine studies. These in vitro models culture isolated primary udder cells but are still hampered by 
both the limited number of cell types that can be studied to interact within a single set-up and their lack 
of dynamism. Indeed, the constant change of cells that influence one another during an inflammation 
process in the udder cannot be addressed by any in vitro approach. Therefore, preclinical in vivo 
models which mimic ruminant udder infections with mastitis-associated bacteria isolated from field 
cases are increasingly used. Unlike in vitro models the latter do include a dynamic multicellular system 
yet in another genetic background. As mice are homologous to other mammals, the murine mammary 
gland inflammation data can at least partly be extrapolated to cows as well as to breastfeeding 
women. Nevertheless, some aspects of both the overall physiology and the specific traits of udders or 
breasts differ from those of murine mammary glands. Therefore, care should be taken when 
attempting to extrapolate results from the mouse to other mammals. Several examples illustrate that 
the pathogenicity of some inflammatory agents and the acquired host response can be species-
dependent (Andersen-Nissen, Smith et al. 2007; Werling, Jann et al. 2009). Although differences may 
be present, this will be less the case for the innate immunity aspects of the mammary gland biology, 
which are quite conserved between mammals. Another argument in favour of the mouse mastitis 
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model is that the use of laboratory Specific-Pathogen-Free (SPF) mice facilitates mastitis experiments 
and allows to downsizing of the number of animals required to achieve a statistically conclusive result. 
This is mainly due to the fact that these strains have the same genotype and are easily housed and/or 
managed. Last but not least, mouse models are extensively investigated for a whole array of 
predominantly human diseases. The use of mice opens up a wide panel of sampling, immunological 
reagents and research tools that are either very difficult or even impossible to perform in cows.  
III.2. Experimental Bacterial Infection of the Murine Mammary Gland 
To more conveniently address the molecular biology of mastitis focusing on key innate signaling 
pathways in the mammary gland, experimental mouse models were first developed and characterized 
already in the 1970s (Chandler 1969; Chandler 1970; Chandler 1970; Chandler 1971). Cow udders 
and mice mammary glands both manifest glands in the inguinal region. In mice, the fourth inguinal 
gland pair is the biggest and therefore preferred one for suckling by the pups. The litter is nursed by 
the mother for about 10 to 14 days. During this lactation period the mammary gland is fully functional 
and can expand to about seven-fold its original volume. Consequently, the teat canal ducts become 
easily accessible for experimental infection (Notebaert and Meyer 2006). 
III.2.1. Inoculation Methods of Mastitis-Associated Bacteria in the Murine Mammary Gland 
There are several methods to mimic bovine mastitis in lactating mice with bovine mastitis isolates. The 
introduction method - as well as the choice of mastitis-associated pathogen - greatly influences the 
elicited inflammation process in these models.  
The first method consists of simply dropping a pathogen-dense inoculum on top of the nipple, enabling 
bacteria to descend through the duct orifice into the mammary gland. With this non-invasive 
procedure, that probably best reflects the natural infection route, the number of bacteria infecting the 
gland is however not controllable. Inter-animal differences are consequently very high. Therefore, 
other techniques were developed that focused on introducing the concentrated bacterial load directly 
into the teat orifice. For this purpose researchers tried to optimize the pipetting of the bacterial 
suspension into the ducts through the use of smaller tips, illumination fibers, microscopes and micro-
manipulators. 
This second method was successfully achieved when small volumes were reproducibly introduced 
with the help of pediatric blunted needles (> 30 Gauge). The point of entry can optionally be enlarged 
by an additional minimal cut in the nipple top. The needle is then positioned at an angle of about 180 
degrees and can thus enter the primary duct fluently when performed by an experienced researcher 
(Fig. 4 A). The released volume spreads through the accessible lactating lobules as visualized by 
Chinese ink administration or even more elegantly with in vivo imaging of luminescent bacteria (Fig. 4 
B-C) and subsequently interacts with the hosts’ tissue. The latter intraductal (or intramammary) 
injection technique is superior to the first strategy as the infection rate is about 100% when the 
mammary glands are fully lactating and thus have become easily accessible. When the inoculum is 
administered correctly, the Colony-Forming Units (CFU) can be as low as 10 CFU/injection and still 
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induce mastitis. Nevertheless, higher inocula have the advantage of lower inter-animal variation. It 
should be remarked that the induction implicates a low-grade induction of inflammation. Therefore, 
sham-inoculated mammary glands should always be included in these experiments (Barham, Sherrill 
et al. 2012).  
The intraductal injection model has been successfully used with different mastitis-associated bacteria 
including E. coli, S. aureus and S. uberis, but still needs to be validated for others such as bovine CNS 
(Sordillo and Nickerson 1986; Tuchscherr, Buzzola et al. 2005; Gonen, Vallon-Eberhard et al. 2007). 
Furthermore, mammary gland inflammation can alternatively be induced by intramammary injection of 
multiple exogenous factors in mice. These intramammary introduced compounds vary from antibiotics, 
host factors (such as cytokines) to MAMPs (e.g. toxins and wall fragments) which all aided in 
unraveling the molecular pathways involved in the complex disease mechanism of mastitis (Brouillette, 
Grondin et al. 2004; Cao, Fu et al. 2014; Elazar, Gonen et al. 2010). A major added value is that these 
findings can be confirmed or elaborated by the use of genetically modified mice.  
Figure 4: Experimental induction of mastitis pathogens in the murine mammary gland. Mastitis 
isolates or bacterial toxins can be intraductally introduced in anesthetized lactating mice by 
means of a blunted pediatric needle to induce an inflammatory reaction in the murine 
mammary gland simulating bovine mastitis (A). The inoculum injected in the mammary gland 
remains local, as visualized with Chinese ink in both glands of the fourth pair (B). 
Bioluminescent E. coli bacteria injected in the right mammary gland of the fourth pair can be 
tracked through in vivo imaging and remain local in a time-lapse of 24h (C). 
III.2.2. Applications of Murine Models to Study the Molecular Biology of Mastitis 
III.2.2.1. Mouse Mastitis Models Corroborate in vitro MIC Data 
Non-transgenic or line bred wild Type (wT) mice are used to study the pathogenesis of bovine mastitis. 
This more simple approach has been most valuable either to improve current treatments or to test 
novel molecular targets for innovative treatment strategies. As described in section I., antimicrobial 
treatment is frequently used as therapeutic strategy for mastitis in dairy cows. Antimicrobial testing of 
putative active substances is primarily screened in vitro by Minimum Inhibitory Concentration (MIC) 
determination. This general microbiological technique has been applied in the mastitis field by 
exposing mastitis-associated isolates to a library of compounds. As such, the MIC defines the lowest 
concentration of an antimicrobial substance that kills or inhibits any visible growth of a selected bovine 
mastitis-associated isolate. These dilution-based (culture) methods reveal the susceptibility of mastitis-
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associated pathogens to candidate antibiotic molecules, which is an important first step that will aid to 
select an optimal therapy. 
Over the past decades this curative strategy along with other measures such as proper management 
has succeeded to significantly decrease the prevalence and incidence of udder infections and has 
also positively affected animal health and milk productivity (Piepers, De Meulemeester et al. 2007). 
Nevertheless, in recent years, both pathogen adaptation to the udder and the observation that the 
current antibiotics are selecting for minor pathogens (e.g. CNS) has resulted in an urgent need to 
improve the treatment of mastitis. Although MIC research certainly provides valuable data, the 
Effective Dose (ED) of an antibiotic substance can differ from the MIC value and influences the clinical 
outcome. The optimal drug concentration in vitro differs from that in vivo due to several factors 
including the dosing regimen, the host-pathogen inflammatory interaction and species-differences. 
Therefore, mouse mastitis models are valuable as an intermediate step because they can extend the 
MIC data of potential antibiotic treatments before going into clinical trials with experimentally-infected 
cows (Brouillette, Grondin et al. 2004; Brouillette, Grondin et al. 2005). These preclinical models 
provide a platform that mimics the pathogen properties such as the exponential growth of bacteria in a 
very dense mammary gland compartment and the expression of bacterial toxins, in addition to host-
related factors such as multicellular interactions, infiltration of (innate) inflammatory cells and milk 
antibacterial factors. In these in vivo set-ups the selected live pathogens are inoculated through the 
teat canal in the mammary gland and another intramammary injection – now with an antibiotic agent - 
is subsequently performed. The use of mice has the advantage that different conditions can be 
compared on a statistically relevant scale in one experiment. The efficacy of one compound can be 
validated by a dose-response control. The lower the concentration of the candidate antibiotic agent, 
the better it performs compared to a reference test compound taken along in the set-up (positive 
control).  
III.2.2.2. Mouse Mastitis Models Corroborate the Importance of MAMP Detection and 
Induced Inflammatory Signaling 
The mouse mastitis model demonstrated that an increased MAMP detection can improve bacterial 
clearance (see Section II). Locally administered sCD14 sensitizes the mammary epithelium for an 
upcoming bacterial hazard and enhanced alertness for future infections (Wang, Zarlenga et al. 2002). 
Upon a intramammary E. coli infection, the host scavenger receptor pretreatment lowered local TNF-α 
levels and lowered mammary bacterial growth compared to the non-sCD14 pretreated controls (Lee, 
Paape et al. 2003). Of relevance, this marked preclinical effect was extrapolated to dairy cows where 
an udder injection of E. coli with sCD14 elicited lower TNF-α and IL-8 levels concomitant with a 
decline of the bacterial growth rate due to a faster neutrophil influx (Lee, Paape et al. 2003). In 
analogy with this innovative sCD14 treatment, other novel therapies focusing on the host immunity 
rather than on antibacterial substances are now rapidly emerging and first evaluated with the 
preclinical mastitis models. 
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An innovative application to boost the host immune system with MAMPs was achieved by engineering 
a fusion protein attaching the streptococcal endolysin endopeptidase domain to the staphylococcal cell 
wall binding domain from the staphylococcal phage K endolysin. This newly bioengineered molecule 
was injected in the mammary gland mice post-infection with S. aureus mastitis. It was able to 
significantly reduce the mammary CFU load and this effect was enhanced when co-injected with 
bacterial lysostaphin (Schmelcher, Powell et al. 2012). Cyclic diguanylate (c-di-GMP) is also a 
bacterial molecule, but which is used as a preventive therapy instead of a curative one. Intramammary 
injection of c-di-GMP 12h and 6h prior to S. aureus reduced the CFU post-infection (Brouillette, Hyodo 
et al. 2005). Furthermore, a preventive treatment to induce easier recognition of an intramammary 
infection with S. aureus by the host has been attempted with other S. aureus MAMPs such as 
fibrinogen and collagen binding proteins. This experiment resulted in a reduction of bacterial growth 
post-infection with fibrinogen binding proteins but not with the collagen binding proteins (Mamo, Boden 
et al. 1994; Mamo, Jonsson et al. 1994; Hu, Gong et al. 2010).  
Instead of injecting just the MAMPs in mice, live bacteria can also be altered to identify MAMPs 
essential for host recognition by PRRs. Mastitis-associated S. aureus isolates have been pre-
incubated with sera from previously vaccinated mice and subsequently injected in the mammary gland 
of mice. At first, mice were injected with the DNA plasmid expressing the virulence/Clumping factor A 
(ClfA) that led to a raise of specific antibody in blood. These antibodies opsonized the circulating 
pathogens released from blood and aided the mouse to clear the bacteria from the mammary gland 
post-infection (Brouillette, Lacasse et al. 2002) When bacterial ClfA Knock-Out (KO) mutants were 
tested in the mouse model, only a delayed infection was seen, implicating that ClfA is not such a 
crucial MAMP of S. aureus after all (Brouillette, Talbot et al. 2003). Moreover, Sortase A (SrtA), 
mutants of S. aureus were made and this affected the attachment of S. aureus to host cells, thus 
attenuating the activation of the NF-kappaB and MAPK signaling pathways (Chen, Liu et al. 2014). 
Next to improved host detection of mastitis inducing bacteria, preventive therapies interfering with 
downstream signaling were also attempted with line bred mice by an increasing number of research 
groups (Chen, Mo et al. 2013; Li, Liang et al. 2013; Boulanger, Brouillette et al. 2007). One of these 
reported an anti-inflammatory compound such as helenalin, acting as an NF-kappaB inhibitor which 
upon intraperitoneal (i.p.) injection reduces mammary S. aureus proliferation and leukocyte infiltration 
in the mammary glands S. aureus inoculation (Boulanger, Brouillette et al. 2007). Other NF-kappaB 
inhibitors that are believed to signal through either Myd88-dependent (Liver X receptor -alpha agonists 
Leonurine, Kaempferol, Alpinetin, Curcumin, Astragalin) or -independent signaling (Glycyrrhizin) were 
shown to reduce the symptoms of LPS-mastitis (Chen, Mo et al. 2013; Li, Liang et al. 2013; Cao, Fu et 
al. 2014; Fu, Gao et al. 2014; Fu, Tian et al. 2014; Fu, Zhou et al. 2014; Song, Wang et al. 2014). 
Similarly, an i.p. injection of Salidroside, Emodin, Magnolol or oxymatrin were suggested to reduce 
next to NF-kappaB also MAPK signaling during LPS-induced mammary inflammation (Li, Fu et al. 
2013; Li, Zhang et al. 2013; Wei, Dejie et al. 2014; Yang, Yin et al. 2014). Another molecule cyanidin-
3-O-beta-glucoside is even believed to inhibit IRF3 activation post-inducing LPS stimulation (Fu, Wei 
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et al. 2014). Furthermore, Selenium deficiency in the food of the mice has been proven to exacerbate 
LPS-mastitis (Wei, Yao et al. 2014).  
III.2.2.3. Transgenic Mouse Models Identify Key Host Factors in the Pathogenesis of Bovine 
Mastitis 
The ultimate goal of mastitis research combines economical with animal health issues. In essence, a 
dairy cow that requires a low amount of dry matter intake to produce a high amount of good quality 
milk and is protected against pathogenic udder infections. Historical breeding programs that rely on 
population genetics have led to distinct beef and dairy cattle, where the latter became specialized in 
high milk yield which compromised their immunity. In contrast, current breeding programs are 
selecting for cows that are more resistant to mastitis. Unfortunately, these latter programs are limited 
by the genes or gene combinations that already reside in the cattle pool (Rainard 2005). Therefore, 
implementation of other genes into cows may provide protection against mastitis. One report 
described the production of lysostaphin in the milk of transgenic cow. Lysostaphin is a staphylolytic 
enzyme secreted by Staphylococcus simulans. Due to the expression of the antibacterial resistance 
gene in the udder, S. aureus was hindered to infect, colonize or grow in the milk of these cows (Wall, 
Powell et al. 2005). Notably, the development of the transgenic cow was based on previous findings in 
mice (Kerr, Plaut et al. 2001).  
Despite the fact that this approach is very valuable, it still remains controversial with regard to public 
acceptance. Consequently, genetically modified cows have not yet been created to study specific 
inflammatory pathways during mastitis. Rather, these innovative approaches have lingered on the 
production of complex human biomolecules such as lactoferrin, α-lactalbumin and lysozyme (van 
Berkel, Welling et al. 2002; Wang, Yang et al. 2008; Yang, Wang et al. 2011; Wu, Ouyang et al. 2012). 
In marked contrast, transgenic mouse models have been employed for decades to study a vast 
number of pathologies. The contribution of a selected gene can be verified either through the lack, or 
the adaptable expression, or the overexpression, or the presence of an additional gene in that host. 
Mastitis research has greatly benefited from the use of different genetically mouse models as 
summarized in Table 2. 
In section II, it was described how bacteria are sensed by host receptors enabling production and/or 
activation of cytokines to guide an elaborate local innate immune response. As such, TLR KO mice 
were tested following intramammary mastitis-associated pathogen exposure (De Schepper, De 
Ketelaere et al. 2008). The use of TLR4 KO mice demonstrated that E. coli triggers more than one 
PRR, while LPS inflicted a neutrophil influx by mere needs of TLR4-expression on the residing 
macrophages (Gonen, Vallon-Eberhard et al. 2007). The latter group elegantly demonstrated this by 
intraductal injection of either a bovine mastitis E. coli isolate or LPS in TLR4 C57BL/6 KO mice with or 
without macrophage transfer from wT C57BL/6 mice. Partly corroborating this pioneer study, a recent 
paper suggested that LPS signaling is not fully TLR4-dependent albeit using another mouse strain 
(Glynn, Hutchinson et al. 2014). Furthermore other PRR such as TLR2 that could be of essence for 
recognizing E. coli were also verified by the latter group. TLR2 KO similarly abrogated Pam3CSK4-
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induced inflammation of the mammary gland. The latter molecule is a synthetic analogue of the 
triacylated lipoproteins present on the cell membrane of Gram-negative bacteria as MAMPs (Fig. 2). 
Interestingly, the KO of TLR2 could not prevent E. coli-induced mastitis. In marked contrast to the 
TLR4 signaling pathway, the TLR2 signaling pathway was found to be macrophage-independent but 
could nevertheless also restrict bacteria from invading the mammary tissue (Mintz, Mintz et al. 2013).
Overall, stimulation of several TLRs clearly results in a proper influx of neutrophils in the infected 
udder during bovine mastitis. The neutrophil diapedesis process has been suggested to be the result 
the induction of different cytokines and chemokines such as TNF-α (primordially resulting from a 
macrophage-dependent response), IL-1 (primordially resulting from a neutrophil- dependent 
response), CXCL8/IL-8 (with 3 chemokines i.e. CXCL1/KC, CXCL5-6/LIX and CXCL2/MIP-2 being the 
orthologues in mice (Hol, Wilhelmsen et al. 2010), and inducible nitric oxide synthase (iNOS). 
Noteworthy, little is known about their individual contribution to the overall inflammatory network. 
Therefore, each contribution has been investigated with proper TNF-α KO, IL-1R KO, IL-8R KO or 
iNOS KO mice, respectively (Elazar, Gonen et al. 2010). With these KO animals it was shown that 
cytokine signaling can influence the influx of neutrophils during LPS- or E. coli- induced mastitis and 
that different cell types (macrophages, mammary epithelia and neutrophils) are involved in the 
production or response of these cytokines. However, a complete map of the complex interplay 
between the different cytokines and their receptors is still lacking. 
The corresponding genes of these key cytokines and chemokines are regulated by TFs such as NF-
kappaB. Already one decade ago, NF-kappaB has been shown by other Belgian researchers as well 
as by our research group to be activated in milk cells derived from mastitic cows (Boulanger, Bureau 
et al. 2003), respectively to inhibit cell death in isolated bovine blood neutrophils (Notebaert, 
Duchateau et al. 2005). By means of transgenic mice as an elegant tool, NF-kappaB activity was also 
at first monitored in vivo by our group. When live E. coli were injected, a transient activation signal was 
observed in these transgenic mice (Notebaert, Carlsen et al. 2008). In a later study, LPS was shown 
to induce cell death pathways and milk loss after local inoculation. The inflamed mammary glands 
were again concomitant with – albeit after a faster onset – transient NF-kappaB activity (Connelly, 
Barham et al. 2010).  
Next to transgenic mice that have an altered the innate immune response (PRR, TF and cytokines), 
mice have also been used to study antibacterial genes and their effect against bacterial mastitis. As 
previously mentioned in this Section, lysostaphin Knock-In (KI) mice had an improved clearance of a 
mammary S. aureus infection compared to non-transgenic mice and the concept could be 
extrapolated to cow. Another immuno-modulating host factor that holds promise is L-amino Acid 
Oxidase (LAO). LAO is an antibacterial enzyme present in mouse milk during the first 10 days of 
lactation. Its antibacterial function is considered to occur through the production of H2O2 by oxidative 
processing of milk L-amino acids. One research group generated LAO KO mice and introduced S. 
aureus mastitis pathogens in the mammary gland of these genetically modified animal strain. It 
resulted in a far higher susceptibility compared to the non-transgenic mice of the same animal strain 
(Nagaoka, Aoki et al. 2009). 
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AIMS OF THE THESIS 
Virulence is one of a number of possible outcomes of the host‐microbe interaction. Unfortunately, the 
specific host responses against different bovine mastitis isolates are not yet fully characterized. 
Previous research from our group focused on the host innate immune response induced by a bovine 
mastitis-associated E. coli isolate. Experimental infection studies were performed with a validated 
mouse mastitis model. The current PhD research aims to elaborate the immune response induced by 
bovine-associated bacterial isolates with this elegant in vivo model. Unravelling differential 
pathogenesis may aid to assess essential inflammatory signaling that needs to be triggered in the host 
to prevent new infections of the mammary gland. Complementary to preventive treatment, mastitis can 
also be treated curatively with antibiotics. However, the prediction of the efficacy of novel antibiotics 
for mastitis may also be influenced by host-related factors which are challenging to simulate under in 
vitro conditions. A laboratory animal mastitis model can implement these factors and thus aid to 
evaluate in vivo candidate antimicrobial compounds with high in vitro efficacy. 
 
 
 
The specific objectives of this thesis were: 
 
 
 
 To explore the differential inflammatory signaling induced by bovine-associated 
bacterial isolates in the mouse mastitis model (Chapter I). Chapter I.1 compares the 
local innate immune response induced by two major mastitis pathogens i.e. E. coli versus 
S. aureus focusing on the processing of IL-1beta. Chapter I.2 validates the mouse mastitis 
model for the first time with a CNS strain isolated from a chronically infected dairy cow 
and then compares the host response induced by three different CNS isolates with that of 
S. aureus. 
 
 To examine whether pretreatment of the murine mammary gland with LPS, a MAMP of E. 
coli, can elicit a beneficial local inflammatory signaling as a basis for a novel preventive 
strategy against S. aureus-induced mastitis (Chapter II). 
 
 To evaluate the efficacy of antimicrobial compounds as a curative strategy for bacterial-
induced mastitis in the mouse mastitis model (Chapter III). Chapter III.1 wants to evaluate 
a series of existing antibiotics from the first generation of cephalosporins, while Chapter 
III.2 assessed a novel candidate from the biphenomycin class against three bovine 
mastitis pathogens. 
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The entrance of a pathogen into the cows' udder results in an inflammatory response called mastitis. 
Key indicators for a mastitic cow are the presence of the microbe in combination with the increase in 
SCC in the milk. The latter are leucocytes, primarily neutrophils. As previously shown by our group, E. 
coli-infected bovine neutrophils activate NF-kappaB, cytokine production, caspases and cell death 
(Notebaert, Duchateau et al. 2005; Demeyere, Remijsen et al. 2013), which could also be 
demonstrated in the mouse model (Notebaert, Carlsen et al. 2008; Notebaert, Demon et al. 2008). For 
S. aureus, a major Gram-positive mastitis pathogen, the information covering all these inflammatory 
parameters is scarce. Therefore, the first aim of CHAPTER I was to assess the involvement of NF-
kappaB activity, cytokine profiling, the presence of caspases and neutrophil influx for S. aureus 
mastitis. Furthermore, we compared these observations with E. coli mastitis and determined whether 
the inflammation is pathogen-dependent.  
CNS have been isolated from the teat apex of lactating dairy cows without symptoms of mastitis 
(Braem, Stijlemans et al. 2014) as well as from milk samples inducing a mild inflammatory response 
(Pyorala and Taponen 2009). Nevertheless, little is known about the CNS and their interaction with the 
host. Therefore, the second aim of CHAPTER I was to assess whether the mouse mastitis model can 
be used as a complementary in vivo tool for future CNS mastitis research and whether a differential 
host innate immune response can be observed between epidemiologically different bovine CNS 
species/strains. 
 
 
  
CHAPTER 
I 
MICROBE-DEPENDENT INFLAMMATORY SIGNALING 
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First aim of CHAPTER I is adapted from: Breyne K., Cool S.K., Demon D., Demeyere K., 
Vandenberghe T., Vandenabeele P., Carlsen H., Van Den Broeck W., Sanders N.N., Meyer E., 
Non-Classical proIL-1beta Activation during Mammary Gland Infection is Pathogen-Dependent 
but Caspase-1 Independent, PLoS One. (2014) 9:e105680. 
 
Second aim of CHAPTER I is adapted from: Breyne, K., S. De Vliegher, A. De Visscher, S. Piepers, 
and E. Meyer. 2015. Technical note: A pilot study using a mouse mastitis model to study 
differences between bovine associated coagulase-negative staphylococci. J Dairy Sci 
98(2):1090-1100. 
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EXPERIMENTAL STUDIES 
I.1. Non-Classical ProIL-1beta Processing during Mammary Gland Infection is Pathogen-
Dependent but Caspase-1 Independent 
I.1.1. Abstract 
Infection of the mammary gland with live bacteria elicits a pathogen-specific host inflammatory 
response. To study these host-pathogen interactions mammary glands of wild type mice, NF-kappaB 
reporter C57BL/6 mice as well as caspase-1/11 and IL-1beta knockout C57BL/6 mice were challenged 
with Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). The murine mastitis model 
allowed to compare the kinetics of the induced cytokine protein profiles and their underlying pathways. 
In vivo and ex vivo imaging showed that E. coli rapidly induced NF-kappaB inflammatory signaling 
concomitant with high mammary levels of TNF-alpha, IL-1 alpha and MCP-1 as determined by 
multiplex analysis. In contrast, an equal number of S. aureus bacteria induced a low NF-kappaB 
activity concomitant with high mammary levels of the classical IL-1beta fragment. These quantitative 
and qualitative differences in local inflammatory mediators resulted in an earlier neutrophil influx and in 
a more extensive epithelial remodeling post-infection with E. coli compared to S. aureus. Western blot 
analysis revealed that the inactive proIL-1beta precursor was processed into pathogen-specific IL-
1beta fragmentation patterns as confirmed with IL-1beta knockout C57BL/6 animals. Additionally, 
caspase-1 knockout animals allowed to investigate whether IL-1beta fragmentation depended on the 
conventional inflammasome pathway. The lack of caspase-1 did not prevent extensive proIL-1beta 
fragmentation by either of S. aureus or E. coli. These non-classical IL-1beta patterns were likely 
caused by different proteases and suggest a sentinel function of IL-1beta during mammary gland 
infection. Thus, a key signaling nodule can be defined in the differential host innate immune defense 
upon E. coli versus S. aureus mammary gland infection, which is independent of caspase-1. 
I.1.2. Introduction 
Infectious mastitis is defined as the inflammatory response initiated when microorganisms enter the 
mammary gland challenging the host defense (Kebaier, Chamberland et al. 2012). This common 
disease has either clinical or asymptomatic (subclinical) characteristics and is generally perceived as a 
significant burden for the well-being of mammals and especially dairy animals (Barkema, Green et al. 
2009). Two main bacterial species that cause bovine mastitis are Escherichia coli (E. coli) and 
Staphylococcus aureus (S. aureus) (Schukken, Gunther et al. 2011). Although both these pathogens 
grow in the mammary gland evoking a host immune response, they activate specific inflammatory 
signaling pathways which result in discriminatory stress profiles (Riollet, Rainard et al. 2000; 
Bannerman, Paape et al. 2004; Farhat, Sauter et al. 2008). This distinctive pathobiology can be 
explained by the microbe-associated molecular patterns (MAMPs) dictating the expression and 
subsequent release of specific pro-inflammatory cytokines (Brand, Hartmann et al. 2011; Jensen, 
Gunther et al. 2013). In the initial phase, these mediators orchestrate the diapedesis of predominantly 
neutrophils into the mammary alveoli activating phagocytic innate immune cells to eliminate pathogens 
or at least prevent their spreading (Bougarn, Cunha et al. 2010; Elazar, Gonen et al. 2010; Stevens, 
De Spiegeleer et al. 2012). Most of the observations seen in cows have been further elaborated at the 
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molecular level through in vivo studies in mouse mastitis models (Gonen, Vallon-Eberhard et al. 2007; 
Elazar, Gonen et al. 2010). 
Our group previously reported that in vitro exposure of bovine neutrophils to live E. coli rapidly 
activates a complex series of molecular pathways involving cell death, the cleaving of the protease 
procaspase-1 and the transcription factor nuclear factor-kappaB (NF-kappaB). This activity occurs 
concomitant with the secretion of the pro-inflammatory cytokine IL-1beta (Notebaert, Duchateau et al. 
2005; Demeyere, Remijsen et al. 2013). Two studies from our group using intramammary infections 
(IMI) in mice confirmed the relevance of these key parameters in vivo (Notebaert, Carlsen et al. 2008; 
Notebaert, Demon et al. 2008). However, elucidation of the link between these innate mammary host 
defense factors and their relevance for other mastitis pathogens than coliforms is just starting to 
emerge. It was already demonstrated for the bovine species that both E. coli and S. aureus bind 
mammary epithelial Toll-like receptor (TLR)4 and TLR2, but that both these pathogens differently 
modulate NF-kappaB (Yang, Zerbe et al. 2008). Indeed, E. coli increases mammary epithelial NF-
kappaB activity through myD88-dependent signaling followed by enhanced mRNA cytokine 
expressions (Yang, Zerbe et al. 2008). In contrast, mammary S. aureus infections are characterized by 
reduced local NF-kappaB levels. These observations are linked to the internalization of these bacteria 
in bovine epithelial cells (Lara-Zárate, López-Meza et al. 2011). To date, NF-kappaB transcriptional 
activity is accepted to induce proIL-1beta transcription and the subsequent release of pro-
inflammatory cytokines either locally and/or systemically. Nevertheless, reported mastitis data are still 
partly contradictory as they on the one hand state that active IL-1beta predominates upon infection 
with S. aureus compared to E. coli, while adverse data have also been published (Persson-Waller, 
Colditz et al. 1997; Gunther, Esch et al. 2011). Additionally, it was recently shown that total IL-1 
signaling is of critical importance for the proper influx of neutrophils into the alveolar lumen following 
an infection with E. coli (Elazar, Gonen et al. 2010). Overall, little is known about the source of proIL-
1beta or about its maturation process during mastitis. In a variety of other infectious pathologies, the 
production of this inactive pro-form is mediated by NF-kappaB, while its biological activity is regulated 
by a cytoplasmic multi-protein complex named the inflammasome. The inflammasome binds 
procaspase-1 and enables its activation; in turn the latter protease activity mediates the maturation of 
proIL-1beta (Lamkanfi and Dixit 2012). 
The current in vivo study aims to further elucidate the main mechanistic differences or similarities 
between mammary S. aureus or E. coli infections as a basis for novel intervention strategies. Key 
findings highlight the non-classical maturation of proIL-1beta independently of caspase-1 during 
mammary inflammation. The resulting cleavage patterns were pathogen-specific and occurred 
concomitant with important steps in the innate immune response of the mammary gland such as the 
NF-kappaB activation, the expression of specific cytokine profiles, the influx of neutrophils and 
changes in the integrity of the epithelial layer.  
 
 
57 
 
EXPERIMENTAL STUDIES 
I.1.3. Materials and Methods 
I.1.3.1. Mice 
Female albino NF-kappaB luc C57BL/6 mice were kindly provided by Harald Carlsen (University of 
Oslo, Department of Nutrition, Institute of Basic Medical Sciences) (Carlsen, Moskaug et al. 2002). 
Genetically these mice are heterozygous for the NF-kappaB luc transgene in a Tyr Knock-out (KO) 
C57BL/6 background and thus easier to visualize for in vivo imaging purposes than C57BL/6 animals. 
Caspase-1/Caspase-11 double KO C57BL/6 and IL-1beta KO C57BL/6 mice were kindly provided by 
Tom Vandenberghe. (Ghent University, Molecular Signaling and Cell Death Unit, Department for 
Molecular Biomedical Research, VIB). The latter were compared with wild type (wT) C57BL/6 mice 
provided by Harlan. All mice were conventionally housed with water and food supplied ad libitum, and 
maintained with a 12 hours (h) light/dark cycle. Sentinels were routinely screened to verify the 
pathogen-free conditions. This study was carried out in strict accordance with the recommendations in 
the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol 
was approved by the Committee on the Ethics of Animal Experiments of the Ghent University (Permit 
Number: EC2011/042 and EC2010/148). All efforts were made to minimize suffering. Surgery was 
performed under isoflurane anesthesia combined with a long-acting analgesic buprenorphine, while a 
ketamine and xylazine containing cocktail was administered prior to euthanasia.  
I.1.3.2. Intramammary infection model 
Eight-week-old mice (wT or transgenic C57BL/6 mice) were allowed to mate with a ten-week-old male. 
Following parturition, the pups were weaned only after ±10 days to enhance mammary gland 
development. One hour after weaning, mice were inoculated using a 32-gauge blunt needle (fourth 
gland pair) with 3.20 x 10
3 
± 374.6 CFU S. aureus Newbould 305 or E. coli P4:032, or PBS under 
inhalational anesthesia. These bacteria are relevant bovine mastitis isolates inducing a specific 
inflammatory response in our established mouse mastitis model (Notebaert, Carlsen et al. 2008; 
Demon, Ludwig et al. 2012).  
During the Intramammary Infection (IMI) experiment, core body temperature of the mice was 
measured with a rectal thermistor and compared to the body temperature pre-IMI. Blood was 
harvested through the tail vain or cardiac puncture, incubated for 1h at 37°C and centrifuged (12250 g) 
for another 1h. Following sacrifice (cervical dislocation) the inoculated glands (and untreated livers) 
were isolated, homogenized and plated in serial logarithmic dilutions on Tryptic soy agar plates to 
determine CFU/g gland. Supernatant/serum samples were stored individually at −80°C until use. 
I.1.3.3. In vivo and ex vivo bioimaging 
Imaging of luciferase activity in intramammary injected transgenic mice was performed with the IVIS 
lumina II (Caliper) (Cool, Breyne et al. 2013). To visualize the NF-kappaB signal a suspension of D-
luciferin (2mg/100μl) dissolved in PBS was injected. NF-kappaB luc C57BL/6 mice were pre-
anesthetized by isoflurane, injected right and left of the abdomen with luciferin, and imaged about 10 
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minutes following injection. Briefly, bioluminescence is visualized when NF- kappaB gets activated, 
translocates to the nucleus where it binds the kappaB sites and transcribes the luciferase gene. As a 
result the injected luciferin is oxidized by the newly produced luciferase together with ATP, which 
yields a bioluminescent light signal. The transgenic mice were measured before (at -2h) and kinetically 
after IMI (at 2h, 4h, 8h, 10h, 12h and 24h). At 12h (n = 11) and 24h (n = 32) mice were sacrificed, 
organs harvested and separately visualized through imaging. The intensity of the bioluminescent 
signal is linked with the level of NF-kappaB activity and normalized through the division of the total flux 
data by the selected area as provided by the living image software 3.2 (Caliper). 
I.1.3.4. Cytokine analysis 
Hundred microliters of mammary gland homogenate were mixed with 200 μl lysis buffer supplemented 
with protease inhibitors (200 mM NaCl, 10 mM Tris-HCl pH 7.4, 5 mM EDTA, 1% Nonidet P-40, 10% 
glycerol, 1 mM oxidized L-glutathion, 100 μM PMSF, 2.1 μM leupeptin and 0.15 μM aprotinin) to 
extract cellular proteins. The suspensions rested overnight at -20°C, were centrifuged (12.250 g) for 
1h and finally the supernatant was centrifuged for another 30 minutes (min) to precipitating the pellet. 
The protein concentration in the supernatant was spectrophotometrically (Genesys 10S) determined 
with Bio-Rad Protein Assay (Biorad). Cytokine quantification in the lysates and serum was performed 
with specific Cytometric Bead Array kits (CBA, Becton Dickinson) for mouse IL-1beta, IL-6, MCP-1, 
TNF-alpha, and IL-1alpha and specific Aimplex multiplex assay kits (YSL Bioprocess Development 
Co.) with minor modifications for mouse KC and MIP-2 on a FACSArray instrument (Becton 
Dickinson). Fifty μg lysate or ¼ diluted serum were applied to each well.  
I.1.3.5. Immunohistochemistry 
Two mammary glands per condition (isolated from the NF-kappaB luc mice) were fixed in buffered 
3.5% formaldehyde for 24h at room temperature and embedded in paraffin wax. Sections were 
deparaffinized, hydrated, and antigens retrieved in a citrate buffer through microwaves and cooker 
pressure for p50 and p65, respectively. To mask endogenous peroxidase activity, specimens were 
pre-treated with 3% hydrogen peroxide in methanol for 5 min at room temperature. Non-specific 
binding sites were blocked by 30% goat serum and 1% BSA for 30 min at 25°C. The tissues were 
incubated overnight at 4°C with p65 (rabbit anti mouse, sc-372, Santa Cruz) and p50/p105 (rabbit anti-
mouse, ab7971, Abcam). The next day, samples were incubated with a biotinylated secondary 
antibody (goat anti-rabbit) that binds streptavidin conjugated to horseradish peroxidase (HRP). A 3,3'-
Diaminobenzidine chromogen generates a brownish peroxidase-based signal visualized through the 
HRP reaction together with a hematoxylin counterstain. All rinsing steps were performed with Tris-
buffered saline (TBS) supplied with Triton-X 100. 
I.1.3.6. Western analysis 
Mammary gland lysates (prepared as described sub cytokine analysis) were loaded in equal volumes 
(18 μg protein/20 μl buffer), proteins were separated on a 12% polyacrylamide Amersham ECL Gel 
(GE Healthcare) and the proteins transferred to a 0.45 μm nitrocellulose transfer membrane (Biorad). 
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A donkey anti-goat IgG (Bioconnect) was used to detect IL-1beta (R&D) and donkey anti-rabbit IgG 
(GE Healthcare) was used to detect caspase-1 (kindly provided by Wim Declercq). 
I.1.3.7. Statistical analysis 
P-values of normal distributed data were calculated by ANOVA testing. Depending on the Levene’s 
test, mean values were compared by Tukey post hoc comparisons. If necessary, normalization 
occurred through log10 transformation and if normalization was impossible, median values were 
compared with non-parametic statistics and Mann-withney U post hoc-testing. 
I.1.4. Results 
I.1.4.1. The intramammary bacterial growth post-intramammary infection with S. aureus and 
E. coli 
Sham-inoculated (PBS) C57BL/6 mice (n = 9; data not shown) were compared to C57BL/6 mice 
inoculated with (3.203 ± 0.38) x 10
3
 CFU of either E. coli (n = 12) or S. aureus (n = 12). Both at 12h 
and 24h post-IMI, mammary glands were isolated and their CFU count was determined (Fig. 1). There 
was no statistically significant median difference (MD) between both treatment groups at the two time 
points of sacrifice. Nevertheless, significant intramammary growth of each of both pathogens was 
detected between these time points (E. coli, P < 0.001; S. aureus, P < 0.01). 
 
 
Figure 1. Changes in mammary bacterial counts post-IMI with E. coli or S. aureus. At 12h and 
24h post-IMI, mammary tissue was harvested and evaluated for bacterial growth. Results are 
presented as mean ± standard deviation (P < 0.01 **, P < 0.001***).  
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I.1.4.2. Mammary cytokine profiles post-intramammary infection with E. coli compared to S. 
aureus 
Differential cytokine patterns were observed in the mammary gland post-IMI with E. coli versus S. 
aureus at 12h or 24h (n = 10 for all groups).  
At the local level, E. coli dominated the innate immune response on both time points by a strong and 
continuing increase of TNF-alpha (at 12h, P < 0.001; at 24h, P < 0.001), IL-1alpha (at 12h, P < 0.001; 
at 24h, P = 0.001) and MCP-1 albeit only at the later time point (at 12h, P = 0.051; at 24h, P = 0.001) 
compared to S. aureus (Fig. 2A). Concentrations of these cytokines in all untreated lactating glands (at 
0h, n = 6) and sham-inoculated glands (PBS, n = 8 at 12h and at 24h) at 12h and 24h remained below 
the detection limit (DL). Absolute MCP-1 levels were up to 8-fold higher than those of TNF-alpha and 
IL-1alpha. The increase of TNF-alpha and IL-1alpha was similar when comparing E. coli to S. aureus 
(R
2
 = 0.81; P < 0.001) i.e. about 3-fold higher for E. coli compared to S. aureus, while this relative 
difference between both pathogens was about 2-fold for MCP- 1 (Fig. 2A). An IMI with both pathogens 
induced a strong and continuing local increase in IL-6 (Fig. 2B). 
In marked contrast to TNF-alpha, IL-1alpha and MCP-1, this response did not significantly differ 
between the E. coli and S. aureus but did significantly differ for each pathogen compared to the sham-
inoculated (PBS) glands (at 12h, P < 0.001; at 24h, P < 0.001) and lactating glands (at 0h, P < 0.001).  
Post- IMI with S. aureus, a strong response albeit only at a later time point was observed for IL-1beta. 
At 12h post-IMI local levels were low and did not differ significantly between both pathogens, while at 
24h post-IMI S. aureus strongly induced high local levels of this cytokine compared to E. coli (P < 
0.001) (Fig. 2C). Concentrations of IL-1beta in the untreated lactating glands (at 0h) and sham-
inoculated glands (at 12h and 24h) remained below the DL (detection limit). Pathogen-specific profiles 
in serum or liver samples were also detected and are discussed in the supporting information section 
(see Fig S1A and S1B). 
I.1.4.3. Maturation of proIL-1beta and procaspase-1 post-intramammary infection with E. coli 
compared to S. aureus 
The observed quantitative differences in cytokines do not necessarily imply biological activity of these 
proteins as for several cytokines this is the result of post-translational modification of their proforms. 
More specifically, activation of proIL-1beta is achieved by cytoplasmic multi-protein complexes named 
inflammasomes. The best known inflammasome enables procaspase-1 (p45) maturation upon vita-
MAMP recognition. This active caspase-1 then mediates the maturation of active IL-1beta as 
characterized by its classical p17 fragment (Lamkanfi and Dixit 2012).  
Based on multiplex results the local active IL-1beta concentration at 24h was higher post-IMI with S. 
aureus than with E. coli (Fig. 2C). This quantitative analysis measures the number of active p17 
fragment. The absence of mammary IL-1beta in IL-1beta KO C57BL/6 animals was confirmed at both 
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time points through multiplex analysis, no significant differences in the local levels of other cytokines 
could be detected either (data not shown). However, using Western blot analysis as a complementary 
immunoassay, the complete fragmentation pattern of mammary proIL-1beta was evaluated post-IMI 
with E. coli compared to S. aureus (Fig. 3A and B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Differential mammary innate immune response post-IMI with E. coli versus S. aureus. 
(A) Local TNF-alpha, IL-1alpha, and MCP-1 concentrations in lactating mammary glands 
compared to mammary glands post-IMI with E. coli, S. aureus or sham-inoculated (PBS). (B) 
Local IL-6 concentrations in lactating mammary glands compared to mammary glands post-IMI 
with E. coli or S. aureus or sham-inoculated (PBS) mice. (C) Local concentrations of active IL-
1beta in lactating mammary glands compared to mammary glands post-IMI with E. coli, S. 
aureus or sham-inoculated (PBS) mice. Results are presented as mean ± standard deviation. 
Letters of homogeneous subsets were marked if the difference between treatments were 
statistically significant (P < 0.001) (DL = detection limit). 
Multiplex analysis showed that an IMI in C57BL/6 mice with E. coli induced the fast but transient 
increase of active IL-1beta (p17) compared to sham-inoculated (PBS) mammary glands (at 12h, P < 
0.001; at 24h, P < 0.001) (Fig. 2C). Western blotting of these samples revealed that this increase of 
p17 the result of a fast proIL-1beta (p31 band, fragment 1) maturation into multiple fragments which 
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were absent post-inoculation with PBS. Indeed, at 12h post-IMI a complex pattern of at least six IL-
1beta fragments were detected concomitant with procaspase fragmentation i.e. at ± 30 kDa, ± 25 kDa, 
± 20 kDa, ± 17 kDa, ± 15 kDa and ± 10 kDa (fragments 1, 2, 3, p17, 4 and 5, respectively; Fig. 3A). In 
marked contrast, only one band (i.e. fragment 1, p31) of the proIL-1beta maturation remained at 24h 
post-IMI with E. coli although procaspase-1 cleavage was induced at that later time point (Fig. 3A).  
As expected, IL-1beta fragments were largely absent in similarly infected IL-1beta KO C57BL/6 
mammary glands while procaspase-1 fragmentation was still observed (Fig. 3A). Interestingly, 
extensive proIL-1beta (p31) maturation was also seen in caspase-1/-11 double KO C57BL/6 
mammary glands at 12h albeit with a lower number of bands (i.e. no fragment 2; Fig 3A). Multiplex 
analysis further showed that IMI with S. aureus also induced active IL-1beta (p17) compared to sham-
inoculated (PBS) mammary glands (at 12h, P < 0.01; at 24h, P < 0.001) (Fig. 2C). This raise of p17 
occurred predominantly at 24h and was also higher than post-IMI with E. coli (P < 0.001). Western 
blotting of mammary gland lysates of C57BL/6  confirmed this late increase of p17 (Fig. 3B). While the 
fragmentation pattern at 12h post-IMI with S. aureus was similar to that of E. coli (except for the 
fragments 4 and 5) the intensity of the bands was lower. In marked contrast, a different cleavage 
pattern was seen at 24h post-IMI with S. aureus compared to that at 12h post-IMI with E. coli (there 
was an additional band, fragment 6) , this maturation was now totally caspase-1 independent as very 
limited fragmentation of procaspase-1 was observed. Compared to post-IMI with E. coli, the IL-1beta 
pattern contained a lower number of fragments post-IMI with S. aureus i.e. at ± 30 kDa, 20 kDa, ± 18 
kDa and 17 kDa (corresponding to fragments 1, 3, 6 and p17, respectively; Fig. 3B). As for E. coli, 
these IL-1beta fragments were all absent in similarly affected IL-1beta KO mammary glands. Again in 
marked contrast to IMI with E. coli, no procaspase-1 was observed at 24h in IL-1beta KO mammary 
glands while an extensive IL-1beta maturation (p17 fragment) was seen in caspase-1/-11 double KO 
mammary glands post-IMI with S. aureus.  
When comparing bacterial growth in IL-1beta KO C57BL/6 mammary glands to their C57BL/6 
counterparts at the selected relevant time points for each of both pathogens, a significantly higher 
number of CFU was seen for E. coli and to a lower extent also for S. aureus (P < 0.01, n = 4 and P < 
0.05, n = 6 Fig. 3C).  
I.1.4.4. The mammary NF-kappaB activity post-intramammary infection with E. coli 
compared to S. aureus 
Our group at first described the fast and transient induction of mammary NF-kappaB transcription 
post-IMI with E. coli (Notebaert, Carlsen et al. 2008). Monitoring the NF-kappaB activity with in vivo 
imaging in reporter mice, a gradual and significant increase was again observed at 4-11h post-IMI with 
E. coli and at first also with S. aureus albeit non-significant (Fig. 4A). The maximal NF-kappaB activity 
was about a 3-fold higher post-IMI with E. coli compared to S. aureus. This correlated with the local 
TNF-alpha and IL-1alpha levels that were stronger upregulated post-IMI with E. coli, compared to S. 
aureus. No significant increase was seen in the sham-inoculated (PBS, n = 6) glands compared to 
pre-IMI. The increase in mammary NF-kappaB activity at 4h, at 6h, at 8h, at 10h and at 11h post-IMI  
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Figure 3. Differential mammary IL-1beta fragmentation post-IMI with E. coli versus S. aureus 
and effect on bacterial growth. (A) Cleavage of IL-1beta in the mammary gland post-IMI with E. 
coli shows a fast, transient IL-1beta maturation with six IL-1beta fragments at 12h i.e. ± 30 kDa, 
25 kDa, ± 20 kDa, ± 17 kDa, ± 15 kDa and ± 10 kDa (fragments 1, 2, 3, p17, 4 and 5, respectively). 
At 24h (only fragment 1 and p31 proform) is seen. In IL-1beta KO C57BL/6 and in sham-
inoculated (PBS) mice no fragments or p31 proform are detected. Despite clear procaspase-1 
maturation, the early complex IL-1beta pattern is not the result of caspase-1 cleavage as the 
latter only occurs extensively at 24 h and as cleavage of pro-IL-1beta still occurs in caspase-1/-
11 double KO C57BL/6 glands (right Western blot images). No caspase-1 maturation was 
detected in caspase-1/-11 double KO C57BL/6 or in sham-inoculated mammary glands. (B) 
Cleavage of IL-1beta in the mammary gland post-IMI with S. aureus shows a slower IL-1beta 
maturation with four IL-1beta fragments at 24h i.e. ± 30 kDa, ± 20 kDa, ± 18 kDa and ± 17 kDa 
(fragments 1, 3, 6 and p17, respectively). At 12h (only fragment 1 i.e the preform p31, 2, 3,and 
p17). The late IL-1beta maturation is not the result of caspase-1 cleavage as IL-1beta cleavage 
still occurs in caspase-1 / -11 double KO C57BL/6 glands (strong p17 fragment albeit in the 
absence of the p31 proform). Both procaspase-1 and its cleavage were low, respectively absent 
in IL-1beta KO C57BL/6 glands (right Western blot images). No IL-1beta or caspase-1 was 
detected in sham-inoculated mammary glands of C57BL/6 mice. (C) ProIL-1beta fragmentation 
affects bacterial growth as in IL-1beta KO C57BL/6 mammary glands on time points of interest 
(12h for E. coli, 24h for S. aureus) CFU counts are significantly higher for both pathogens than 
in mammary glands of C57BL/6, especially for E. coli. Results are presented as mean ± 
standard error of the mean. (P < 0.01 *, P < 0.001**). DL = detection limit. 
C 
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was stronger for E. coli (P < 0.01, n = 8) compared to sham-inoculated glands. Upon in vivo imaging at 
12h post-IMI this difference no longer remained, while ex vivo imaging still displayed a significant 
difference compared to sham-inoculated glands at 12h (P < 0.01) and 24h (P < 0.01; Fig. 4C and D). 
Although not significant in vivo; there was a difference between E. coli infected and S. aureus infected 
glands (n = 8) through ex vivo imaging at 12h post-IMI (P < 0.05) and at 24h post-IMI (P < 0.001). 
I.1.4.5. Histology confirms the differential local NF-kappaB activation, demonstrates a 
delayed immune cell influx and less pathophysiological changes of the mammary epithelium 
post-IMI with S. aureus compared to E. coli 
NF-kappaB-mediated transcription is only possible through translocation of its subunits to the nucleus. 
Immunohistochemistry was performed at 12h and 24h post-IMI with both pathogens on mammary 
gland sections.  
The NF-kappaB p65 subunit was detected in the nucleus of mammary epithelial cells and immune 
cells post-IMI with E. coli (Fig. 5A: -1a- and -3b-) as well as post-IMI with S. aureus (Fig. 5A: -4a- and -
8a-) but was absent in both sham-inoculated (Fig. 5A -11-) and lactating mammary glands (Fig. 5A -
12-). As suggested by the NF-kappaB activity imaging data, the nuclear NF-kappaB subunit p65 in the 
mammary epithelia was mainly visualized at 12h and less pronounced at 24h post-IMI with E. coli (Fig. 
5A; -1a- compared to -6a-) and post-IMI with S. aureus (Fig. 5A; -4a- compared to -10a-). In marked 
contrast to post-IMI with E. coli, the p65 subunit couldn’t be detected in all nuclei of the epithelial cells 
at 12h post-IMI with S. aureus (Fig. 5A; -4a- compared to -4b-) again confirming the higher NF-kappa 
activity post-IMI with E. coli compared to post-IMI with S. aureus.  
Small cells with a characteristic multilobular polymorphonuclear morphology of neutrophils were 
detected post-IMI with E. coli (Fig. 5A: -3a- and -7a-) and S. aureus (Fig. 5A -8a-) but not in sham- 
inoculated (Fig. 5A -11-) or in lactating mammary glands (Fig. 5A -12-). At 12h post-IMI with E. coli the 
alveolar lumen contained a mixture of neutrophils either with (Fig. 5A -3a-) or without (Fig. 5A -3b-) 
nuclear p65 the NF-kappaB subunit. However, at 24h post-IMI, no p65 subunit was detected in these 
neutrophils (Fig. 5A -7a-). In contrast, for S. aureus, neutrophils could only be detected at 24h post-IMI 
and with (Fig. 5A -8a-) or without (Fig. 5A -8b-) nuclear p65 subunit. Remarkably, post-IMI with S. 
aureus also cells without nuclei (likely red blood cells) were observed outside the blood vessels, which 
was not the case post-IMI E. coli (Fig. 5A -9a-). This observed delay in neutrophil influx post-IMI with 
S. aureus was confirmed by quantitative IL-8-like (i.e. KC and MIP-2) multiplex analysis (Fig. 5B). At 
12h post-IMI, there was already a significant difference for E. coli compared to sham-inoculated 
glands (PBS) for both these chemokines which persisted at 24h post-IMI (P < 0.01 and P < 0.001, 
respectively). In marked contrast, post-IMI with S. aureus this IL-8 like chemoattractant signaling was 
delayed until 24h for both chemokines compared to sham-inoculated glands (P < 0.05 and P < 0.001, 
respectively) . 
Additionally, as a result of the strong E. coli-inflicted immune response, the mammary epithelium was 
less structured compared to sham -inoculated and lactating mammary glands (Fig. 5A -2a- compared 
to -11- and -12-). At 12h post-IMI with E. coli mammary epithelial cells started to protrude from the 
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mammary epithelial layer (Fig. 5A -1b-) resulting in “empty spots” (Fig. 5A: -2b-), and many large cells 
drifting (Fig. 5A: -2b-) next to the polymorphonuclear cells in the alveolar lumen at 24h post-IMI (Fig. 
5A: -2a- and -3c-). This major histological finding at 12h post-IMI with E. coli resulted in even more cell 
budding (Fig. 5A -5b-), empty spots (Fig. 5A -5c-), and discarded cells (Fig. 5A: -6b- and -5a-) at 24h 
post-IMI. Remarkably, this cell budding phenomenon was far less pronounced in the S. aureus 
infected glands and again clearly delayed as it could only be detected at 24h post-IMI (Fig. 5A: -10b-). 
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Figure 4. In vivo mammary NF-kappaB activity post-IMI with E. coli compared to S. aureus. (A) 
In vivo imaging of local NF-kappaB activity in mammary glands (ventral view) showed a 
transient and fast activation for both pathogens compared to sham-inoculated (PBS) glands 
and also about a 3-fold higher activation post-MI with E. coli compared to S. aureus. Data 
represent the flux density (total flux radiance per selected body area (in p*(s*m
2
))) as a 
quantitative measure of the bioluminescent signal correlating with the NF-kappaB activity. (B) 
A representative photograph of lactating mice (at 0h, most left) compared to mice at 6h post-
inoculation with sham (PBS, 2nd from left), at 6h post-IMI with S. aureus (3rd from left), or at 6h 
post-IMI with E. coli (most right) . The intensity of luminescence was scaled based on the 
radiance (in p*(s*m
2
)). (C) Mammary glands of NF-kappaB reporter mice were excised at 12h 
and 24h post-inoculation and their ex vivo luminescence was measured. The graph represents 
the ratio between the total flux radiance per area (in p*(s*m
2
)) of the inoculated gland and the 
value from the non-injected 3th gland in the same mouse. Although the maximal activation 
occurred earlier, the local NF-kappaB activity was still significantly higher in E. coli compared 
to S. aureus mammary glands at both these time points of relevance for cytokine transcription. 
(D) Representative photographical view of excised mammary glands post-IMI with E. coli (top), 
S. aureus (middle) or after sham-inoculation (PBS, bottom). Results are presented as mean ± 
standard deviation. Letters of homogeneous subsets were marked if the difference between 
treatments were statistically significant (P < 0.05) . 
I.1.5. Discussion 
Infectious mastitis is a complex bacteria-inflicted inflammatory disease that often affects dairy cows. 
As its traditional antibiotic treatment elicits public controversy and involves human health issues, an 
increased interest in novel superior therapeutic alternatives has emerged. Therapies that enhance the 
natural host defense systems by targeting specific pathogens and that limit antibiotic resistance would 
be very well received in this specific field. Therefore, the detailed molecular description of key 
signaling modules activated during different types of mammary gland infections is needed but lacking 
to date. In the current study, an acute murine mastitis model was used to compare the hosts’ 
inflammatory response against the scientifically best documented Gram-negative and Gram-positive 
bovine mastitis pathogens i.e. E. coli strain P4:032 and S. aureus strain Newbould 305. Both 
pathogens multiplied rapidly in the murine mammary gland while triggering the release of pathogen-
dependent as well as pathogen-independent immune responses. The different mammary multi-protein 
patterns each delineated a pathogen-specific infection and occurred concomitantly with discriminatory 
NF-kappaB activation. More specifically, our data emphasized the importance of evaluating proIL-
1beta maturation by complementary immuno-assays as well as IL-1beta KO C57BL/6 and caspase- 
1/11 double KO C57BL/6 mice to gain insight in the IL-1beta activity in the mammary gland. While 
quantitative multiplex analysis showed only the high induction of the classical IL-1beta activity (p17) 
post-IMI with S. aureus compared to E. coli, Western blot analysis revealed a differential fragmentation 
pattern of mammary pro-IL-1 between both pathogens. This twice involved a non-classical pathway.  
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Figure 5. Differential nuclear translocation of mammary NF-kappaB p65, immune cell influx and 
the less structured mammary epithelium post-IMI with S. aureus compared to E. coli. (A) At 12h 
post-IMI, a nuclear translocation of NF-kappaB subunit p65 was observed in the epithelia of 
both E. coli (-1a-) and S. aureus-infected glands (-4a-). At this early time point, a strong 
cytoplasmatic NF-kappaB p65 signal was only seen post-IMI with E. coli. At 24h post-IMI, NF-
kappaB p65 was mainly detected in the cytoplasm in the mammary epithelium of both E. coli-(-
6-) and S. aureus-infected glands (-10-). while at this time both sham-inoculated (PBS, -11-) and 
lactating (at 0h,-12-) glands displayed very low basal levels of latent expressed cytoplasmic 
NF-kappaB p65. At 12h post-IMI with E. coli the polymorphonuclear cells in the alveolar lumen 
could morphologically be identified as neutrophils (-3a- and -3b-), while these immune cells 
were still absent at that time post-IMI with S. aureus (-4-) or in sham-inoculated (PBS, -11-) and 
lactating (at 0h,-12-) glands. In contrast, the influx of neutrophils could only be detected at 24h 
post-IMI with S. aureus (-8-). A clear nuclear translocation of NF-kappaB p65 could be detected 
at 12h post-IMI with E. coli and 24h post-IMI with S. aureus (-3a- and -8a-) in these immune 
cells. At 24h post-IMI with E. coli, epithelial structure at mammary alveoli was characterized by 
budding of mammary epithelia (-5b-) and resulted in cells in the lumen (-5a-) and empty spots 
in the luminal layer (-5c-), while at 24h post-IMI with S. aureus only some cells started to 
protrude from the epithelial layer (-10b-). (B) IL-8 like chemokines (i.e. KC and MIP-2) confirmed 
this difference in kinetics of the neutrophil influx between both pathogens. Both chemokines 
were significantly induced in E. coli infected glands compared to sham-inoculated glands 
(PBS) already at 12h post-IMI (a), while for S. aureus this strong induction was only seen at 24h 
post-IMI (b). Results are presented as mean ± standard deviation. Letters of homogeneous 
subsets were marked if the difference between treatments were statistically significant (P < 
0.05) 
Infection with S. aureus resulted in a later IL-1beta cleavage pattern and was associated with a 
markedly delayed influx of neutrophils compared to infection with E. coli. Furthermore, the mammary 
epithelium was already less structured at 12h post-IMI with E. coli as characterized by the presence of 
cells in the lumen and empty spots in the architecture, features which were observed later and less 
prominently post-IMI with S. aureus. These data are indicative for a protective cell death mechanism, 
especially in response to a Gram-negative infection, wherein mammary epithelial cells are massively 
shed to restrict bacterial growth as well as neutrophil cytotoxicity (Monks, Rosner et al. 2005). 
Corroborating previous reports generated with either single protein detection analyses (i.e. ELISA) or 
multi-expression studies (i.e. microarray) of murine mammary glands (Li, Liang et al. 2013), udder 
tissue (Rinaldi, Li et al. 2010) or milk samples (Ibeagha-Awemu, Ibeagha et al. 2010), our initial 
quantitative mouse multiplex protein analysis approach demonstrated that an equal count of mammary 
CFU of E. coli and S. aureus each induced specific local cytokine profiles. The E. coli mediated 
immune response was characterized by a fast and substantial synthesis of active TNF-alpha, IL-
1alpha and MCP-1. These three cytokines were also detected post-IMI with S. aureus although only to 
a relatively minor extent. Intramammary infection with E. coli or S. aureus was found to equally 
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enhance IL-6 secretion, which can thus be categorized as a Gram-independent immune response. 
This latter observation indicates that IL-6 induction is differently regulated compared to TNF-alpha, 
MCP-1 and IL-1alpha during an intramammary infection. In that respect, gene expression of IL-6 has 
been proposed to be induced by both an E. coli and a S. aureus infection of udder epithelia and 
occurs independently of MyD88 in contrast  to TNF-alpha and IL-1alpha (Gunther, Esch et al. 2011).  
In contrast to TNF-alpha, IL-1alpha, MCP-1 and IL-6, the active IL-1beta concentrations at 24h post-
IMI were significantly higher in mammary glands exposed to S. aureus compared to E. coli. Apparently 
low levels of IL-1beta were induced at this later time point post-IMI with E. coli, nevertheless this pro-
inflammatory cytokine was still significantly increased at both time points when compared to sham-
inoculated glands and attained its highest level already at 12h post-IMI. Although this quantitative 
analysis allowed us to demonstrated different active IL-1beta levels in the mammary gland post-IMI 
with both pathogens, the proteolytic cleavage of proIL-1beta required for this key proinflammatory 
mediator to achieve its biological activity remained to be demonstrated as previously stated (Wittmann, 
Kingsbury et al. 2011). Therefore, the presence of IL-1beta fragments was at first verified upon Gram-
negative versus the Gram-positive infection by Western blot analysis of the C57BL/6 mice-derived 
mammary glands. As suggested by our multiplex data, the classical p17 IL-1beta cleavage fragment 
was already detected at 12h post-IMI with E. coli albeit transiently as less p17 was detected at 24h 
post-IMI. In contrast, , the intensity of the p17 band was much higher at 24h post-IMI than at 12h post-
IMI with S. aureus, indicating slower kinetics for this pathogen. Furthermore, Western blot analysis 
revealed several additional cleavage fragments besides the classical p17 fragment characterizing the 
markedly different IL-1beta fragmentation patterns upon infection with both pathogens. More 
specifically, E. coli promoted the formation of a fragment at 25 kDa and two fragments at 15 kDa, 
while S. aureus showed a unique band between 17 kDa and 20 kDa. Both bovine mastitis pathogens 
induced common bands at 17 kDa, 20 kDa and at 30 kDa. In a subsequent experiment, the 
comparative analysis of mammary glands from IL-1beta KO C57BL/6 mice-compared to C57BL/6 mice 
unequivocally confirmed that all these fragments did indeed derive from IL-1beta. Maturation of pro-IL-
1beta is typically controlled by caspase-1 or -11 in large multi-molecular complexes called 
inflammasomes which sense (vita-)MAMPs from live bacteria (Lamkanfi and Dixit 2012). To determine 
whether mammary caspase-1 is also involved in proIL-1beta activation as recently questioned by our 
group (Breyne and Meyer 2013), the cleavage of procaspase-1 was investigated. Procaspase-1 
fragmentation was clearly visible at 12h and at 24h post-IMI with E. coli, but unexpectedly far less 
present at both time points post-IMI with S. aureus. This important finding provided a first indication 
that IL-1beta maturation can also occur independently of caspase-1 in the murine mastitic mammary 
gland. This caspase-1 independency was confirmed in a subsequent experiment performed to further 
investigate this process through infection of caspase-1/-11 double KO C57BL/6 mice. These 
innovative data strongly supported the hypothesis of a non-conventional maturation of proIL-1beta into 
active p17 by other proteases than the conventional pro-inflammatory caspase-1, a hypothesis which 
also was recently postulated by our group (Notebaert, Demon et al. 2008). More specifically, the 
detected protein bands in the IL-1beta fragmentation patterns suggest the likely involvement of 
secreted neutrophil serine proteases (Wittmann, Kingsbury et al. 2011). Indeed, neutrophil elastase 
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and proteinase-3 are known to cleave proIL-1beta (i.e. 31kDa) into fragments of 20 kDa (Coeshott, 
Ohnemus et al. 1999) and of 17.5 kDa (Wittmann, Kingsbury et al. 2011) with different biological 
activities (Wittmann, Kingsbury et al. 2011). Cathepsin (Meyer-Hoffert and Wiedow 2011), another 
major neutrophil-associated protease, cleaves this immature protein proform directly into two identical 
fragments of 17.5 kDa (Meyer-Hoffert and Wiedow 2011). These reported fragments match with the 
low molecular weight bands retrieved around 20 kDa and p17 for both bovine mastitis pathogens in 
the current study. The alternative cleavage of pro-IL1beta was detected for E. coli at 12h post-IMI 
while only at 24h post-IMI with S. aureus. This nicely correlated both with the presence of neutrophils 
and with local NF-kappaB activation at each of these time points in the mammary gland. The 
concentrations of two mouse IL-8 like chemokines i.e. KC and MIP-2 were additionally measured in 
the mammary glands at the relevant time points for each pathogen. As expected, a massive influx of 
neutrophils was microscopically observed already at 12h for E. coli, while only at 24h for S. aureus. 
The local chemoattractant concentrations strongly supported this delayed influx as again a milder and 
slower innate immune response in the mammary gland was seen post-IMI with a Gram-positive 
compared to a Gram-negative bovine mastitis pathogen. 
In contrast to the fragments seen post-IMI with S. aureus, E. coli infection induced less classical p17 
as well as additional non-classical fragment formation upon proIL-1beta cleavage. We here suggest 
that these fragments can result from matrix metalloproteinases (MMPs) which are secreted by the 
either mammary epithelial cells (Kousidou, Roussidis et al. 2004) or neutrophils (Lin, Li et al. 2005). 
Interestingly, these extracellular enzymes are able to cleave proIL-1beta into either active, or less 
active, or even non-active IL-1beta fragments (Hazuda, Strickler et al. 1990). For example, MMP-9 can 
cleave proIL-1beta into an inactive 26 kDa fragment besides the classical active p17 fragment, while 
MMP-3 produces inactive 28 kDa as well as less active 14 kDa peptides. In addition, other papers - 
albeit not in a mammary gland context - describe that MMP-2 can cleave proIL-1beta into both a very 
low activity 16 kDa and an inactive 10 kDa fragment (Schonbeck, Mach et al. 1998; Mehrzad, 
Desrosiers et al. 2005). At least some of these reported fragments should correspond to fragments 
from the complex pattern of low-molecular weight bands found in the current study post-IMI with E. coli 
(ranging from 25 kDa to 10 kDa). Importantly however, they do not correspond with the molecular 
weight of those band found in the current study post-IMI with S. aureus. The suggestion that MMPs 
are induced during the hosts’ innate immune response against E. coli to inactivate IL-1beta is 
strengthened by our histological findings (Ito, Mukaiyama et al. 1996). Indeed, the epithelial layer post-
IMI with E. coli was clearly different as seen on mammary gland sections, a deterioration which again 
was only mildly present post-IMI with S. aureus. Of relevance, a high NF-kappaB activity during 
mammary gland infection increases caspase-3 mediated cell budding and shedding of epithelial cells 
(Connelly, Barham et al. 2010). Although not shown during this study, the loosening of epithelia 
suggests a form of accelerated involution which is suggested in literature to be associated with the 
production of MMPs. Finally, there was also one additional band with a MW between 17.5 kDa and 20 
kDa that was selectively present post-IMI with S. aureus and not post-IMI with E. coli. It is here 
hypothesized that the latter cleavage fragment might be the product of pathogen-associated proteases 
(i.e. auto-cleavage) as previously described (Li, Zhao et al. 1999). 
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Above mentioned arguments implicate the involvement of epithelial (MMPs) and neutrophilic (serine 
proteases) proteases in the maturation of proIL-1beta. Surprisingly, in both these mammary cell types 
we could also detect NF-kappaB activity upon immunohistochemical evaluation. Furthermore, it should 
be highlighted that till date, the precise origin of the mammary proIL-1beta protein remains vague. 
Nevertheless, from the current study it is clear that the responsible transcription factor inducing the IL-
1beta proform is certainly active prior to 12h post-IMI with both pathogens. However, its maturation 
occurs only shortly before 12h post-IMI with E. coli, while for S. aureus this process occurs about 12h 
later i.e. around 24h. Furthermore, our immunohistochemical data unequivocally demonstrated that for 
both bacteria the main subunit p65 of the transcription factor NF-kappaB is translocated to the nucleus 
of the murine mammary epithelial cells. The latter translocation is an essential step for activation of 
this key inflammatory transcription factor. To evaluate the level of NF-kappaB activation, both 
pathogens were compared with in vivo imaging in the reporter model previously established by our 
group for E. coli (Notebaert, Carlsen et al. 2008). As described for E. coli in this latter paper, a fast and 
strong NF-kappaB activation was again observed in the current study. However, in marked contrast, 
an on average 3 times lower NF-kappaB activity was detected in the mammary gland for S. aureus. 
Remarkably, the transient enhancement of this NF-kappaB activity already peaked for both pathogens 
at 6h post-IMI. This observation highlights that next to the production of TNF-alpha, IL-1alpha and 
MCP-1, the production of proIL-1beta can be NF-kappa-induced but its activation is likely not. Of 
relevance in this context, there is still the possibility of other transcription factors which have been 
reported in udder infections such as activator protein-1 (AP-1) (Kim, Im et al. 2011), or peroxisome 
proliferator-activated receptors (PPARs) (Mandard and Patsouris 2013), or regulatory factors such as 
CAAT box enhancer binding proteins (C/EBPs) (Liu, Shi et al. 2011). 
Regardless the underlying transcription mechanism, our data overall imply that proIL-1beta is both 
highly and differentially processed within 12h to 24h post-IMI with both mastitis pathogens, which 
suggests its tight regulation. Based on the intramammary infections of IL-1beta KO C57BL/6 mice, IL-
1beta affects local bacterial growth of Gram-negative to a low extent and the reduction of bacterial 
growth following a Gram-positive bacterial infection was even influenced to a lesser extent. Moreover, 
the revealed maturation process is certainly also non-classical as it occurs independently from the 
classical caspase-1 pathway. As a differential IL-1beta fragmentation pattern was observed after 
Gram-negative compared to Gram-positive mastitis, the cytokine protein profile data from the current 
study support the hypothesis that E. coli and S. aureus overall induce a markedly different IL-1beta 
activity. Our data also corroborate previous findings in KO C57BL/6 mice demonstrating that 
neutrophil IL-1R signaling in mammary gland inflammation mediates neutrophil influx from the 
interstitium and capillaries into the lumen of the alveoli (Elazar, Gonen et al. 2010). Additionally these 
innate immune cells restrict E. coli invasion into the mammary epithelial cells, which is only a 
characteristic of S. aureus infections in wild type mice (Elazar, Gonen et al. 2010). We hypothesize 
that proIL-1beta is locally secreted by the mammary epithelial cells and that multiple fragments likely 
result from the molding of bacterial proteases and/or NF-kappaB-induced non-caspase proteases 
secreted from neutrophils (i.e. serine proteases) and mammary epithelial cells (i.e. MMPs). Following 
infection with both pathogens, the IL-1beta proform is likely present in the interstitium where it is 
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cleaved by serine proteases produced by NF-kappaB activity in neutrophils, which are already 
sensitized by the preceding release of other pro-inflammatory cytokines following epithelial NF-kappaB 
signaling. Upon E. coli infection in mice, the host rapidly induces an efficient protective program that 
involves mammary NF-kappaB transcription to enhance TNF-alpha (E. coli mediated immune 
response). Interestingly, TNF-alpha is a well-known inducer of MMPs, which subsequently accelerates 
mammary gland involution (Black, Kronheim et al. 1988; Balasubramanian, Fan et al. 2011). 
Subsequently, proIL-1beta becomes inactivated by additional cleavage into fragments abolishing an 
additional neutrophil influx into the lumen but increasing the number of shedded epithelial cells in 
order to restrict bacterial growth as well as neutrophil cytotoxicity (Monks, Rosner et al. 2005). This 
explains the lower IL-1beta levels at 24h post-IMI versus 12h post-IMI with E. coli. In marked contrast, 
NF-kappaB is also rapidly but far less activated after S. aureus and thus a delayed influx of neutrophils 
occurs. Moreover, significantly less TNF-alpha is released and thus MMPs will not cause their typical 
IL-1beta cleavage patterns. In contrast to the early neutrophil-mediated E. coli mediated immune 
response, our data are indicative for the activity of S. aureus-derived proteases that alternatively 
cleave proIL-1beta enabling the typical evasion of these Gram-positive pathogens from the alveolar 
lumen. 
These innovative insights obtained in mice revealed at first a sentinel function for IL-1beta during the 
early innate inflammatory response to mammary gland infections. Additionally, they highlight the 
limitations of single analysis methods. To acknowledge the proposed novel molecular mechanism of 
proIL-1beta in the early innate immune signaling during mastitis, additional studies are mandatory. 
Attractive options to extend our current findings are either the use of acute models with other relevant 
mastitis-associated germs (Demon, Breyne et al. 2013), or of more complex chronic mouse mastitis 
models (Brouillette and Malouin 2005) and last but not least of different mammalian target species, 
especially dairy animals. 
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ADDENDUM 
 
Differences secondary to the local immune response in mice post-IMI with E. coli versus post-IMI with 
S. aureus could be detected based on serum and hepatic cytokines, hepatic NFkappaB-activity and 
body temperature. 
The levels of IL-6 and KC in blood were marked by a response post-IMI with S. aureus or post-IMI with 
E. coli, respectively (Fig. S1A). IL-6 levels in blood were higher post-IMI with S. aureus compared to 
sham-inoculated (PBS) glands and showed a trend to be higher than E. coli-inoculated animals. This 
observation could be linked to the susceptibility of mice to the virulence of S. aureus because 
temperature regulation is associated with systemic IL-6 levels (Shalaby, Waage et al. 1989; Chai, 
Gatti et al. 1996; Stewart, Landseadel et al. 2010) (see further). Therefore, the higher increase in 
systemic IL-6 levels at 24h post-IMI is associated with the hypothermia post-IMI with S. aureus (Fig. 
S1C). The KC blood levels were significantly higher post-IMI with E. coli compared to PBS. It is known 
that a chemotactic gradient of KC guides blood neutrophils into the mammary alveolar lumen 
(Bucerius, Naubereit et al. 2008). As such, this observation is in line with the earlier detected 
neutrophil influx post-IMI with E. coli compared to S. aureus. Furthermore, levels of TNF-alpha, IL-
1alpha, MCP-1 and IL-1beta in the blood were not elevated compared to the sham-inoculated mice.  
As shown in Fig. S1B and Fig. S2, elevated cytokines and NF-kappaB transcription were also 
detected in the liver at 24h post-IMI both pathogens compared to sham-inoculated (PBS) mice. 
Similarly as in the blood, hepatic IL-6 and KC were also elevated post-IMI with S. aureus and post-IMI 
with E. coli compared to the sham-inoculated mice. As the liver controls the homeostasis, hepatic 
production of cytokines (van Meijl, Popeijus et al. 2010) and acute phase proteins (Trautwein, Boker et 
al. 1994) are likely to control the systemic inflammatory responses (Tacke, Luedde et al. 2009). As 
already suggested by our group post-IMI with E. coli (Notebaert, Carlsen et al. 2008), both E. coli and 
S. aureus induced a high NF-kappaB activity in the liver.  
The mice were significantly influenced by the S. aureus pathogenicity in contrast to E. coli or sham-
inoculated (PBS) mice as reflected in the drop in body temperature (Fig. S1C). This observation is in 
line with previous reports. Corroborating characteristics of nearly all S. aureus strains, this subspecies 
is characterized by hemolysin and coagulase activity (Bhakdi and Tranum-Jensen 1991; Dinges, 
Orwin et al. 2000; Brouillette, Grondin et al. 2004; Bouchard, Peton et al. 2012). Both these exotoxins 
are associated with high virulence in the mouse mastitis model (Jonsson, Lindberg et al. 1985). Mice 
are in particular sensitive to the alpha-hemolysin/alpha-toxin (hla), especially when S. aureus bacteria 
are introduced in the mammary gland at a high inoculum dose. This was elegantly demonstrated by 
the fact that depletion of the toxin in the S. aureus strain -when inoculated at the same high dose- 
completely reversed the S. aureus lethality during mastitis in mice (Bramley, Patel et al. 1989). 
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Figure S1. Secondary host response post-IMI with E. coli or S. aureus. (A) IL-6 and KC blood 
values post-IMI with E. coli and S. aureus compared to the sham-inoculated (PBS) and lactating 
(0h) negative controls. (B) Hepatic IL-1alpha, IL-6 and KC values 24h post-IMI with E. coli or 
with S. aureus compared to sham-inoculated (PBS) negative controls. (C) Changes in core 
body temperature post-IMI with E. coli or with S. aureus. Results are presented as mean ± 
standard deviation. Letters of homogeneous subsets were marked if the difference between 
treatments were statistically significant (P < 0.05). DL = detection limit. 
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Figure S2. Hepatic NF-kappaB activity in transgenic reporter mice post-IMI with E. coli or S. 
aureus. (A) In vivo imaging follow-up of NF-kappaB activity in the liver (ventral view) after an 
IMI with E. coli or S. aureus. The data represents the flux density (total flux radiance per 
selected body area (in p*(s*m
2
))). (B) Representative photograph of lactating mice (most left) 
compared to sham-inoculated (PBS, 2nd from left) mice at 24h post-IMI with S. aureus (3rd 
from left), or E. coli (most right). The intensity of luminescence was scaled based on the 
radiance (in p*(s*m
2
)). (C) Livers of NF-kappaB reporter mice were excised at 12h and at 24h 
post-IMI, and their luminescence was measured ex vivo. The graph represents the total flux 
radiance per area (in p*(s*m
2
)) as a measure for the NF-kappaB activity. (D) Representative 
photographical view of excised livers post-IMI with E. coli (top), S. aureus (middle) or PBS 
(bottom). Results are presented as mean ± standard deviation. Letters of homogeneous 
subsets were marked if the difference between treatments were statistically significant (P < 
0.05). 
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I.2. A Pilot Study using a Mouse Mastitis Model to study Differences between Bovine-
Associated  Coagulase-Negative Staphylococci 
I.2.1. Abstract 
Coagulase-negative staphylococci (CNS) are a group of bacteria classified as minor mastitis 
pathogens. Recent research suggests species- and even strain-related epidemiological and genetic 
differences within the large CNS group. The current pilot study investigated in two experiments 
whether a mouse mastitis model validated for bovine Staphylococcus aureus (S. aureus) can be used 
to explore further differences between CNS species and strains. In a first dose-titration experiment, a 
low inoculum dose of S. aureus Newbould 305 (positive control) was compared to increasing inoculum 
doses of a S. chromogenes strain originating from a chronic bovine intramammary infection (IMI) (S. 
chromogenes IM), and to sham-inoculated mammary glands (negative control). In contrast to the high 
bacterial growth following inoculation with S. aureus, S. chromogenes was retrieved in very low levels 
at 24h post-induction (p.i.). In a second experiment, the inflammation inflicted by three CNS strains 
was studied in mice. The host immune response induced by the S. chromogenes IM strain was 
compared with the one induced by a S. fleurettii strain originating from cow bedding sawdust and by a 
S. chromogenes strain originating from a teat apex of a heifer (S. chromogenes TA). As expected, at 
28h and 48h p.i. low bacterial growth and local neutrophil influx in the mammary gland were induced 
by all CNS strains. As hypothesized, bacterial growth p.i. was the lowest for S. fleurettii compared to 
that induced by the two S. chromogenes strains and the overall immune response established by the 
three CNS strains was less pronounced compared with the one induced by S. aureus. Pro-
inflammatory cytokine profiling revealed that S. aureus locally induced IL-6 and IL-1beta but not TNF-
alpha, while overall CNS-inoculated glands lacked a strong cytokine host response but also induced 
IL-1beta locally. Compared to both other CNS strains, S. chromogenes TA inflicted a more variable IL-
1beta response characterized by a more intense local reaction in several mice. 
This pilot study suggests that an intraductal mouse model can mimic bovine CNS mastitis and has 
potential as a complementary in vivo tool for future CNS mastitis research. Furthermore, it indicates 
that epidemiologically different bovine CNS species/strains induce a differential host innate immune 
response in the murine mammary gland.  
I.2.2. Introduction 
Coagulase-negative staphylococci (CNS) are a group of bacteria that cause mastitis in both heifers 
and multiparous cows (Thorberg, Danielsson-Tham et al. 2009; De Vliegher, Fox et al. 2012; 
Ajitkumar, Barkema et al. 2013). Until recently, it was difficult to draw consistent conclusions on the 
relevance of CNS for bovine udder health. Some studies considered CNS as true mastitis pathogens 
although mostly retrieved from subclinical mastitis cases (Pyorala and Taponen 2009), while others 
considered CNS to be bacteria with limited or absent negative effects on SCC, milk quality and milk 
production (Schukken, Gonzalez et al. 2009; De Vliegher, Fox et al. 2012). The development and 
validation of molecular identification techniques specifically for bovine-associated CNS were the basis 
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to eliminate this confusion (Zadoks and Watts 2009). While older studies dealt with CNS as one 
homogenous and coherent group (Schukken, Gonzalez et al. 2009; Piepers, Opsomer et al. 2010; 
Piepers, Schukken et al. 2013), more recent studies addressed the CNS species separately revealing 
heterogeneous characteristics between them (Åvall-Jääskeläinen, Koort et al. 2013). In essence, 12 
CNS species are frequently isolated from bovine milk. Evidence exists for diversity between and even 
within those species in their epidemiologic behavior and traits such as persistence, antibiotic 
resistance, susceptibility to phagocytosis by mouse macrophages and (putative) virulence (Piessens, 
Van Coillie et al. 2011; Supré, Haesebrouck et al. 2011; Åvall-Jääskeläinen, Koort et al. 2013; 
Vanderhaeghen, Piepers et al. 2014; Vanderhaeghen, Piepers et al. 2014). 
To make further progress in our understanding of CNS mastitis, the interaction between CNS species 
and strains and the host should be studied in more detail. Ideally, such experimental infection studies 
are conducted using dairy cows. Unfortunately, these bovine studies are expensive and labour-
intensive. For those reasons, a mouse mastitis model was developed and characterized (Chandler 
1970) and has since been successfully validated for studying the specific host immune response to 
intramammary infection (IMI) with major mastitis pathogens such as Escherichia coli and 
Staphylococcus aureus (S. aureus) (Brouillette and Malouin 2005; Demon, Ludwig et al. 2012; 
Demon, Breyne et al. 2013), yet not for CNS. 
The usefulness of a mouse mastitis model as a complementary tool to investigate differences between 
bovine CNS species and strains was explored. Specifically, two experiments were performed to 
answer clear-cut objectives: (1) do bovine-associated CNS grow in the murine mammary gland, (2) do 
they induce mastitis in mice, and (3) is it possible to detect differences in bacterial growth, clinical 
symptoms and host immune response between CNS species or strains with a different origin using 
this mouse mastitis model? 
I.2.3. Material and Methods 
The set-up of the two experiments is outlined in Figure 1. For both experiments, eight-week-old female 
Hsd:ICR (CD1) mice that mated with ten-week-old male Hsd:ICR (CD1) mice (Harlan labouratories, 
Horst, The Netherlands) were used. Pups were weaned ± 10 days after parturition to ease the 
intraductal accessibility. All inoculations were performed two hours post weaning under isoflurane 
anesthesia combined with a long-acting analgesic buprenorphine (10 µg/kg Vetergesic, Patheon UK 
Ltd, Swindon, UK) using a 32-gauge blunt needle. During both experiments, core body temperature of 
the mice was measured with a rectal thermistor. All experiments were approved by the committee on 
the ethics of animal experiments of Faculty of Veterinary Medicine, Ghent University (Permit Number: 
EC2013/166). In a first dose-titration experiment, 4 increasing inoculum doses (i.e. 2.5 x 10
2
, 2.5 x 
10
3
, 2.5 x 10
4
 and 2.5 x 10
5
 colony forming units (CFU)/100µl) of a bovine-associated S. chromogenes 
strain originating from a chronic IMI (S. chromogenes IM (Supré, Haesebrouck et al. 2011) were 
injected in the 4
th 
gland
 
pair of each of the 12 mice (nmice/dose = 3; nglands/dose = 6) to evaluate both 
bacterial growth and immune cell influx in the mammary glands 24h post-induction (p.i.). An additional 
number of 6 mice were inoculated with either a 100 µl sham solution (PBS + 10% glycerol) (nmice = 3) 
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or 1 x 10
2
 CFU/100µl S. aureus Newbould 305 (nmice = 3), and included as negative and positive 
controls, respectively (Fig. 1A). Twenty-four hours p.i., all mice were first sedated by administering a 
mixture of ketamine (100 mg/kg Anesketin, Eurovet Animal Health BV, Bladel, The Netherlands) with 
xylazine (10 mg/kg; Xylazini Hydrochloridum, Val d’Hony-Verdifarm, Beringen, Belgium) 
intraperitoneally and subsequently euthanized. After euthanasia, all S. chromogenes inoculated 
glands (nglands/inoculum = 6) were isolated to determine their bacterial load. Also, the S. chromogenes-
inoculated glands with clinical signs of inflammation after dissection (i.e. red color, hard, swollen), as 
well as the 2 sham-inoculated glands and the 2 S. aureus-inoculated glands were further processed 
for histology. To quantify bacterial growth, the mammary glands were weighed, homogenized and 
spotted (20µl) in serial logarithmic dilutions on Tryptic soy agar plates (Oxoid, Drongen, Belgium) 
overnight at 37°C to determine CFU/100µl and divided by the exact weight of a mammary gland (g). 
For the histologic sections, mammary glands were divided in three transverse proportions to validate 
the homogeneity of the infection: near the nipple (i.e. near the inoculation site), near the lymph node 
and near the back. Two mammary glands for every inoculation (sham-, S. aureus- and 10
5
 CFU S. 
chromogenes IM-inoculated glands) were fixed in buffered 3.5% formaldehyde (Sigma-Aldrich, St. 
Louis, MO, USA) for 24h at room temperature (24°C). Subsequently, the samples were dehydrated 
and embedded in paraffin wax. Sections were deparaffinised, hydrated and stained with hematoxylin 
and eosin (Sigma-Aldrich, St. Louis, MO, USA). As the inoculated mammary glands displayed clinical 
symptoms of inflammation following a S. chromogenes IM inoculum dose as high as 10
5
 CFU but not 
at lower doses, only these CNS-inoculated glands were collected for histological evaluation.  
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic presentation of the set-up of the 2 experiments (A and B) performed in this 
study. The patterned glands represent the glands inoculated with S. aureus, or S. 
chromogenes intramammary (IM), or S. chromogenes teat apex (TA) or S. fleurettii, while the 
grey and dark grey mammary glands represent the unchallenged and the PBS/glycerol (sham)-
inoculated mammary glands, respectively. 
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In the second experiment, two additional bovine CNS strains were included [a S. fleurettii strain 
originating from sawdust (Supré, Haesebrouck et al. 2011) and a S. chromogenes strain originating 
from a teat apex of a heifer (S. chromogenes TA) (De Vliegher, Opsomer et al. 2004)]. The 4
th
 gland 
pair of each of the 18 mice (nmice/CNS strain = 6; nglands/CNS strain = 12) were injected with either S. 
chromogenes IM, S. chromogenes TA or S. fleurettii at an inoculum dose of approx. 10
5
 CFU (9.6 x 
10
4
 CFU/100µl S. chromogenes IM, 9.3 x 10
4 
CFU/100µl S. chromogenes TA and 8.5 x 10
4
 CFU/100µl 
S. fleurettii, respectively). Three additional mice were inoculated with 2.5 x 10
2
 CFU/100µl S. aureus 
Newbould 305 (nmice/dose = 3; nglands/dose = 6) and included as positive control (Fig. 1B). The 5
th
 gland 
pair of each mouse was inoculated with 100µl sham solution and served as negative control. At 28h 
p.i., 12 mice (3 mice per CNS strain and 3 S. aureus Newbould 305-inoculated mice) were sedated 
and euthanized as earlier described. The other mice (n = 9) were sedated and euthanized at 48h p.i.. 
After euthanasia, the inoculated glands were isolated to determine bacterial growth, cytokine levels 
and histology. Bacterial growth was determined for every inoculum and time point as described. For 
cytokine quantification, mammary gland lysates were prepared from the mammary homogenates as 
previously reported (Breyne, Cool S. K. et al. 2014). Briefly, the IL-6, IL-1beta levels and TNF-alpha 
were determined in the protein suspensions (50µg) as described by the manufacturer with specific 
cytometric Bead Array kits (CBA, Becton Dickinson Biosciences, Erembodegem, Belgium) on a 
FACSArray instrument (Becton Dickinson Biosciences). For the histology, a sagittal section was used. 
Two mammary glands for every inoculum and time point were fixed and prepared as described. 
Statistical differences in bacterial growth at 28h and 48h p.i. and between the three CNS strains were 
determined using non-parametric or ANOVA tests (SPSS 20.0, IBM Corporation, Armonk, NY) with the 
log10-transformed CFU/ml, as outcome variables and the three CNS strains as categorical 
independent variable. A similar approach was followed to determine the association between the 
inoculum (S. aureus, S. chromogenes IM, S. chromogenes TA, or S. fleurettii) and the IL-6, IL-1beta 
and TNF-alpha concentration, respectively, either 28 h or 48h p.i.. For parametric testing, mean values 
of inoculation groups were compared through Tukey post-hoc testing. A P-value lower than 0.05 was 
considered statistically significant, values are represented as mean with standard deviation (P < 0.05 
*; P < 0.01 **; P < 0.001 ***). 
Bacteria were extracted as described above from randomly chosen CNS-inoculated mammary glands 
(nglands/CNS strain = 4) to validate the results of both experiments and commensal microbiota was 
determined in unchallenged lactating glands and sham-inoculated mammary glands (n = 9 and n = 4). 
All colonies were counted on Tryptic soy agar plates and streaked onto Columbia agar (Oxoïd) to 
obtain pure cultures. After 24h aerobic incubation at 37°C, colonies were checked for purity and 
identified following National Mastitis Council (NMC) procedures (Hogan, Gonzalez et al. 1999). All 
CNS were identified to the species level using transfer RNA-intergenic spacer PCR (tDNA-PCR) 
(Supré, De Vliegher et al. 2009). If no identification could be obtained, isolates were subjected to 
sequencing of the 16S rRNA gene (Park, Fox et al. 2011).  
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I.2.4. Results 
1.2.4.1. Experiment 1: Intramammary infection of mice with increasing inoculum doses of a 
S. chromogenes IM  
Staphylococcus chromogenes IM-inoculated glands at 24h p.i. displayed higher bacterial levels 
compared to sham-inoculated glands. Still, bacterial growth in the S. chromogenes IM inoculated 
glands was limited compared to the S. aureus Newbould 305 inoculated glands, regardless of the 
inoculum dose (Fig. 2 and Table 1). The presence of S. chromogenes in the challenged glands was 
confirmed. A marked increase in mammary CFU p.i. was observed in S. aureus Newbould 305-
inoculated glands compared to both the sham-inoculated glands as well as S. chromogenes IM 
inoculated glands (Fig. 2). 
Figure 2. Bacterial growth (expressed as log10CFU/g gland) in mammary glands at 24h post 
infection (p.i.) of sham- (PBS/glycerol), S. aureus- and S. chromogenes IM-inoculated mice of 
experiment 1. The line in each box represents the median of these individual datasets. The 
color and pattern code of each group correspond to these explained in Fig. 1. DL: detection 
limit.  
Upon histological evaluation, both S. aureus and S. chromogenes IM induced an influx of immune 
cells in the alveoli (Fig. 3 – B and C) which was absent in sham-inoculated glands (Fig. 3 – A). The 
latter had an intact alveolar structure with a swollen luminal area at 24h p.i. with accumulated milk. In 
S. aureus-inoculated mammary glands, the general structural integrity of the alveoli was still present 
but the milk was replaced by a vast number of invading cells (Fig. 3 – B: white arrow heads) that were 
tentatively identified as neutrophils mainly based on their characteristic polymorphonuclear feature. In 
analogy, the alveoli from the S. chromogenes IM-inoculated glands were also packed with immune 
cells (Fig. 3 – C: white arrow heads). This influx of cells in the mouse mammary gland was however 
more invasive following S. aureus inoculation as red blood cells were clearly observed in the 
interstitium which was not the case after inoculation with S. chromogenes IM (Fig. 3 – B: black arrow 
heads).  
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Table 1. Overview of the amount of bacteria
1
 in mammary glands at 24h post infection (p.i.) of 
sham- (PBS/glycerol), S. aureus- and S. chromogenes IM-inoculated mice of experiment 1. 
 
 S. aureus sham S. chromogenes IM 
CFU/inoculum 10
2
 - 10
2
 10
3
 10
4
 10
5
 
Minimum 8.32 1.57 3.34 3.44 3.38 3.08 
25% Percentile 8.49 1.60 3.47 3.51 4.14 3.18 
Median 9.00 1.72 3.54 3.95 5.13 3.87 
75% Percentile 9.06 1.86 3.76 4.04 5.38 5.84 
Maximum 9.08 1.89 3.99 4.19 5.41 6.37 
1
expressed as log10CFU/g gland 
 
1.2.4.2. Experiment 2: Intramammary infection of mice with different CNS strains 
For none of the 3 tested CNS strains, a significant overall change in the number of CFU between 28h 
and 48h p.i. was detected. At both time points p.i. no significant difference in bacterial growth was 
detected between S. chromogenes IM (6.94±1.56 log10CFU/g gland) and S. chromogenes TA 
(7.13±2.11 log10CFU/g gland) (Fig. 4). In contrast, S. fleurettii (4.41±1.01 log10CFU/g gland) was 
retrieved at significantly lower levels compared to both S. chromogenes strains (P < 0.01). Moreover, 
the first was not grown in the murine mammary gland but seems even decreased in log10CFU/g gland 
p.i. at 28h or 48h compared to the administered inoculum. In analogy with the first experiment, S. 
aureus displayed an exponential bacterial growth compared to each of the CNS p.i..  
The presence of each inoculated strain p.i. was confirmed. No distinct differences in histological 
features were observed between both time-points p.i.. All tested strains induced an influx of immune 
cells of which the majority likely consisted of neutrophils. Still, in marked contrast to S. aureus, no 
vascular congestion was observed in the interstitium after challenge with each of the CNS strains (Fig. 
5 – A, B, C and D). Corroborating the results of the first experiment, sham-inoculated control gland 
alveoli had an enlarged lumen filled with milk and lacked the presence of immune cells (Fig. 5 – E). 
Both S. chromogenes strains had a similar scattered distribution of immune cells in contrast with the 
densely packed neutrophils retrieved in the alveolar lumen of the mouse mammary glands upon 
inoculation with S. fleurettii (Fig. 5 – A , B and C).  
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Figure 3. Representative hematoxylin and eosin-stained sections of (A) sham- (PBS/glycerol) 
(B) S. aureus- and (C) S. chromogenes-inoculated mammary glands isolated from mice of 
experiment 1. The histology images in the upper panel are taken from sections sampled near 
the nipple, the ones in the middle panel near the subiliac lymph node and the ones in the 
lowest panel near the dorsal gland tissue. The white arrows mark the immune cell content in 
the alveoli, while the black arrows point to the red blood cells in the interstitium. The scale bar 
represents a length of 200µm. 
Although a lower inoculum dose was injected, cytokine quantification revealed significantly higher IL-6 
levels in the S. aureus-inoculated glands (3.11±0.17 log10IL-6 pg/ml) than in the sham- (0.93±0.19 
log10IL-6 pg/ml) or CNS-inoculated glands (1.15±0.56 log10IL-6 pg/ml, P < 0.001; Fig. 6 – A). 
Furthermore, significant differences in the local IL-6 concentrations were observed neither between 
the three CNS strains nor between the two time points p.i. within strains nor between the sham- and 
CNS-inoculated glands. A similar trend was observed for the local IL-1beta levels which were 
substantially higher in S. aureus-inoculated glands (2.97±0.14 log10IL-1beta pg/ml), compared to the 
sham- (1.06±0.42 log10IL-1beta pg/ml, P < 0.001) and CNS-inoculated glands (1.87±0.61 log10IL-1beta 
pg/ml, P < 0.05; Fig. 6 - B). Still, the differences in local IL-1beta concentrations induced by S. aureus 
compared to S. chromogenes IM, S. chromogenes TA and S. fleurettii was less pronounced between 
S. aureus and S. chromogenes TA (i.e. 0.9±0.24 log10IL-1beta pg/ml, n = 30; P < 0.05) than between 
S. aureus and the two other CNS-strains (i.e. 1.07±0.16 log10IL-1beta pg/ml for S. chromogenes IM, P 
< 0.001 and 1.34±0.15 log10IL-1beta pg/ml for S. fleurettii, P < 0.001) (Fig. 6 – B). There was again no 
significant difference in local IL-1beta concentrations between the two time points p.i. Notably, there 
was a small difference between the CNS- and sham-inoculated glands in their IL-1beta concentration 
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(i.e. 0.92±0.26 log10IL-1beta pg/ml, n = 30; P < 0.05) for both S. chromogenes strains but not for S. 
fleurettii and sham-inoculated glands. TNF-alpha levels remained below the quantification limit for 
CNS-, S. aureus- and sham-inoculated glands. Two out of 6 mice inoculated with S. chromogenes TA 
had a severe local irritation (one mouse at 28h p.i. and one at 48h p.i.). In these glands (n = 4), a more 
pronounced bacterial growth as well as higher local IL-6 and IL-1beta concentrations were observed 
compared to other glands inoculated with the same strain, explaining the high variation for S. 
chromogenes TA in Fig. 6 A and B. Such distinct differences in response among mammary glands 
inoculated with the same strain were not observed for S. chromogenes IM or S. fleurettii. Upon 
infection with each of the three CNS strains the body temperature remained normothermic (36.6 ± 0.1 
°C; n = 21). This was in marked contrast to S. aureus-inoculated mice, which initially also remained 
normothermic until at least 24h p.i. but became severely hypothermic (drop in body temperature of 7 ± 
1.6 °C, P < 0.001; n = 3) within 48h p.i.. 
Figure 4. Bacterial growth (expressed as log10CFU/g gland) in the S. aureus-, S. chromogenes 
IM-, S. chromogenes TA- and S. fleurettii-inoculated mammary glands isolated from mice of 
experiment 2 after 28h (left box) or 48h (right box). The line in each box represents the median 
of these individual datasets. (P < 0.01, **). The dotted line (*) represents the log10CFU CNS/g 
gland injected in the mammary gland of CNS-inoculated mice. The color and pattern code of 
each group correspond to the one clarified in Fig. 1. DL: detection limit. 
Because CNS can be retrieved in the milk of clinically healthy lactating dairy cows (Oikonomou, 
Bicalho et al. 2014), the residential microbiota in mammary glands of mice was verified in lactating and 
sham- inoculated glands of both experiments. Twenty-three percent of the unchallenged mammary 
glands were sterile. When non-inoculated glands contained bacteria (1.74 ± 0.77 log10CFU/g gland) a 
limited number of bacterial species were extracted and genotypically identified from the remaining 
glands: Staphylococcus lentus (23%), Kocuria spp. (7%), Bacillus spp. (7%), Alcaligenaceae spp. 
(15%), Streptococcus spp. (15%) and Microbacterium spp. (15%) (Table 2).   
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Figure 5. Representative hematoxylin and eosin-stained sections of (A) S. chromogenes IM-, 
(B) S. chromogenes TA-, (C) S. fleurettii-, (D) S. aureus- and (E) sham (PBS/glycerol)-inoculated 
mammary glands isolated from mice at 48h post inoculation of experiment 2. The white arrows 
mark the immune cell content in the alveoli, while the black arrows point to the red blood cells 
in the interstitium. The scale bar represents a length of 200µm. 
I.2.5. Discussion 
This pilot study explored the usefulness of a previously validated mouse mastitis model for bovine 
CNS research, which has been mentioned as relevant for human CNS research (Thomsen, Mogensen 
et al. 1985). A valid mouse model for CNS mastitis would circumvent the major drawbacks of cow 
challenge experiments. In the first experiment, our data unambiguously displayed limited growth in the 
murine mammary gland of the bovine CNS isolate that was administered. At 24h p.i., the glands 
inoculated with the highest inoculum dose of 10
5
 CFU of CNS colored red and had a relatively mild 
alveolar influx of immune cells compared to the mammary glands that were inoculated with S. aureus. 
The latter results corroborate the observations in cows where high inocula of CNS are necessary to 
obtain colonization in the udder as described for S. chromogenes, S. simulans and S. epidermis 
(Simojoki, Orro et al. 2009; Simojoki, Salomaki et al. 2011). Moreover, -in contrast to mastitis caused 
by S. aureus, mastitis induced by CNS is less severe and accompanied by mild local signs such as 
slight swelling of the udder and color changes in the milk (Taponen and Pyorala 2009). Remarkably, 
sham-inoculated glands were only occasionally sterile. Molecular identification of the bacteria isolated 
from these glands suggests they originate from the pups as they are closely related to the commensal 
microbiota (Martin, Langa et al. 2004) from the murine gut and respiratory system (Rodrigue and 
Lavoie 1996; Shim, Seo et al. 2009; Dimitriu, Boyce et al. 2013). These bacteria were retrieved in 
limited number compared to the inoculum and are therefore not considered to have influenced our 
results to a large extent. Actually, the same species are also isolated from dairy products i.e. raw milk 
or cheese (Quigley, O'Sullivan et al. 2011). To our knowledge this is the first time that resident 
bacteria from murine mammary glands were considered in respect to experimentally induced mastitis 
in this laboratory animal. In order to have a global profile of the microbiota in the mammary gland of 
mice a meta-genomic analysis should be performed in future research. 
B C D E A 
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Figure 6. IL-6 (A) and IL-1beta (B) cytokine levels (expressed as pg/ml cytokine in 50µg total 
protein) of S. aureus-, sham (PBS/glycerol)- and CNS-inoculated mammary glands isolated 
from mice of experiment 2 after 28h (left box) or 48h (right box). The line in each box 
represents the median of these values. (P < 0.001, ***; P < 0.05; *). The color and pattern code 
of each group correspond to the one clarified in Fig. 1. DL: detection limit. 
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In the second experiment, the mouse mastitis model allowed the comparison between three CNS 
isolates differentiated by their anticipated main reservoirs. Again, limited growth of CNS p.i. was 
observed compared to a S. aureus challenge although each of the CNS strains as well as the S. 
aureus caused a neutrophil influx following challenge. Additional cytokine data implied in general only 
a moderate pro-inflammatory immune response to a challenge with a CNS strain in comparison with 
the one to S. aureus. This corroborated bovine studies as IL-6 is retrieved following S. aureus IMI in 
contrast to CNS IMI (Hagiwara, Yamanaka et al. 2001). TNF-alpha was not detectable post-
inoculation with CNS and/or S. aureus. This corroborates TNF-alpha is highly induced by Gram-
negative mastitis pathogens in cows (Bannerman 2009) and in mice (Notebaert, Carlsen et al. 2008) 
compared to Gram-positive infections in mice. The higher virulence of S. aureus versus each of the 
tested CNS isolates suggested through histology (experiment 1 and 2) and limited cytokine profiling 
(experiment 2) could be further endorsed with the overall clinical findings in the mice. It should be 
emphasized that the host innate immune response generated by S. aureus challenge was previously 
reported by several groups (Bramley, Patel et al. 1989; Bhakdi and Tranum-Jensen 1991; Dinges, 
Orwin et al. 2000; Brouillette, Grondin et al. 2004; Chinchali and Kaliwal 2014) and therefore not 
unexpected. Our results substantiate the high sensitivity of mice towards the toxins produced by S. 
aureus in this in vivo mastitis model (Jonsson, Lindberg et al. 1985). The absence of coagulase 
production in a transformed S. aureus, remarkably diminished its intramammary virulence in mice 
(Jonsson, Lindberg et al. 1985), and most likely also relates to the minimal virulence of CNS isolates 
in mice at first observed in the current study. This lower pathogenicity of the CNS isolates compared to 
S. aureus explains the high prevalence of the former pathogens in milk of clinically healthy cows and 
their less detrimental effects during bovine mastitis (Pate, Zdovc et al. 2012; Braem, De Vliegher et al. 
2013; Oikonomou, Bicalho et al. 2014). 
Importantly, our data also reflect - at least to some extent - the difference observed in cows between 
the so-called environmental S. fleurettii and the so-called host-adapted S. chromogenes IM and S. 
chromogenes TA. Corroborating our bacterial growth, cytokine level data, the discriminating grouping 
of presumed neutrophils in the murine mammary gland sections, and the low prevalence in milk 
samples of cows allowed to speculate that S. fleurettii is able to colonize the milk habitat but is less 
likely to multiply locally compared to both S. chromogenes isolates (Piessens, Van Coillie et al. 2011; 
De Visscher, Supré et al. 2014). Although the number of animals should be increased to allow for a 
precise interpretation of the statistical relevance of our results, these suggest an underlying difference 
in the hosts’ innate immune response between S. chromogenes IM and S. chromogenes TA. More 
specifically, the S. chromogenes IM strain might be more adapted to the intramammary niche (milk 
environment) and as such induce less pathophysiological effects compared to the likely more teat-
adapted S. chromogenes TA. 
In conclusion, this study suggests that, as previously demonstrated for S. aureus, the mouse model 
can be an attractive complementary in vivo tool for bovine CNS mastitis research, however minding 
the limitations such as the presence of a commensal murine mammary gland microbiota. 
Nevertheless, it overall mimics the mild inflammation in cows induced by an IMI with CNS, through a 
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neutrophil influx accompanied either with or without a low induction of certain pro-inflammatory 
cytokines. Moreover, the limited data of our pilot study tentatively suggest that the CNS mouse model 
can distinguish the differences in host response inflicted by different isolates of the CNS group. Future 
research is however warranted and should include infection studies with longer duration besides the 
comparison of even more bovine CNS isolates. This would allow drawing reliable conclusions on the 
specific differences between CNS isolates as observed in cows. Moreover, analyzing the influence of 
the mouse strain would be valuable for the in-depth validation of our mouse mastitis CNS model. At 
last, this mouse model is potentially also an elegant tool to explore the inflammatory factors including 
cytokines that are enhanced by CNS when inducing a local neutrophil influx.  
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ADDENDUM 
 
Table 2. Residential microbiota in the mammary gland of mice. 
treatment
1
 
mammary 
gland
2
 
replicates dilution 
number of 
colonies
3
 
result 
lactating 1 A 1 - - 
lactating 1 B 1 1 Staphylococcus lentus 
lactating 2 A 1 1 Staphylococcus lentus 
lactating 2 B 1 1 Staphylococcus spp. 
lactating 3 A 1 1 Kocuria spp. 
lactating 3 B 1 - - 
lactating 4 A 1 - - 
lactating 4 B 1 - - 
lactating 5 A 1 2 Microbacterium spp. 
lactating 5 B 1 1 Microbacterium spp. 
lactating 6 A 1 1 Bacillaceae 
lactating 6 A 1 1 Staphylococcus lentus 
lactating 6 B 1 1 Staphylococcus lentus 
lactating 7 A 1 - - 
lactating 7 B 1 - - 
lactating 8 A 1 - - 
lactating 8 B 1 - - 
lactating 9 A 1 - - 
lactating 9 B 1 2 Microbacterium spp. 
sham 1 A 1 - - 
sham 1 B 1 1 Streptococcus spp. 
sham 1 A 2 55 Streptococcus spp. 
sham 1 B 2 73 Streptococcus acidominimus 
sham 2 A 1 6 Streptococcus acidominimus 
sham 2 B 1 5 Streptococcus spp. 
sham 2 A 2 31 Streptococcus acidominimus 
sham 2 B 2 49 Streptococcus acidominimus 
sham 3 A 1 31 Alcaligenaceae 
sham 3 B 1 38 Alcaligenaceae 
sham 3 A 2 5 Alcaligenaceae 
sham 3 B 2 6 Alcaligenaceae 
sham 3 A 1 22 Alcaligenaceae 
sham 4 B 1 20 Alcaligenaceae 
sham 4 A 2 2 Alcaligenaceae 
sham 4 B 2 2 Alcaligenaceae 
1
lactating mammary glands were not injected and not weaned from the litter while sham-inoculated 
glands were weaned from the litter for at least 24h prior to inoculating with PBS. 
2 
Different number 
represents a different mammary gland. 
3 
The number of colonies with a distinct phenotype compared 
to other colonies. 
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Lipopolysaccharide (LPS) is the major cell wall component of the Gram-negative pathogen 
Escherichia coli. When host cells are exposed to this Microbe-Associated Molecular Pattern, LPS 
triggers host toll-like receptor 4 signalling that results in the production and secretion of a plethora of 
inflammatory mediators. In contrast, an initial LPS stimulus protectively dampens against the 
excessive inflammatory signalling due to endotoxin shock (Zingarelli, Hake et al. 2002; Morris and Li 
2012). The phenomenon is confusingly referred to as endotoxin tolerance (ET) as it suggests a state 
of immune dysfunction or immunoparalysis (Varma, Durham et al. 2005). Although the molecular 
mechanisms are not yet fully understood, ET is now considered as a complex epigenetic 
reprogramming and not just a mere decrease in excessive sterile inflammation. Increasing reports 
using infectious mouse models with fungi, Cryptococcus neoformans, Salmonella enteritica or poly-
microbial sepsis established that the altered inflammation during an ET phenotype is concomitant with 
either an increased bacterial clearance and/or decreased colonization of the infectious agent and an 
improved survival (Lehner, Ittner et al. 2001; Cavaillon and Adib-Conquy 2006; Wheeler, Lahni et al. 
2008). 
In the context of mastitis, repeated exposure to microbial pathogens or their MAMPs have high 
implications. The milkspace of the udder is rarely sterile and therefore superinfections are common. 
However, little is known about the phenomenon and somewhat contradictory reports have been 
published. Therefore, the main aim of CHAPTER II was to assess whether preconditioning of the 
mammary gland with LPS results in a beneficial effect during the later combat of bovine S. aureus-
induced mastitis in mice. 
 
CHAPTER 
II 
PREVENTIVE MASTITIS STRATEGY 
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The aim of CHAPTER II is adapted from: Breyne K., Vanden Berghe T., Demeyere K., and Meyer 
E., Immunomodulation by Lipopolysaccharide Protects while CCL5/RANTES Partially Protects Against 
an Intramammary Infection with Bovine Staphylococcus aureus in a Mouse Mastitis Model, Manuscript 
in preparation  
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II.1. Immunomodulation by Lipopolysaccharide Protects While CCL5/RANTES Partially 
Protects Against an Intramammary Infection with Bovine Staphylococcus aureus in a Mouse 
Mastitis Model  
II.1.1. Abstract 
Studies with multiple mouse infection models demonstrated that pretreatment with lipopolysaccharide 
(LPS) - the major cell wall component of the Gram-negative pathogen Escherichia coli - can alter the 
hosts’ immune state, increasing the resistance against infectious bacteria and reducing the severity of 
the symptoms. This phenomenon has been suggested to reduce the severity of Escherichia coli- 
mastitis in cows yet the underlying molecular mechanisms are not well understood. The present study 
aimed to demonstrate that LPS pretreatment can also be effective against Staphylococcus aureus (S. 
aureus) mastitis for preventive purposes. For this purpose, a mouse model was used and it was 
assessed how the host immune response is altered during this process. An intramammary LPS bolus 
prior to administration of the mastitis pathogen significantly decreased the local levels of inflammatory 
cytokines TNF-alpha, IL-1beta, IL-6, the IL-8 homologues (CXCL1/KC and CXCL2/MIP-2) and 
CCL3/MIP-1alpha. The observations were concomitant with a reduced bacterial load and severity of 
clinical symptoms upon exposure to S. aureus. In addition, a protein array analysis confirmed that the 
chemokines CCL5/RANTES and another IL-8 homologue (CXCL5/LIX) were selectively induced. 
Applying this novel insight, the increase of CCL5/RANTES prior to the intramammary S. aureus 
infection was shown to partially mimic the beneficial immunomodulation after pretreatment with LPS. 
These novel findings in a mouse mastitis model indicate that pretreatment LPS alters the host 
inflammatory response, resulting in a low local CFU of the infectious agent. 
I.1.2. Introduction 
Lipopolysaccharide (LPS) is the major cell wall component of the Gram-negative pathogen 
Escherichia coli (E. coli). When host cells are exposed to this Microbe-Associated Molecular Pattern 
(MAMP), it triggers host toll-like receptor 4 (TLR4) signalling that results in the production and 
secretion of a plethora of inflammatory mediators. In contrast, an initial LPS stimulus protectively 
dampens the excessive inflammatory signalling due to endotoxin shock (Zingarelli, Hake et al. 2002; 
Morris and Li 2012). This phenomenon is often and confusingly referred to as endotoxin tolerance 
(ET), a name which suggests a state of immune dysfunction or immunoparalysis (Varma, Durham et 
al. 2005). Although the underlying molecular mechanisms hereof are not yet fully understood, ET is 
now considered as a complex epigenetic reprogramming and its phenotype can be mediated by a 
multitude of agents such as TNF-alpha and IL-1beta (Ferlito, Romanenko et al. 2001), lipoteichoic acid 
(Lehner, Morath et al. 2001) and CpG DNA (Yeo, Yoon et al. 2003). In contrast to the initially assumed 
immunoparalysis state,– it is now clear that the suppression of pro-inflammatory factors (typically NF-
kappaB induced signalling) during ET occurs concomitant with the activation of anti-microbial factors 
(Foster, Hargreaves et al. 2007; Biswas and Lopez-Collazo 2009; Liu, Yoza et al. 2011). It is now 
increasingly stated that this ET phenotype provides the host with an ideal strategy to reach a balance 
in its immune system. It allows to appropriately modify ongoing responses through cellular 
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reprogramming to focus on the phagocytosis of different infectious agents and dead cells and the 
healing of the affected site of infection (Pena, Pistolic et al. 2011). As such, increasing reports using 
infectious mouse models with fungi, Cryptococcus neoformans, Salmonella enteritica or poly-microbial 
sepsis established that the attenuated inflammation during an ET phenotype occurs concomitant with 
either an increased bacterial clearance and/or decreased colonization of the pathogen and improves 
survival (Lehner, Ittner et al. 2001; Cavaillon and Adib-Conquy 2006; Wheeler, Lahni et al. 2008). 
Remarkably, several aspects of the ET phenotype and its related anti-bacterial properties have widely 
been studied in macrophages, nevertheless, other innate immune cells such as neutrophils also 
seems to be prone to the ET concept (Landoni, Chiarella et al. 2012).  
Extending the observations of LPS as the key MAMP for the ET concept, indications are now 
available showing that local pretreatment with LPS or bacteria can reduce the severity of a 
subsequent mammary gland infection (Petzl, Gunther et al. 2012). Such bacterial-induced 
inflammation is called mastitis and results from either chronically or acutely infected udders, being a 
major challenge in the dairy sector and affecting both milk quality and animal welfare (Waage, Mork et 
al. 1999; Piepers, De Meulemeester et al. 2007). Bacterial udder infections can be elicited by Gram-
negative bacteria such as E. coli or by Gram-positive bacteria such as Staphylococcus aureus (S. 
aureus). Classical curative therapy to treat mastitis consists mainly of antibiotics (Vanderhaeghen, 
Cerpentier et al. 2010; Barlow 2011; Demon, Ludwig et al. 2012), while complementary anti-
inflammatory treatment is given to ease clinical symptoms during acute mastitis (Shpigel, Chen et al. 
1994). Despite all these efforts, mastitis is still difficult to eradicate from a herd. Therefore, the main 
objective of the current pilot study was to explore the potential of pretreatment with LPS in order to 
reduce the severity of a detrimental inflammatory host response, by decreasing the severity of 
symptoms while increasing bacterial clearance and/or colonization potential upon S. aureus mastitis. 
II.1.3. Materials and Methods 
II.1.3.1. Mice 
Hsd:ICR (CD1) mice were purchased from a commercial supplier (Harlan labouratories, Horst, The 
Netherlands). The mice were fed ad libitum in a controlled environment that included light and dark 
cycles (12 hours (h) light:12 hours darkness). All the protocols that involved animals were approved by 
the Committee on the Ethics of Animal Experiments of the Faculty of Veterinary Medicine, Ghent 
University (Permit Number 2014/107). Eight-week-old female mice were mated with 10-week-old male 
mice. To ease the intraductal accessibility of the lactating mothers, the 10-day old pups were weaned 
2 h before the first inoculation. All intraductal injections using a 32-gauge blunt needle were performed 
in the 4
th 
gland
 
pair of each of the mice under isoflurane anaesthesia combined with the long-acting 
analgesic buprenorphine (10 µg/kg Vetergesic, Patheon UK Ltd, Swindon, UK) and core body 
temperature was post-operative monitored with a rectal thermistor.  
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II.1.3.2. Intramammary infection model 
For the injection regimen described in Fig. 1A, mice were injected with LPS (10 µg, Sigma-Aldrich, St. 
Louis, MO, USA) diluted in 100 µl phosphate buffered saline (PBS) 6 h prior to inoculation with S. 
aureus Newbould 305 (2.5 x 10
2
 colony forming units or CFU/100µl PBS; nmice = 3; nglands = 6). These 
mice were compared to control mice that received only the same S. aureus injection (nmice = 3; nglands = 
6). For the injection regimen described in Fig. 2A, mice were injected with LPS (10 µg, Sigma-Aldrich, 
St. Louis, MO, USA) diluted in 100 µl PBS 6 h prior to inoculation with S. aureus (2.5 x 10
2
 CFU/100µl 
PBS; nmice = 6; nglands = 12). These mice were compared to control mice that received twice a PBS 
injection (nmice = 3; nglands = 6) or a PBS injection prior to the S. aureus infection (nmice = 6; nglands = 12). 
For the injection regimen described in Fig. 3A, 2.5 x 10
2
 CFU/100µl PBS of 2 bovine mastitis isolates 
i.e. E. coli P4 and S. aureus Newbould 305 were inoculated in mice (nmice = 2; nglands = 3). One 
additional mouse was included as sham control following injection of 100 µl PBS. For the injection 
regimen described in Fig. 4A, 3 groups of mice were injected with either PBS (nmice = 3; nglands = 6), or 
LPS (nmice = 3; nglands = 6) or recombinant mouse CCL5/RANTES (20 µg, Affymetrix, CA, USA) (nmice = 
4; nglands = 8) at 6 h prior to S. aureus inoculation (2.5 x 10
2
 CFU/100µl PBS).  
II.1.3.3. Bacterial growth, Cytokine analysis and Histology 
At relevant time-points post-infection (p.i.) mice were sedated by an intraperitoneal administered 
mixture of ketamine (100mg/kg Anesketin, Eurovet Animal Health BV, Bladel, The Netherlands) and 
xylazine (10mg/kg; Xylazini Hydrochloridum, Val d’Hony-Verdifarm, Beringen, Belgium) and 
subsequently euthanized through cervical dislocation. Mammary glands were harvested to determine 
local bacterial growth, analyse cytokine levels or perform histology.  
Local bacterial growth (CFU/g gland) was determined as previously described (Breyne, Cool et al. 
2014). For cytokine profiling, mammary gland lysates were prepared from homogenates as previously 
described (Breyne, Cool et al. 2014). The mouse cytokine panel A array and chemokine array (R&D 
systems, MN, USA) were performed according to the manual. Briefly, 400 µg total protein was 
incubated with a detection antibody cocktail and afterwards with a blocked nitrocellulose membrane 
containing different capture antibodies immobilized on spots. Chemiluminescent detection on a 
photographic film was performed following incubation of the membrane with streptavidin-horseradish 
peroxidase. The relative change in cyto-/chemokine levels of all inoculated glands was visualised with 
the ImageJ protein analyzer. Cyto-/chemokine quantification in the lysates was performed with specific 
Aimplex multiplex assay kits (YSL Bioprocess Development Co., CA, USA) for mouse CXCL5/LIX, 
CXCL1/KC, CCL5/RANTES, CCL3/MIP-1alpha and CXCL2/MIP-2 on a FACSArray instrument 
(Becton Dickinson, NJ, USA). For histology, mammary gland sections were stained with hematoxylin 
and eosin as previously described (Breyne, Cool et al. 2014). 
II.1.3.4. Statistics 
Statistical differences were determined for the injection regimen described in Fig.1A with an 
independent sample T-test (SPSS 20.0, IBM Corporation, Armonk, NY). The statistical differences for 
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the injection regimen described in Fig.2A and Fig.4A were determined using ANOVA tests for 
normalised data. Mean values between the different priming groups were determined through Tukey 
post-hoc testing. Values were expressed as mean with standard deviation (SD; levels of statistical 
significance P < 0.05 *; P < 0.01 **; P < 0.001 ***). 
II.1.4. Results 
II.1.4.1. Pretreatment with LPS reduces the severity of clinical symptoms concomitant 
with a low local bacterial growth and low levels of TNF-alpha, IL-1beta, and IL-6 in the 
mouse mastitis model 
Mammary glands of mice were pretreated with LPS prior to S. aureus-induced mastitis (Fig. 1A). The 
pretreatment with LPS insured that mice stayed normothermic until at least 48 h p.i. with S. aureus i.e. 
showed a mean change in body temperature of 0.4±0.6 °C at 28 h p.i. compared to 0 h., while non-
pretreated mice had a mean change of 7.0±2.8 °C at 28 h p.i. compared to 0 h as a consequence of 
the infection (Fig. 1B). Furthermore, LPS resulted in a low local bacterial growth of S. aureus p.i. 
compared to non-pretreated mice (Fig. 1C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Effect of a local LPS pretreatment on the severity of S. aureus mastitis. (A) Schematic 
presentation of the experimental set-up. Highlighted in orange are the glands treated with LPS, 
in green are the glands inoculated with S. aureus. The effect on (B) the change in body 
temperature and in (C) local bacterial load (expressed as log10(CFU/g gland) was examined at 
28 h p.i. without LPS injection and at 48 h p.i. with LPS pretreatment. Results are presented as 
mean ± standard deviation and DL = detection limit. 
In the second experiment, the proinflammatory cytokines induced p.i. with S. aureus were additionally 
verified besides the change in body temperature and the bacterial growth, now using both once and 
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twice PBS-inoculated (sham) mice as control groups (Fig 2. A). Confirming the previous differences in 
change in body temperature and in bacterial growth, pretreatment with LPS again significantly reduced 
the change in body temperature triggered in both groups by S. aureus with a significant mean 
difference of 4.3 ± 1.3 °C at 48 h p.i. (P < 0.05) between these once with PBS- and the LPS-pretreated 
groups. The latter had a similar body temperature compared to the control mice that had been twice 
inoculated with PBS (sham). Indeed, these twice PBS-inoculated control mice (sham) differed 
significantly from the once PBS-inoculated and then S. aureus-infected mice with a mean difference of 
4.2 ± 1.5 °C (P < 0.05). This observation was concomitant with a significant lower bacterial growth 
both in the infected glands pretreated with LPS (3.2 ± 0.2 log10CFU/g gland, P < 0.001) and the twice 
PBS-inoculated control mice (sham, 2.4 ± 0.2 log10CFU/g gland, P < 0.001), compared to the infected 
glands that were once PBS-inoculated (9.1 ± 0.2 log10CFU/g gland). 
Furthermore, cytokines that are typically induced with a mastitic infection were determined in the 
glands of each group (Fig. 2 C). TNF-alpha levels in the infected glands once inoculated with PBS 
(145.9 ± 13.0 pg/ml) were significantly higher than in the infected glands pretreated with LPS (20.4 ± 
11.8 pg/ml; P < 0.001) and even more so than in the twice PBS-inoculated control glands (5.6 ± 16.7 
pg/ml; P < 0.001). Similarly, IL-1beta levels were significantly higher in the infected glands once 
inoculated with PBS (1479.3 ± 106.7 pg/ml) than in the infected glands pretreated with LPS (89.6 ± 
97.4 pg/ml; P < 0.001) and even more so than in the twice with PBS-inoculated control glands (sham, 
2.2 ± 137.8 pg/ml; P < 0.001).This was also true for the IL-6 levels which were significantly higher in 
the infected glands once inoculated with PBS (1407.2 ± 82.1 pg/ml; P < 0.001) than in the infected 
glands pretreated with LPS (3.6 ± 75.0 pg/ml; P < 0.001) and sham controls (0.3 ± 106.0 pg/ml; P < 
0.001) (1407.1 ± 82.1 pg/ml; P < 0.001). 
II.1.4.2.Candidate inflammatory mediators prone to immunomodulation are identified by 
differential protein array between E. coli- and S. aureus–infected glands 
Single injection of mastitis pathogens induces high levels of cytokines. To identify the pathogen-
dependent profiles, a comparative protein array on E. coli-, S. aureus- and PBS-inoculated mammary 
glands was performed (Fig. 3A and B). Mammary gland infection by E. coli and S. aureus both 
resulted in a neutrophil influx in the alveolar lumen at 18 h p.i., while these immune cells were absent 
in the PBS-inoculated control glands (Fig. 3C).  
More specifically, the relative changes of 52 cyto- and chemokines were compared at the protein level 
for all 3 groups (Fig. 3B). Hereof, a selected panel of 14 cyto-/chemokines were analysed by both the 
mouse cytokine and the chemokine antibody array (Additional Figure 1). These protein arrays showed 
discrepancies in sensitivity. Nevertheless, except for C5a, qualitative differences in cytokine levels 
observed between E. coli- and S. aureus-infected glands were comparable. In the E. coli-infected 
glands 35 cytokines were relatively enhanced compared to PBS-inoculated (sham) control glands 
(Additional File 2). Of these, CCL5/RANTES, CCL3/MIP-1alpha and CXCL5/LIX had the highest 
values of fold induction. Moreover, when the relative levels of these 35 cytokines between both types 
of infection were compared, CCL5/RANTES and CXCL5/LIX again showed the highest fold induction 
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p.i. with E. coli compared to S. aureus. CXCL5/LIX is a murine homologue of IL-8 (Hol, Wilhelmsen et 
al. 2010). Interestingly, the two other murine IL-8 homologues CXCL2/MIP-2 and CXCL1/KC were 
differently induced in E. coli compared to S. aureus: while CXCL2/MIP-2 was equally induced by both 
pathogens compared to sham, CXCL1/KC had comparable levels in all three groups of inoculated 
glands. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Effect of a local LPS pretreatment on the local bacterial load of S. aureus and the 
mammary inflammatory cytokine response. (A) Schematic presentation of the experimental set-
up. Highlighted in white, orange and green are the glands inoculated with PBS (sham), LPS and 
S. aureus, respectively. (B) Local bacterial growth (expressed as log10(CFU/g gland) was 
examined next to the cytokines TNF-alpha (C), IL-1beta (D) and IL-6 (E). Results are presented 
as mean ± standard deviation, DL = detection limit. 
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II.1.4.3. LPS pretreatment modulates murine IL-8-like homologues differently and 
increases CCL5/RANTES, while pretreatment with the latter only partially mimics the 
immunomodulation and does not inhibit the bacterial growth 
The previously with protein array screening identified chemokines of interest being the 3 IL-8 like 
homologues (i.e. CXCL5/LIX, CXCL2/MIP-2 and CXCL1/KC), CCL5/RANTES and CCL3/MIP-1alpha 
were now quantitatively analysed in a combined set-up, extending the LPS pretreatment with 
pretreatment CCL5/RANTES (Fig. 4A). Corroborating our previous results and again based on both 
body temperature and local CFU counts, pretreatment with LPS subsequently induced a milder 
inflammation phenotype compared to a PBS injection prior to S. aureus infection. At 28 h p.i., all LPS-
pretreated mice had a normothermic body temperature differing 10.2±2.1 °C (P < 0.01, Fig. 4B) and 
4.4±0.2 log10(CFU/g) (P < 0.01, Fig. 4C) with the values of the PBS-injected control mice. As expected 
from the previous protein array screening experiment, LPS pretreatment significantly altered the local 
levels of all the studied chemokines compared to PBS-injected control mice. LPS pretreatment 
decreased cytokines that - based on our previous experiment - were not considered to be very 
pathogen dependent i.e. CXCL1/KC CXCL2/MIP-2 were decreased with LPS treatment compared to 
the PBS-inoculated mammary glands prior to S. aureus infection (Table 1). Moreover, this LPS-
pretreatment also decreased CCL3/MIP-1alpha levels compared to the non-pretreated glands. The 
LPS-induced immunomodulation was also characterized by an increase in chemokines that were in a 
previous experiment considered to be highly E. coli-dependent namely CCL5/RANTES and 
CXCL5/LIX.  
 
Table 1. Concentrations (expressed as means ± standard deviation, pg/ml per 50 µg total 
protein) of the chemokines CCL5/RANTES, CXCL1/KC, CCL3/MIP-1alpha, CXCL2/MIP2 and 
CXCL5/LIX, in the mammary glands of the mice pretreated with either LPS, or CCL5/RANTES or 
PBS prior to a second PBS or S. aureus inoculation. 
Item 
PBS 
+ 
S. aureus 
LPS 
+ 
S. aureus 
CCL5/RANTES 
+ 
PBS 
CCL5/RANTES 
+ 
S. aureus 
CCL5/RANTES 47.6 ± 7.0
a,b,c
 712.9 ± 104.2
a,d,e
 1511.0 ± 243.5
b,d
 1592.0 ± 213.8
c,e
 
CXCL1/KC 1265.0 ± 183.1
a,b,c
 617.1 ± 137.6
a,d
 204.3 ± 145.9
b,d,e
 817.7 ± 300.5
c,e
 
CCL3/MIP-1alpha 4938.0 ± 1177.0
a,b,c
 2111.0 ± 1015.0
a,d
 26.5 ± 9.0
b,d,e
 2379.0 ± 1244.0
c,e
 
CXCL2/MIP-2 7308.0 ± 371.4
a,b
 4287.0 ± 1167.0
a
 92.2 ± 25.6
b
 5808.0 ± 774.4 
CXCL5/LIX 157.0 ± 51.1
a
 785.0 ± 66.2
a,b,c
 128.9 ± 12.8
b
 189.1 ± 17.8
c
 
a-e 
Letters of homogeneous subsets were marked if the difference between treatments were 
statistically significant (P < 0.05). 
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This experiment therefore additionally verified whether the previously identified CCL5/RANTES could 
induce a host-protecting effect during S. aureus mastitis (Fig. 4A). At 28 h p.i., the latter 
CCL5/RANTES induced moderate immunomodulation resulting in an intermediate change in 
bodytemperature of 5.5±2.0 °C compared to PBS-inoculation (P = 0.06; Fig. 4B). In marked contrast, 
PBS- and CCL5/RANTES-injected mammary glands did not significantly differ in their bacterial growth 
as both groups contained on average 4.3±0.2 log10(CFU/g gland) (P < 0.01) more bacteria than those 
pretreated with LPS (Fig. 4C). The CCL5/RANTES injection also induced generally more moderate 
changes in cytokine levels than observed after LPS pretreatment (Table 1).  
Nevertheless, pretreatment with this chemokine still significantly decreased the local levels of two 
other chemokines CXCL1/KC (P < 0.01) and CCL3/MIP-1alpha (P = 0.01) compared to PBS-injected 
glands (sham), while only a trend was visible for CXCL2/MIP-2. Moreover, the local CXCL5/LIX levels 
were significantly lower (P < 0.01) with CCL5/RANTES compared to the LPS-pretreated mammary 
glands (Table 1). Of note, injection with CCL5/RANTES without subsequent infection (i.e. prior to 
sham) did not increase local CXCL1/KC, CCL3/MIP-1alpha, CXCL2/MIP-2 and CXCL5/LIX compared 
to LPS, CCL5/RANTES and PBS-injection with a subsequent S. aureus infection. In addition, the 
former injection regimen did not induce an influx of neutrophils in contrast to the the influx observed in 
the S. aureus infected glands pretreated either with LPS or CCL5/RANTES (Fig. 5). In essence, 
immunomodulation through CCL5/RANTES pretreatment has no detected disadvantage for the host. 
Fig. 4. Effect of a local CCL5/RANTES pretreatment on the severity of S. aureus mastitis . (A) 
Schematic presentation of the experimental set-up. Highlighted in orange, purple and green are 
the glands treated with LPS, CCL5/RANTES or inoculated with S. aureus, respectively while the 
ones marked in white are the PBS-inoculated mammary glands. Effect on the change in (B) 
body temperature and in (C) local bacterial load (expressed as log10(CFU/g gland) was 
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examined at 28 h p.i.. Letters of homogeneous subsets differ if the difference between 
treatments was statistically significant (P < 0.05). Results are presented as mean ± standard 
deviation, DL = detection limit. 
II.1.5. Discussion 
In current study, we first investigated whether a challenge with LPS before the establishment of a 
mammary infection may influence the detrimental immune response induced by S. aureus. Secondly, 
we searched for cytokines in the mammary gland that may be prone to altering during the LPS 
treatment based on differential cytokine array screening between E. coli - as a key source of LPS - 
and S. aureus. Thirdly, we examined the quantitative differences of these identified cytokines during 
LPS pretreatment. Finally, we checked whether cytokines upregulated as a result of LPS treatment 
such as CCL5/RANTES can mimic the immunomodulatory effect. 
Fig. 5 Representative hematoxylin- and eosin-stained sections at 28 h p.i. of (A) LPS- or (B) 
CCL5/RANTES-pretreated mammary glands prior to S. aureus mastitis, (C) CCL5/RANTES-
pretreated mammary glands prior to PBS-inoculation. The white arrows mark the alveolar 
immune cell content. The scale bar represents a length of 50 µm. 
Our investigated concept is derived from ET, a complex immunomodulatory phenomenon 
predominantly described for macrophages (Biswas and Lopez-Collazo 2009). Nowadays, this concept 
has been shown to enhance bacterial clearance or  decrease bacterial colonization and has been 
extrapolated to multiple innate immune cell types such as neutrophils through the formation of 
neutrophil extracellular traps (Landoni, Chiarella et al. 2012). In the context of bovine mastitis, the 
repeated exposure to either microbial pathogens or their MAMPs has important implications. Indeed, 
the milkspace of the udder is generally not sterile and therefore superinfections in milk are common in 
practical conditions. Nevertheless, little is known about the effect of these recurrent challenges of the 
udder and the few reports on this phenomenon are partly contradictory. One study infected cows twice 
with live E. coli which reduced the severity of the clinical symptoms associated with the second 
challenge (Suojala, Orro et al. 2008). Likewise, in an earlier study the first of both inflammation 
reactions was induced by LPS-infusion of the udder at a high dose (100 µg) which completely 
prevented the subsequent induction of E. coli mastitis in these cows (Lohuis, Van Leeuwen et al. 
1988; Lohuis, Kremer et al. 1990). In a more recent study, a low LPS dose (1 µg) - that in contrast to 
the high one didn’t induce visible clinical signs - still was able to reduce bacterial E. coli growth 10 
days after this initial LPS bolus (Petzl, Gunther et al. 2012). When the latter second inoculation was 
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replaced by a sequence of multiple intermediate LPS doses (10 µg), the inflammation reaction induced 
by the first inoculation was gradually resolved and finally a complete recovery of the milk yield and 
other parameters was obtained despite a local increase in SCC (Shuster and Harmon 1991). In 
contrast, another report which also used an intermediate second LPS dose (33 µg) induced more 
inflammation as indicated by a subsequent higher TNF-alpha production (Rainard and Paape 1997). 
Furthermore, the effect of LPS-injection on the udder does not seem to be restricted to E. coli mastitis 
but seems to be altering the an S. aureus udder infection as well. In vitro inoculation of milk obtained 
from udder quarters infused with LPS demonstrated that the growth of S. aureus in milk from these 
udder quarters was significantly inhibited (Lohuis, Kremer et al. 1990; Kauf, Vinyard et al. 2007). 
Unfortunately, when LPS was injected post- instead of pre-infection with S. aureus the effect lasted 
only temporally.  
Altogether it is important to know whether a preceding challenge with a MAMP or bacteria in the udder 
is beneficial to have. It is suggested that LPS pretreatment increases bovine epithelia to fight mastitis 
pathogens better and may enable them to protect against excessive reactions of the immune 
response (Gunther, Petzl et al. 2012). From a clinical standpoint, a preventive treatment that 
attenuates the host inflammatory response, yet improving bacterial clearance and/or decreasing of 
bacterial colonization, has obvious interest and a thorough mechanistic understanding is warranted. 
Such a beneficial effect can be the basis for novel innovative preventive treatments which are highly 
anticipated yet have remained relatively unsuccessful till date in this field (Barkema, Schukken et al. 
2006). Preventive measures are preferred over curative ones against clinical and chronic S. aureus 
mastitis as the latter are hampered both by the production of biofilms as well as the complicating factor 
of the intracellular localization in the udder epithelium of these Gram-positive bacteria (Melchior, van 
Osch et al. 2011). Hence, this limits the action and penetrance of classical antibiotics to the region of 
interest, which is reflected by an effectiveness of only 30% depending on the cows’ age and parity 
(Sol, Sampimon et al. 1997). Moreover, the overuse of antimicrobial agents in the dairy management 
is a fact and hence increases the risk of resistance to these latter drugs (Oliver, Murinda et al. 2011).  
For reasons of costs and labour-intensity a mouse mastitis model was used that was previously 
reported by our group and others as a relevant tool in ruminant mastitis research (Brouillette and 
Malouin 2005). This preclinical in vivo model was validated, applied for the molecular study of bovine 
mastitis pathogenesis (Notebaert, Carlsen et al. 2008) and used for the screening of potential novel 
therapies (Demon, Breyne et al. 2013). To study LPS immunomodulation in our mastitis model, the 
host innate immunity has to be challenged either with a single non-lethal stimulus or by a combination 
of multiple stimuli prior to infection with the bovine pathogen. In other mouse models, a decrease of 
pro-inflammatory cytokines such as IL-6 and TNF-alpha can be achieved by one LPS bolus prior to an 
infection that can be dampened even further by additional LPS pretreating boli (Lehner, Ittner et al. 
2001). The altered inflammatory response is believed to be due to a change in composition of the 
transcription factor NF-kappaB from a heterodimeric p65/p50 complex to a p50/p50 homodimer 
(Biswas and Lopez-Collazo 2009). In the mouse mammary endotoxin model, NF-kappaB activity 
occurs around 6-8 h p.i. which was therefore considered as the ideal time point to introduce a 
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subsequent bovine mastitis-associated S. aureus isolate (Notebaert, Carlsen et al. 2008). The 
transcription produces a large number of cytokines as seen with the cytokine and chemokine arrays in 
our study. These arrays indicated that single infections with bovine S. aureus- or E. coli isolates 
enhance a large number of - albeit sometimes to a different extent - cytokines in the murine mammary 
gland including IL-1beta, IL-6 and TNF-alpha. A pretreating bolus of LPS decreased the cytokines IL-
1beta and TNF-alpha which is believed to be triggered through NF-kappaB and IL-6, the latter 
signalling being likely unrelated to NF-kappaB. Both these pathways are presumed to be essential for 
a major pathogen mastitis infection in cows (Gunther, Esch et al. 2011). Our results indicate that LPS 
pretreatment does not induce the excessive inflammation that could be expected of a single LPS bolus 
but decreases pathogen-induced inflammation. This anti-inflammatory strategy has been proven to be 
effective against S. aureus mouse mastitis (Boulanger, Brouillette et al. 2007).  
Neutrophils are essential for bacterial clearance in the innate response of mastitis (Elazar, Gonen et 
al. 2010). Mice have a single receptor for CXC chemokines homologous to the bovine CXCR1 and 
CXCR2. This receptor (CXCR2) is activated by CXCL5/LIX, CXCL1/KC and CXCL2/MIP-2, the 
functional homologs of bovine CXCL8 (IL-8) (Lahouassa, Rainard et al. 2008). Although CXCL1/KC 
and CXCL2/MIP-2 are highly acknowledged, CXCL5/LIX is less well characterized but has proven its 
importance in guiding the critical mammary influx of circulating neutrophils in mice (McDonald and 
Kubes 2010). Furthermore, its homologue has occasionally been mentioned in the context of bovine 
mastitis (Pareek, Wellnitz et al. 2005; Le Marechal, Jardin et al. 2011; Petzl, Gunther et al. 2012). 
Moreover, other main neutrophil receptors - also present on macrophages - are CCR1 and CCR5 and 
they are believed to be stimulated by CCL5/RANTES and CCL3/MIP-1alpha. As such, these cell types 
are recruited to the site of infection (Diab, Abdalla et al. 1999; Pan, Parkyn et al. 2000; Hartl, Krauss-
Etschmann et al. 2008). These chemokines and receptors are also expressed in cows and activated 
during mastitis (Buitenhuis, Rontved et al. 2011; Widdison and Coffey 2011). We verified whether 
these neutrophil-recruiting chemokines could be detected in our mouse model and whether they were 
modulated during LPS pretreatment. A broad protein array screening comparing early E. coli-, S. 
aureus- and sham-inoculated mammary glands of mice indicated whether they were of essence for 
mastitis. Unexpectedly, the host response patterns of these cytokines were differently influenced by 
the pathogens in the mammary gland. The chemokines CCL5/RANTES and CXCL5/LIX were 
selectively enhanced with an E. coli infection, while MIP-1alpha was present in both S. aureus- and E. 
coli-infected glands albeit much higher after E. coli. In contrast, CXCL2/MIP-2 was equally enhanced 
in both S. aureus- and E. coli-infected glands and CXCL1/KC was almost not enhanced by both these 
pathogens compared to sham. When LPS was injected prior to S. aureus we again detected a 
decrease in inflammatory signalling by the cytokines MIP-1alpha, CXCL2/MIP-2 and CXCL1/KC. 
Furthermore, we also showed that the LPS pretreatment is not a mere decrease of inflammation but 
can be better appreciated as immunomodulation because it also actively increased CCL5/RANTES 
and CXCL5/LIX.  
Immunomodulation can be triggered by cytokines without LPS. It was shown that TNF-alpha treatment 
can decrease cytokines comparable to a LPS pretreatment (Ferlito, Romanenko et al. 2001). As such, 
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TNF-alpha primed bovine neutrophils have an enhanced oxidative burst upon their subsequent 
stimulation (Sample and Czuprynski 1991). While cytokines are decreased, other cytokines are 
preferably enhanced during LPS pretreatment and are suggested to be host-protecting. The latter 
authors detected also an increased gene expression of chemokines such as IL-8 and CCL5/RANTES 
in addition to antimicrobial and tissue protecting factors, concomitant with a decrease in key 
inflammatory cytokines (including IL-6) and other immune effectors (Gunther, Petzl et al. 2012). To 
evaluate its potential host-protecting effect, we injected the chemokine CCL5/RANTES. Although 
CCL5/RANTES did not elicit an immune response and immune cell influx per se, it could nonetheless 
decrease some immune-tolerant cytokines when injected prior to a S. aureus infection. More 
specifically, while the local levels of CXCL1/KC and CCL3/MIP-1alpha decreased comparably as upon 
LPS pretreatment and the decrease in local CXCL2/MIP-2 levels was far less pronounced. 
Furthermore, no increase of the other host-protecting chemokine CXCL5/LIX was observed following 
CCL5/RANTES pretreatment in contrast to LPS pretreatment. 
In addition to the significant modulation of local cytokine levels upon LPS treatment, there an inhibited 
local bacterial growth and increased survival rate following a subsequent S. aureus infection. The 
phenotype is believed to be reasoned by an increased neutrophil influx and amplify the killing and 
antigen presentation state macrophages (Ariga, Abatepaulo et al. 2014; de Lima, Sampaio et al. 
2014). This phenomenon is in contrast to what would be expected from just lowering immunity and 
suggests an active process through the enhancement of specific cytokines. As demonstrated here, the 
results cannot be solely attributed to the enhancement of CCL5/RANTES alone as the 
immunomodulation of this cytokine alone could not mimic the bacterial clearance and/or decrease in 
bacterial colonization and only partially - but not significantly – dampened the severity of the clinical 
symptoms. Nevertheless, a non-detrimental challenge seems to provoke an enhanced basal alertness 
of the mammary gland and our findings suggest that future mastitis research should further elaborate 
these functions of cytokines which are enhanced as a consequence of LPS pretreatment. 
In conclusion, our results demonstrated that the mouse mastitis model can be used to study the 
complex innate immunity alterations by a LPS pretreatment as observed in experimentally infected 
cows. Furthermore, we at first showed that the concept of LPS pretreatment is able to modulate 
inflammatory response, bacterial growth and the reduction of S. aureus virulence in vivo. Moreover, 
although the beneficial effect elicited by the chemokine CCL5/RANTES were only moderate compared 
to that observed by LPS, we suggest that the former immunomodulation can be ameliorated with 
complementary cytokines. 
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Antibiotics have been and still are the main curative measure against bovine mastitis. The most 
effective therapy - as dictated by the National Mastitis Council (NMC_Guidelines 2014). - is to 
administer a long-acting antibiotic during the dry-off period, preferably after thorough characterization 
of the causal pathogen. Generally, the efficacy of antibiotics against these pathogens is at first 
demonstrated in vitro. The well-known dilution methods (Minimum Antibiotic Growth or MIC) 
(Tenhagen, Köster et al. 2006), disk diffusion methods (Pillar, Stoneburner et al. 2014), specific 
bioassays (Owens and Watts 1988), E-tests (Gentilini, Denamiel et al. 2002) or genotypic methods 
(Moon, Lee et al. 2007) all suggest which antibiotic should be used against a certain mastitis-
associated pathogen and in which concentration. However, mastitis-associated bacteria are 
pathogens that thrive in the high-caloric milk matrix with changing composition, as well as in an 
anaerobic or facultative aerobic atmosphere, form biofilms, nestle intracellularly, and induce local 
inflammation. These complex features are very difficult to mimic in vitro and may hence lead to wrong 
conclusions drawn from the above-mentioned methods (Owens, Ray et al. 1997; Olson, Ceri et al. 
2002). Moreover, different formulations of the antibiotics’ excipients influence their efficacy in the 
udder, an aspect which is again not feasible to evaluate in vitro. Therefore, veterinary researchers as 
well as R&D departments from Animal Health Companies increasingly utilize an intermediate in vivo 
step to check which antibiotic is best fitted to treat a selected mastitic infection without the cost and 
other disadvantages of using cows (Brouillette, Grondin et al. 2004).  
The first aim of CHAPTER III was to evaluate whether the mouse mastitis model is suited to test the 
efficacy of different first generation Cephalosporins and excipients against an intramammary bovine S. 
aureus infection. The second aim of CHAPTER III was to evaluate whether this mouse model is also 
suited to check a novel broad-spectrum antibiotic against different bovine mastitis-associated isolates. 
It should be highlighted that although K. Breyne is not the first author of this work, he has made 
significant contributions to both papers. Indeed, under the direct leadership of Dr. D. Demon, K. 
Breyne helped in conceiving and designing the experimental set-up, assisted during the experiments, 
supported in analyzing the data and reviewed the manuscripts. Moreover, the latter have not and will 
not be used in other PhD theses.  
CHAPTER 
III 
CURATIVE MASTITIS 
STRATEGY 
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First aim of CHAPTER III is adapted from: Demon D., Ludwig C., Breyne K., Guede D., Dorner J.C., 
Froyman R., Meyer E., The intramammary efficacy of first generation cephalosporins against 
Staphylococcus aureus mastitis in mice, Vet Microbiol. (2012) 160:141-150. 
Second aim of CHAPTER III is adapted from: Demon D., Breyne K., Schiffer G., Meyer E., Short 
communication: Antimicrobial efficacy of intramammary treatment with a novel biphenomycin 
compound against Staphylococcus aureus, Streptococcus uberis, and Escherichia coli-induced 
mouse mastitis, Journal of Dairy Science. (2013) 96:7082-7087. 
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EXPERIMENTAL STUDIES 
III.1. Intramammary Efficacy of First Generation Cephalosporins against Staphylococcus 
aureus Mastitis in Mice. 
III.1.1. Summary 
Staphylococcus aureus-induced mastitis in cattle causes important financial losses in the dairy 
industry due to lower yield and bad milk quality. Although S. aureus is susceptible to many 
antimicrobials in vitro, treatment often fails to cure the infected udder. Hence, comprehensive 
evaluation of antimicrobials against S. aureus mastitis is desirable to direct treatment strategies. The 
mouse mastitis model is an elegant tool to evaluate antimicrobials in vivo while circumventing the high 
costs associated with bovine experiments. An evaluation of the antimicrobial efficacy of the 
intramammary applied first generation cephalosporins cefalexin, cefalonium, cefapirin and cefazolin, 
was performed using the S. aureus mouse mastitis model. In vivo determination of the effective dose 
2log10 (ED2log10), ED4log10, protective dose 50 (PD50) and PD100 in mouse mastitis studies, support that 
in vitro MIC data of the cephalosporins did not fully concur with the in vivo clinical outcome. Cefazolin 
was shown to be the most efficacious first generation cephalosporin to treat S. aureus mastitis 
whereas the MIC data indicate that cefalonium and cefapirin were more active in vitro. Changing the 
excipient for intramammary application from mineral oil to miglyol 812 further improved the 
antimicrobial efficacy of cefazolin, confirming that the excipient can influence the in vivo efficacy. 
Additionally, statistical analysis of the variation of S. aureus-infected, excipient-treated mice from 
fourteen studies emphasizes the strength of the mouse mastitis model as a fast, cost-effective and 
highly reproducible screening tool to assess the efficacy of antimicrobial compounds against 
intramammary S. aureus infection. 
III.1.2. Introduction 
Mastitis provokes detrimental damage to epithelial cells. Hence, it jeopardizes milk production and 
entails prohibitive costs in the dairy industry (Piepers et al., 2007). Staphylococcus aureus is 
historically one of the most important causes of subclinical mastitis and clinical mastitis that becomes 
chronic (Piepers et al., 2007 and Tenhagen et al., 2009). Despite intensive research and multiple 
preventive measures (NMC, 2006), the dairy industry has not managed to eradicate S. aureus mastitis 
(Zadoks and Fitzpatrick, 2009). So, antimicrobial therapy remains an essential component of 
staphylococcal mastitis control programs. The major concern with S. aureus infections is that once 
established they are extremely difficult to eradicate from the mammary gland. Although S. aureus is 
susceptible to numerous antibiotics in vitro (Erskine et al., 2002 and EUCAST, 2011), this pathogen 
has developed several features to influence the host immune system and to escape from antimicrobial 
treatment (Barkema et al., 2006). 
Over 50% of the single component preparations on the dairy market in Belgium are cephalosporins 
(BCFI, 2011). Together with penicillins they belong to the group of β-lactam antibiotics, but are less 
susceptible to inactivation by S. aureus β-lactamases. The first generation cephalosporins show good 
activity against bovine S. aureus species in vitro (Table 1). Notably, these species show very low 
resistance rates against first generation cephalosporins (Erskine et al., 2002, Kaspar, 2006 and 
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Maran, 2010), an encouraging advantage with regard to public safety and antimicrobial efficacy. The 
aim of the current study was to assess in vivo side-by-side the intramammary efficacy of the 4 first 
generation cephalosporins cefalexin, cefalonium, cefapirin and cefazolin in the S. aureus mouse 
mastitis model. In addition, the efficacy of cefazolin was evaluated using two different excipients. 
Finally, the reproducibility of the mouse mastitis model was statistically analyzed to evaluate its 
robustness. 
Table 1. Distribution of the Minimal Inhibitory Concentration 50 (MIC50), MIC90, MIC range and 
number of samples for cefalexin, cefalonium, cefapirin and cefazolin against Staphylococcus 
aureus species isolated from bovine mastitis cases worldwide. MIC50 and MIC90 are the 
epidemiological MICs that indicate that 50% and 90%, respectively, of the S. aureus strains 
have a MIC below this value.  
Cephalosporin 
MIC50 
(μg/ml) 
MIC90 
(μg/ml) 
Range 
(μg/ml) 
Number of 
samples 
References 
Cefalexin 4.0 4.0 1.0–8.0 119 Guerin-Faublee et al. 
 
4.0 128 0.50–256 102 EUCAST 
Cefalonium 0.08 NR 0.04–0.08 330 Groothuis and Frik 
Cefapirin 0.50 0.50 ≤0.06–1.0 135 Watts et al. 
 
0.25 0.50 ≤0.06–64 79 Salmon et al. 
 
0.125 0.25 ≤0.06–0.25 20 Owens et al. 
 
0.12 0.25 0.03–0.50 119 Guerin-Faublee et al. 
 
≤1 ≤1 ≤1–4 331 Sato et al. 
Cefazolin 0.39 0.39 0.20–1.56 51 Yoshimura et al. 
 
0.25 0.50 0.063–32 105 Brix 
 
0.50 0.50 0.12–1.0 119 Guerin-Faublee et al. 
 
0.25 1.0 0.125–2.0 30 Nunes et al. 
 
0.50 4.0 0.064–32 19,051 EUCAST 
NR = Not Reported 
III.1.3. Materials and methods 
III.1.3.1. Antibiotics and excipients 
Cefalexin (ABCR GmbH & Co. KG, Germany), cefalonium (Sigma–Aldrich, Germany), cefapirin (Fluka 
Analytical, Switzerland), cefazolin (ABCR GmbH & Co. KG, Germany) and excipients (mineral oil and 
miglyol 812) were provided as ready to use suspensions by Bayer Animal Health GmbH. 
III.1.3.2. S. aureus inoculum preparation 
S. aureus Newbould 305 (ATCC 29740) was used for infection. This bacterial strain was isolated from 
a clinical mastitis case in 1958 (Prasad and Newbould, 1968) and is since widely used for 
experimental intramammary infection of cows (Gudding et al., 1984 and Schukken et al., 1999) and 
mice (Brouillette et al., 2004). Overnight brain heart infusion (BHI; Oxoid Limited, Belgium) cultures of 
S. aureus were diluted in sterile phosphate-buffered saline (PBS; Gibco, Belgium) and quantified by 
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flow cytometry (BD Biosciences, Belgium). Briefly, 1 ml of a 1000-fold PBS-diluted bacterial 
suspension was added to a TRU count tube (BD Biosciences), which contained a known number of 
fluorescent beads. The number of bacteria was then calculated using the following equation: 
                
                                                 
           
 
The actual colony forming units (CFU) of the inoculum was confirmed by overnight culture of a serial 
logarithmic dilution on tryptic soy agar (TSA; Oxoid Limited) plates. 
III.1.3.3. Minimal inhibitory concentration (MIC) determination 
Determination of the MIC of the 4 first generation cephalosporins for the bovine mastitis isolate S. 
aureus Newbould 305 was performed using the Mueller–Hinton agar dilution assay according to CLSI 
guidelines (CLSI, 2008). Plates were incubated at 35 °C (±2 °C) for 16–20 h in an aerobic 
atmosphere. 
III.1.3.4. Staphylococcal mouse mastitis model 
The general procedure for mouse mammary gland infection was adapted from the method used by 
Brouillette et al. (2004). Briefly, CD-1 lactating mice (Harlan Labouratories Inc., Netherlands) were 
utilized 12–14 days after birth of the offspring. The mice typically weigh 50 g at that time. The pups 
were weaned 1–2 h before bacterial inoculation of the mammary glands. A mixture of oxygen and 
isoflurane (2–3%) was used for inhalational anesthesia of the lactating mice. A syringe with 32-gauge 
blunt needle (Thiebaud Biomedical Devices, France) was applied to inoculate both L4 (on the left) and 
R4 (on the right) glands of the fourth abdominal mammary gland pair with approximately 150 CFU of 
S. aureus. Each orifice was exposed by a small cut at the near end of the teat and 100 μl of the 
inoculum was injected slowly through the teat canal. The cephalosporin formulations were instilled into 
the mammary gland of anesthetized mice using the desired dose (μg/gland) and excipient, usually 
mineral oil, at 4 h after bacterial inoculation. This 4 h time point was chosen, because a relevant 
bacterial load of about 5log10 CFU/g gland together with phagocytosed bacteria are typically observed 
at that time (Brouillette et al., 2004). Immediately thereafter the postoperative analgesic Buprecare 
(Codifar NV, Belgium) was administered intraperitoneally, i.e. at 4 h after bacterial inoculation. The 
animal experiments were approved by the Ethical Committee of the Faculty of Veterinary Medicine, 
Ghent University (EC2009/010). In all studies, a group with S. aureus-infected, excipient-treated mice 
(“excipient control group”) was compared with several test groups, in which mice were infected with S. 
aureus and treated with a particular dose of a cephalosporin. The control groups in the different 
studies were generally composed of 2 mice (4 mammary glands). The test groups were generally 
composed of 4 mice (8 mammary glands). Detailed information on the used dosages and number of 
glands per group is provided in Table 2 and Table 3. 
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III.1.3.5. Mammary gland homogenization and CFU quantification 
After sacrifice of the mice by cervical dislocation at 14 h post-treatment, mammary glands (two per 
mouse) were harvested, weighed and homogenized on ice in sterile PBS using a tissue ruptor 
(QIAGEN Benelux BV, Netherlands). The mammary glands, which are structurally separate, were 
considered as individual samples. Bacterial CFU counts were obtained after quantification of serial 
logarithmic dilutions of mammary gland homogenates on TSA plates and transformation of the raw 
CFU counts into base 10 logarithm values. The detection limit (DL) was 3log10 CFU/g gland weight for 
the cefalonium and cefapirin dose-titration studies. Further optimization of the serial dilution technique 
for plating resulted in a decrease of the DL to 1.7log10 CFU/g gland weight. This lower DL was handled 
in the cefalexin and cefazolin dose titration, the intra-experimental comparative and the excipient 
studies. Importantly, the data collected in the studies with the 20-fold higher DL had no impact on the 
final conclusions, as was verified in the intra-experimental comparative study. 
III.1.3.6. Calculation of the effective (ED) and protective dose (PD) for each cephalosporin 
The mean intramammary CFU/g gland of S. aureus-infected glands from mice treated with different 
doses of each of the 4 cephalosporins (“test groups”) are compared with each other and with the 
mean CFU/g gland of infected glands from mice injected with excipient only (“excipient control group”). 
To evaluate the dose–response relationship for each cephalosporin the ED2log10, ED4log10, PD50 and 
PD100 were calculated. The ED2log10 and ED4log10 values are the concentrations of the cephalosporin 
needed to reduce the mean CFU/g gland from the control group by 2log10 and 4log10, respectively. 
The PD50 and PD100 are the doses of cephalosporin needed to observe respectively 50% and 100% of 
cleared mammary glands (with CFU/g below DL). To calculate the ED values, the CFU/g gland were 
analyzed separately with a mixed-effect Emax model as a function of the dose. The model was 
parameterized as follows: 
 
           
           
          
               
eps (epsilon) is the residual variability, assuming an independent normal distribution: eps ∼ N(0, σ 2). 
Animal is the inter-animal variability, assuming an independent normal distribution: Animal ∼ N(0, 
    
 ). CFU/g gland below the DL were censored at log10(DL) and the cumulative normal distribution 
was specified in the likelihood function. E0 estimates the overall arithmetic mean CFU/g gland in the 
untreated group and Emax estimates the maximum change to the CFU/g gland. Because the CFU/g 
gland for mice of the control group were all comparable (see Section III.1.3.7), they were pooled to 
increase the precision to estimate E0. The ED50 is the dose required to produce 50% of the maximal 
effect. 
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The ED4log10 dose was determined as: 
 
          
        
       
 
 
The ED2log10 dose was determined as: 
 
          
        
      
 
 
To calculate the PD50, the proportion of cleared glands versus the compound dose was analyzed 
using a logistic regression model, i.e. cleared/not cleared. The model was defined as: 
Logit(P.(gland is cleared))=intercept+slope×dose 
The PD50 was determined from the model as: 
 
      
         
     
 
 
The PD100 cannot be calculated from the model and was therefore deduced from the experimental 
data. To compare the efficacy of the cephalosporins in the separate dose-titration studies with their 
efficacy in the comparative study, the Emax model described above was estimated again for each 
compound separately and by pooling all data from the separate dose-titration and the comparative 
studies. For each cephalosporin, the mean CFU/g gland were compared between the separate and 
the comparative study with a mixed-effect analysis of variance (ANOVA) model. The model was 
parameterized as follows: 
 
Mu = mean(logCFU)|study + animal + eps 
 
mean(logCFU)ǀstudy is the mean value observed from the separate or the comparative study. The 
difference between the study means was calculated as: 
diff = mean (logCFU)|comparative study − mean(logCFU)|separate study 
All statistical analyses were carried out using SAS v 9.2 under PC windows. The 
estimations and tests were performed with the NLMixed and GenMod procedures in 
SAS. 
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II.1.3.7. Analysis of the reproducibility of the S. aureus mouse mastitis model 
The CFU/g gland of 14 excipient control groups, i.e. mice inoculated with S. aureus and treated with 
mineral oil, were included in the statistical analysis. The data of 6 of the 14 groups is presented in the 
current manuscript. The data of the additional 8 excipient control groups were from other studies, in 
which mice were inoculated with S. aureus and treated with mineral oil, performed in our research unit 
(data not shown). The evaluation was performed according to the analysis of reproducibility based on 
linear mixed-effect models (Stanish and Taylor, 1983). Three items were addressed to evaluate the 
reproducibility of the model. At first, to assess change over time, the CFU/g gland were analyzed with 
a mixed-effect linear regression as a function of time. The model included the mean-centered study 
date as covariate. The significance of the change with time was assessed using an F-test at the 2-
sided 5% level. If not significant, a reduced model without time effect was estimated. Then, to evaluate 
the main sources of variability within and across studies, a linear mixed-effect model was applied to 
the CFU/g gland. The total variability was broken down into 3 distinct sources, i.e. (a) the variability 
across studies (inter-study variability), (b) the variability across animals (intra-study variability) and (c) 
the variability between the left and right gland of each animal (intra-animal variability). The intra-class 
correlation coefficients (ICC) were calculated to quantify the degree of consistency: 
- The intra-study level ICC: 
 
         
        
 
      
         
            
  
 
- The intra-animal level ICC: 
 
           
        
          
 
      
         
            
  
 
The ICC values range between 0 and 100%. A large (small) value indicates strong (weak) agreement 
in the response within the component. It is typical to consider that a value below 40% indicates poor 
correlation, whereas a value greater than 75% indicates excellent correlation. Prior to these 
calculations, the upper and lower outlier studies were removed by using the Cook's distance for each 
study to determine the influence of the study on the results. Finally, it was determined what could be 
considered as a normal CFU/g gland in any future study. The range of plausible individual and mean 
CFU/g gland was predicted using Bayesian posterior predictive methods. A flat prior was specified for 
all parameters, making the likelihood function the posterior. The predicted distribution of CFU/g gland 
was evaluated for several glands and mice per study. 95% prediction intervals were calculated to 
obtain acceptance ranges for subsequent studies.  
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III.1.4.Results 
III.1.4.1. Minimal inhibitory concentration of cephalosporins 
The MIC of the 4 compared first generation cephalosporins against the bovine mastitis isolate S. 
aureus Newbould 305 ranged between 0.06 and 4 μg/ml, approximating previously determined MIC50 
values (Table 2). The MIC value of the 4 cephalosporins overall indicates adequate antimicrobial 
activity against S. aureus Newbould 305. 
 
 
 
Fig.1. S. aureus count reduction (CFU/g gland) at 14 post-treatment in mouse mammary glands 
treated with multiple doses of cefalexin (A), cefalonium (B), cefapirin (C) and cefazolin (D). An 
artificial detection limit (DL) was drawn at 3log10 for cefalexin and cefazolin to allow 
straightforward comparison with cefalonium and cefapirin, for which 3log10 was the 
experimental DL. Data details are summarized in Table 2. Dashed line: experimental DL. Dotted 
line: artificial DL.  
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III.1.4.2. Assessment of cephalosporin efficacy in S. aureus-induced mouse mastitis 
a. Dose titration studies 
The in vivo dose–response relationship of each cephalosporin was analyzed in 4 separate dose 
titration studies, from which the ED2log10, ED4log10, PD50 and PD100 were calculated (Fig. 1 and Table 2). 
The ED2log10 value of the 4 cephalosporins was found to be similar, ranging between 27 and 58 
μg/gland. This indicates that all 4 compounds can clear 99% of the bacteria at a low dose. In contrast, 
the ED4log10 value, i.e. 99.99% bacterial clearance, of the 4 cephalosporins varied substantially, 
ranging between 65 μg/gland for cefazolin and 248 μg/gland for cefapirin. The PD50 values also varied 
substantially between 117 μg/gland for cefazolin and >2000 μg/gland for cefapirin, indicating that the 
antibacterial efficacy of the 4 cephalosporins can be better discriminated when tested at higher doses 
(Table 2). This variation is also reflected in the dose needed to eradicate all bacteria from the glands 
(PD100). For example, 200 μg/gland cefazolin eradicates all bacteria in all mammary glands to at least 
the DL, while not one of the analyzed cefalexin or cefapirin doses was able to achieve this objective 
(Table 2). Notably, the DL was 3log10 CFU/g gland weight for the cefalonium and cefapirin dose-
titration studies and 1.7log10 CFU/g gland weight for the cefalexin and cefazolin studies. Importantly, 
the conclusion was identical when the DL was artificially drawn at 3log10 CFU/g gland weight for the 
cefalexin and cefazolin studies (Fig. 1 and Table 2), indicating the negligible influence of the 
alternative DLs on the data. 
 
 
 
 
 
 
Figure 2. S. aureus count reduction (CFU/g gland) at 14 post-treatment in mouse mammary 
glands treated with a selected dose of cefalexin, cefalonium, cefapirin and cefazolin. Of note, 
cefalonium was analyzed in 2 concentrations, because the detection limit in the cefalonium 
study (Fig. 1) did not allow unambiguous identification of the optimal dose to be compared in 
this comparative study. Data details are summarized in Table 3. Dashed line: experimental 
detection limit. 
b. Confirmatory study 
To rule out inter-experimental variations, a selected dose of each of the 4 cephalosporins was 
compared in the same study (Fig. 2 and Table 3). The selected dose for each cephalosporin was the 
dose in the separate dose-titration studies that reduced the bacterial load virtually to the DL in the 
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majority of the mammary glands. This dose was 200 μg/gland for cefazolin and cefalonium. 
Nonetheless, the less sensitive DL in the cefalonium dose-titration study may have masked bacterial 
growth which would have been detected with the lower DL of 1.7log10. Therefore, a dose of 400 
μg/gland cefalonium was also included. Since a dose that cleared all bacteria in nearly all mammary 
glands was not observed for cefalexin nor cefapirin, the highest dose of 400 μg/gland was chosen for 
both compounds. The mean CFU/g gland of cefalexin, cefalonium and cefazolin in the dose-titration 
studies did not differ significantly with its respective mean in the intra-study (p = 0.15, 0.87, 0.14 
respectively), indicating adequate reproducibility. Although there was significantly more reduction in 
the mean CFU/g gland for cefapirin in the confirmatory study than in the dedicated dose-titration study 
(p = 0.003), the ranking of efficacy for the four cephalosporins in the former study corroborated well 
the efficacy results obtained in the dose titration studies. 
Table 3. Intra-study comparison of (1) a selected dose of cefalexin, cefalonium, cefapirin and 
cefazolin, and (2) the influence of the excipient on the efficacy of cefazolin in the mouse 
mastitis model of S. aureus infection. CFU: colony forming unit; SD: standard deviation. 
Treatment 
Dose 
(μg/gland) 
Number 
of 
Glands 
CFU/g 
gland 
(log10) 
Glands cleared 
(%) 
Mean SD 
(1) Mineral oil 0 4 7.81 0.42 0 
Cefalexin 400 6 1.98 0.28 33 
Cefalonium 200 4 3.44 1.21 25 
Cefalonium 400 6 1.70 0.00 100 
Cefapirin 400 6 2.06 0.45 50 
Cefazolin 200 6 2.33 0.98 66 
(2) Mineral oil 0 10 7.64 0.18 0 
Cefazolin in mineral 
oil 
100 8 3.88 0.62 0 
Cefazolin in Miglyol 
812 
100 8 1.89 0.53 88 
 
c. Antibacterial efficacy of cefazolin suspended in two excipients 
The influence of the excipient on the in vivo antibacterial activity was evaluated by comparing the 
therapeutic efficacy of 100 μg/gland cefazolin suspended in either mineral oil or miglyol 812 (Fig. 3 
and Table 3). The mean CFU/g gland for mineral oil-suspended cefazolin was reduced with 3.7log10, 
when compared with the mean CFU/g gland from the negative control group. Miglyol 812-suspended 
cefazolin decreased the mean CFU/g gland nearly to the DL. 
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Figure 3. S. aureus count reduction (CFU/g 
gland) at 14 post-treatment in mouse mammary 
glands treated with 100 μg/gland cefazolin 
suspended in either mineral oil or miglyol 812. 
Data details are summarized in Table 3. Dashed 
line: experimental detection limit. 
 
 
 
d. Assessment of the reproducibility of the mouse mastitis model 
The mean CFU/g gland of the excipient control groups, i.e. S. aureus-inoculated mice treated with 
mineral oil, from the 6 studies included in the current manuscript and 8 other studies performed in our 
research unit (n = 14) were statistically analyzed on three levels to evaluate the robustness of the S. 
aureus mouse mastitis model. At first, the variation over time was assessed (Fig. 4A). The mean 
CFU/g gland across all studies is 8.06log10 ± 0.11. There is a negligible, non-significant (p = 0.133) 
trend toward an increase in CFU/g gland with time (0.02log10 ± 0.01 per month). Secondly, the inter-
study, intra-study and intra-animal variability together with the intra-study and intra-animal level ICC 
estimates were evaluated. The inter-study variability is 0log10 CFU/g gland. The intra-study variability 
is 0.65log10 CFU/g gland and is identical to the total variability. The intra-study level ICC is 0.0%, 
indicating no reciprocal dependency among the animals within a study group. As a consequence of 
this, the results are completely reproducible and exchangeable across the studies. The intra-animal 
variability is 0.40log10 CFU/g gland, also showing a reasonable degree of consistency (ICC = 
61.66%). Finally, to predict normal ranges for future studies, the distribution of plausible CFU/g gland 
in a future study counting 4 animals was calculated. In addition, the 98% prediction ranges for CFU/g 
gland in a single gland and in a single animal (2 glands) were predicted (Fig. 4B). The estimated 
CFU/g gland are close to 8.06log10, which is identical with the mean CFU/g gland across the studies. 
Logically, the more glands included, the more precise the estimation of the CFU/g gland becomes. 
III.1.5. Discussion 
Antimicrobial drug research both into novel antibiotics and improved formulations in cows associated 
with several limitations such as stringent ethical constraints and excessive costs. A valid strategy to 
circumvent the high costs associated with screening studies in cattle but still determine the in vivo 
potential of candidate antimicrobials, is their analysis in the experimental mouse mastitis model. The 
latter model was characterized for S. aureus in 2004 and suggested as a valuable and highly 
reproducible intermediate in vivo alternative for antimicrobial efficacy studies (Brouillette et al., 2004). 
This aspect is supported in the current study by the high reproducibility over time for the S. aureus 
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load (CFU/g gland) of the excipient control group from 14 independent studies performed in our 
research unit. Analysis of the inter-study, intra-study and intra-animal variability also indicated that the 
results are highly reproducible across the studies. 
The first generation cephalosporins cefalexin, cefalonium, cefapirin and cefazolin make up one third of 
the single component antibiotics on the Belgian market currently used to treat mastitis (BCFI, 2011). 
Both in vitro and bovine field studies evaluated the efficacy of these 4 cephalosporins individually 
(Apparao et al., 2009, Bradley et al., 2010, Maneke et al., 2011, Moroni et al., 2006, Nunes et al., 
2007 and Roy et al., 2009). However, a side-by-side comparison of their in vivo antimicrobial efficacy 
has never been performed. The present study addressed this issue by evaluating the dose–response 
relationship in a dose-titration experiment for each of the 4 cephalosporins and by a subsequent 
confirmatory comparison of a selected dose. In addition, the influence of the excipient on the efficacy 
of cefazolin was evaluated. 
From the 7 cephalosporins, i.e. 4 first, 2 third and 1 fourth generation, that have been described for 
mastitis treatment, only cefapirin (1st), ceftiofur (3rd) and cefoperazone (3rd) have been analyzed in 
the S. aureus-induced mouse mastitis model (Anderson and Craven, 1984, Brouillette et al., 2004 and 
Yancey et al., 1987). Comparison of our study results with those of the aforementioned authors is 
informative. However, making strong statements based on such comparison would be inappropriate 
as the experiments were performed with different mouse and/or S. aureus strains, with variable 
bacterial inoculation doses, and with different antimicrobial doses, administration routes and 
incubation times. Converting the intramammary PD50 doses obtained in our studies into PD50 doses 
expressed as mg/kg bodyweight (BW), assuming a mean mouse BW of 50 g, results in PD50 doses of 
>40, 7.2, >40 and 2.3 mg/kg for cefalexin, cefalonium, cefapirin and cefazolin, respectively. The PD50 
(confusingly named ED50 by Yancey) of ceftiofur and cefoperazone is respectively 0.8 and 1.8 mg/kg 
with a higher bacterial inoculation dose and a longer incubation time (Yancey et al., 1987). It is 
therefore likely that both these third generation cephalosporins have similar antimicrobial potential as 
cefazolin but are more efficacious than the other analyzed first generation cephalosporins. Likewise, 
intramammary injection of 8 mg/kg cefapirin in our study reduced the median bacterial growth with 
4.5log10, which approximates the 3.6log10 reduction after intravenous injection of 10 mg/kg cefapirin 
but is lower than the 7.4log10 reduction upon intramuscular injection with the same dose (Brouillette et 
al., 2004). Intra-study comparison of the cephalosporins in the mouse mastitis model would be an 
excellent strategy to evaluate their relative efficacies whether or not in function of the administration 
route. Initial assessment of the efficacy of antimicrobials is based on in vitro analysis according to the 
guidelines of the CLSI (CLSI, 2008). However, it is generally accepted that in vitro results do not 
necessarily fully correlate with in vivo outcome of antimicrobials (Apparao et al., 2009). Interaction of 
S. aureus with host mammary and immune cells during the infection is impossible to mimic in vitro 
(Brouillette and Malouin, 2005). 
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Figure 4. (A) Graphical presentation of the reproducibility over time of the predicted mean 
CFU/g gland (black line) with 95% confidence interval (blue band) for S. aureus-infected, 
paraffin oil-treated mice of 14 independent studies performed in our research group. Each 
circle corresponds to the CFU/g gland for an individual gland. The mean CFU/g gland was 
comparable between studies and the variability did not significantly change over time. (B) 
Graphical presentation of the 98% prediction range in CFU/g gland for individual glands (blue 
line), a single animal (2 glands; red line) or 4 animals (green line). The expected mean CFU/g 
gland are close to 8.04log10. The estimation of the CFU/g gland became more precise when 
more glands were used.  
A 
B 
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Moreover, the milk environment in the mammary gland influences bacterial growth, the expression of 
genes that control S. aureus pathogenesis, and the absorption, distribution, half-life and metabolism of 
the antimicrobial (Brouillette and Malouin, 2005 and Gehring and Smith, 2006). When the 4 first 
generation cephalosporins in the current study are compared according to their in vitro and in vivo 
efficacy, a different ranking is observed. More specifically, our in vitro MIC data indicate that 
cefalonium has the best antimicrobial efficacy against S. aureus, followed by cefapirin, cefazolin and 
cefalexin. In contrast, the objective efficacy parameters derived from the in vivo mouse mastitis data 
indicate that cefazolin is the most effective cephalosporin for intramammary treatment, followed by 
cefalonium, cefalexin and cefapirin. Although side-by-side comparison of these cephalosporins in 
cows is required to formulate definitive conclusions for the target species, their doses currently applied 
in the mastitis field support the classification of the in vivo mouse mastitis study (BCFI, 2011). This 
underscores the crucial importance of in vivo studies for antimicrobial drug evaluation. 
Of interest for future treatment directions, the efficacy of an antibiotic can be analyzed in experimental 
mouse mastitis induced by other bovine mastitis isolates than S. aureus Newbould 305. In the current 
study, the S. aureus Newbould 305 was selected because of its historical use as mastitis-inducing 
pathogen in cow studies, but numerous bovine S. aureus strains with different persistence and 
therapeutic response have been identified (Zadoks et al., 2011). Several S. aureus strains have 
already been applied in the mouse mastitis model [reviewed in Brouillette and Malouin, 2005]. 
Optimizing the excipient is possibly a cost-effective strategy to improve the efficacy of existing 
compounds. In comparison to mineral oil, miglyol 812 has higher stability against oxidation, better 
spreadability and absorption, and improved compound stability and solubility characteristics (Sasol, 
2004). These characteristics most likely explain why cefazolin suspended in miglyol 812 showed 
improved antimicrobial activity against S. aureus-induced mouse mastitis compared to the classical 
mineral oil-suspended cefazolin. This observation indicates that an inert substance is not necessarily 
an optimal excipient. The latter substance should support the active compound in vivo by providing 
improved adsorption, distribution, metabolism and excretion characteristics (Gehring and Smith, 2006, 
Gruet et al., 2001 and Van Bambeke et al., 2006). 
In summary, our study supports that in vivo analysis of antimicrobials is of utmost importance to 
assess their therapeutic potential. It also indicates that cefazolin has the most efficient in vivo 
antimicrobial activity against S. aureus of the 4 tested first generation cephalosporins, as could be 
deduced from the ED2log10, ED4log10, PD50 and PD100 parameters calculated from the in vivo mouse 
mastitis experiments. Additionally, our data also highlight the influence of the excipient on the 
antimicrobial efficacy, an observation which is in line with previous findings. Overall, the current study 
emphasizes the strength of the mouse mastitis model as a fast, cheap and reproducible intermediate 
in vivo alternative for antimicrobial compound efficacy studies in cattle. 
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III.2 Antimicrobial Efficacy of Intramammary Treatment with a Novel Biphenomycin 
Compound against Staphylococcus aureus, Streptococcus uberis, and Escherichia coli-
induced Mouse Mastitis 
III.2.1. Summary 
Bovine mastitis undermines udder health, jeopardizes milk production, and entails prohibitive costs, 
estimated at $2 billion per year in the dairy industry of the United States. Despite intensive research, 
the dairy industry has not managed to eradicate the 3 major bovine mastitis-inducing pathogens: 
Staphylococcus aureus, Streptococcus uberis, and Escherichia coli. In this study, the antimicrobial 
efficacy of a newly formulated biphenomycin compound (AIC102827) was assessed against 
intramammary Staph. aureus, Strep. uberis, and E. coli infections, using an experimental mouse 
mastitis model. Based on its effective and protective doses, AIC102827 applied into the mammary 
gland was most efficient to treat Staph. aureus, but also adequately reduced growth of Strep. uberis or 
E. coli, indicating its potential as a broad-spectrum candidate to treat staphylococcal, streptococcal, 
and coliform mastitis in dairy cattle. 
III.2.2. Introduction 
Mammary gland inflammation, or mastitis, provokes detrimental damage to mammary epithelial cells 
and results in highly impaired milk production. As the most common disease in dairy cows, mastitis is 
the principal cause of economic losses in the dairy industry (Piepers et al., 2007; Pinzón-Sánchez et 
al., 2011). Clinical mastitis caused by environmental pathogens such as Streptococcus uberis and 
Escherichia coli can mostly be cured by antibiotic therapy (Pyörälä, 2009). Nevertheless, the incidence 
of coliform mastitis has been increasing relentlessly, and multidrug resistance is a typical feature for E. 
coli (Bradley, 2002; Saini et al., 2012). Although use of the preventive measures in the well-known 10-
point checklist of the National Mastitis Council (NMC, 2006) has significantly improved the incidence of 
mastitis induced by contagious pathogens such as Staphylococcus aureus, staphylococcal mastitis is 
still frequently observed (Hogeveen et al., 2010; Zadoks et al., 2011). Therefore, novel antimicrobial 
therapies remain highly desired for treatment of not only Strep. uberis and E. coli mastitis but also 
Staph. aureus mastitis. 
The antimicrobial AIC102827 belongs to the cyclopeptide biphenomycin class (Ezaki et al., 1985), 
acting at the level of bacterial protein synthesis; that is, inhibition of the thermo-unstable elongation 
factor (EF-Tu). Specifically, the thermo-unstable elongation factor mediates the entry of the aminoacyl-
transfer (t)RNA into the free A-site of the ribosome (Agirrezabala and Frank, 2009). This mode of 
action makes no distinction between gram-positive and gram-negative pathogens, suggesting the 
potential for efficient antibiotic activity against gram-positive Staph. aureus and Strep. uberis and 
gram-negative E. coli. The objective of the current study was to screen, both in vitro and in vivo, the 
intramammary efficacy of the novel candidate antimicrobial AIC102827 against the bovine mastitis 
pathogens Staph. aureus, Strep. uberis, and E. coli. Bovine mastitis studies are time consuming and 
extremely costly. Therefore, the mouse model for bovine mastitis, which has been recognized as a 
fast, cheap, and reproducible intermediate in vivo alternative for antimicrobial compound efficacy 
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studies in cattle (Brouillette et al., 2004; Notebaert et al., 2008; Demon et al., 2012), was applied as an 
elegant screening tool in the current study. 
III.2.3. Materials and methods 
In the present study, the excipient (hydrogel) and different concentrations of AIC102827 (2, 4, 8, and 
12 mg/mL) were provided as ready-to-use suspensions by AiCuris GmbH & Co. (Wuppertal, 
Germany). Staphylococcus aureus Newbould 305 (ATCC 29740), Strep. uberis NADC C-1 (ATCC 
27958), and E. coli P4:O32 were used for infection of mice (challenge isolates). These bacterial 
strains were originally isolated from clinical mastitis cases (Prasad and Newbould, 1968; Bramley, 
1976; McDonald and McDonald, 1976). Overnight cultures of the bacteria were diluted in sterile PBS 
and quantified by flow cytometry (BD Biosciences, Erembodegem, Belgium), as described in detail by 
Demon et al. (2012). In vitro determination of the MIC of AIC102827 against the challenge isolates 
Staph. aureus Newbould 305, Strep. uberis NADC C-1, and E. coli P4:O32, and a random selection of 
recent bovine mastitis field isolates (n = 10 for each species) was performed using the Mueller-Hinton 
agar dilution assay according to Clinical and Laboratory Standards Institute guidelines (CLSI, 2008). 
The procedures for mouse mammary gland infection, postmortem mammary gland homogenization, 
and bacterial quantification have been described recently by our group (Demon et al., 2012). Briefly, 
CD-1 lactating mice (Harlan Labouratories Inc., Horst, the Netherlands) were anesthetized and 
intraductally inoculated with approximately 150 cfu of challenge isolate in 100 µL of PBS in both 
glands of the fourth abdominal mammary gland pair. Similarly, 100 µL of the excipient and test doses 
of AIC102827 were instilled at 4 h after bacterial inoculation. After killing of the mice at 14 h 
posttreatment, mammary glands were harvested, weighed, and homogenized on ice in sterile PBS. 
Bacterial counts (cfu) were obtained after quantification of serial log10 dilutions of mammary gland 
homogenates on tryptic soy agar plates and transformation of the raw counts into base 10 logarithmic 
(log10) values. The detection limit was 1.7log10 cfu/g of gland. In the dose-titration studies, a group 
with bacteria-infected, excipient-treated mice (excipient control group) was compared with 3 test 
groups, in which mice were infected with bacteria and treated with a particular dose of AIC102827. In 
the intra-experimental comparison study, the excipient control group was compared with one test 
group, in which mice were infected with bacteria and treated with 800 µg/gland of AIC102827. The 
groups in the different studies were composed of 4 mice (8 mammary glands), except the 3 mice (6 
glands) in the 800 µg/gland test group in the E. coli dose-titration study. The animal experiments were 
approved by the Ethical Committee of the Faculty of Veterinary Medicine, Ghent University, 
Merelbeke, Belgium (EC2009/133). To evaluate the dose-response relationship for the antimicrobial, 
the effective dose (ED)2log10, ED4log10, protective dose (PD)50 and PD100 values were calculated from the 
dose-titration studies. The ED2log10 and ED4log10 values are the concentrations of AIC102827 needed to 
reduce the mean bacterial count from the excipient control group by 2log10 and 4log10 cfu/g of gland, 
respectively. The PD50 and PD100 are the doses of AIC102827 needed to observe, respectively, 50 and 
100% of cleared mammary glands (with mean bacterial count below the detection limit). The model 
parameters were calculated by nonlinear regression analysis using Microsoft Excel software (Microsoft 
Corp., Redmond, WA). The models that fitted best; that is, that yielded the highest R2 value, with the 
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dose-response relationship of the antibiotic were polynomial for Staph. aureus Newbould 305 (y = 
7.10−5x2 − 0.0471x + 8.5966) and Strep. uberis NADC C-1 (y = 5.10−6x2 − 0.0101x + 6.1556) and 
exponential for E. coli P4:O32 (y = 8.6977e−0.002x). The ED2log10 and ED4log10 values were then 
computed by calculating x from these models, in which y is replaced by z − 2 and z − 4, respectively, 
with z being the mean bacterial count (log10 cfu/g of gland) from the excipient control group. To 
determine the volume of the secretory fluid in the bacterially infected mammary gland, mice (n = 8) 
were intraductally infected with Staph. aureus Newbould 305 as described. Mammary glands (n = 15; 
1 gland was omitted due to improper inoculation) were harvested at 4 h postinoculation. The glands 
were weighed, placed on a cell strainer of 40 µm, and centrifuged at 2,000 × g for 1 h to expel their 
milk content. After centrifugation, the glands were weighed again and subtracted from the gland 
weight before centrifugation. The resulting weight was divided by the density of mouse milk (1.06 
mg/mL) to calculate the corresponding volume. 
III.2.4. Results 
Table 1 reports MIC values of AIC102827, the newly formulated antimicrobial from the biphenomycin 
class, against the 3 major bovine mastitis pathogens. The MIC values of AIC102827 against 10 bovine 
mastitis field isolates of Staph. aureus, Strep. uberis, and E. coli were 4 to 8, ≥16, and 2 to 4 µg/mL, 
respectively.  
 
Table 1. Antimicrobial efficacy of AIC102827 against Staphylococcus aureus, Streptococcus 
uberis, and Escherichia coli evaluated in vitro by determination of MIC values and in vivo by 
analyzing effective and protective doses using the mouse mastitis model. 
 
1: Minimal concentrations of the antimicrobial required to inhibit visible growth of Staph. aureus (n = 
10), Strep. uberis (n = 10), or E. coli (n = 10) field isolates and Staph. aureus Newbould 305, Strep. 
uberis NADC C1, or E. coli P4:O32 mouse mastitis challenge isolates .2: ED2log10 and ED4log10 values 
are the concentrations of AIC102827 needed to reduce the mean bacterial count (log10 cfu/g of gland) 
from the excipient control group by 2log10 and 4log10, respectively.3: The PD50 and PD100 values are 
the doses of AIC102827 needed to observe, respectively, 50% and 100% of cleared mammary 
glands; that is, with a count (log10 cfu/g of gland) below the detection limit. 
 MIC
1
 (µg/mL) Effective 
dose
2
 (µg/gland) 
Protective 
dose
3
 (µg/gland) 
Species Field 
isolates 
Mouse 
mastitis 
challenge 
ED2log10 ED4log10 PD50 PD100 
Staph. aureus 4–8 4 45 100 200 80 
Strep. uberis ≥16 >16 215 530 400–800 800 
E. coli 2–4 4 130 310 400–800 >800 
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Figure 1. Staphylococcus aureus Newbould 305 (A), Streptococcus uberis NADC C-1 (B), and 
Escherichia coli P4:O32 (C) count reduction (log10 cfu/g of gland) at 14 h posttreatment in 
infected mouse mammary glands treated with increasing doses of the novel antimicrobial 
agent AIC102827; (D) intra-experimental comparison study indicating Staph. aureus Newbould 
305, Strep. uberis NADC C-1, and E. coli P4:O32 count reduction (log10 cfu/g of gland) at 14 h 
posttreatment in mouse mammary glands treated with 800 µg/gland AIC102827. Dashed line 
indicates detection limit. Hydrogel = excipient only (no AIC102827). 
These MIC values illustrate efficient in vitro antimicrobial activity of AIC102827 against Staph. aureus 
and E. coli, but less adequate activity against Strep. uberis. The adequate activity of AIC102827 
against Staph. aureus and E. coli indicates its ability to act against both gram-positive and gram-
negative bacteria. However, the inadequate activity against Strep. uberis shows that, although 
AIC102827 inhibits a universal bacterial growth mechanism, species-specific characteristics are 
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involved in the susceptibility to the antimicrobial. The MIC values of AIC102827 against the mouse 
mastitis challenge isolates of Staph. aureus Newbould 305, Strep. uberis NADC C-1, and E. coli 
P4:O32 were 4, >16, and 4 µg/mL, respectively, and strongly correlated with the sensitivity of the 
bovine mastitis field isolates, indicating the suitability of the latter as reference strains in the current in 
vivo mouse mastitis study. The in vivo dose-responses of mouse mastitis induced by Staph. aureus 
Newbould 305, Strep. uberis NADC C-1, and E. coli P4:O32 to hydrogel-suspended AIC102827 were 
analyzed in 3 separate dose titration studies (Figure 1A to C). These data were used to calculate the 
ED2log10 , ED4log10, PD50, and PD100 values (Table 1). The ED2log10 value (corresponding to 99% bacterial 
clearance) of AIC102827 was 45, 215, and 130 µg/gland for Staph. aureus, Strep. uberis, and E. coli, 
respectively. These values indicate that AIC102827 can clear 99% of the Staph. aureus bacteria from 
the lactating mammary gland, even at a low dose, whereas a higher dose is needed to clear Strep. 
uberis and E. coli. In line with this finding, the ED4log10 value (corresponding to 99.99% bacterial 
clearance) of AIC102827 was 100, 530, and 310 µg/gland for Staph. aureus, Strep. uberis, and E. coli, 
respectively. The PD50 and PD100 values of AIC102827 for the 3 mouse mastitis challenge isolates 
additionally indicated that its intramammary treatment is more efficient in curing glands infected by 
Staph. aureus than by Strep. uberis or E. coli. An intra-experimental study with one selected dose of 
AIC102827 was then performed to evaluate reproducibility and compare the antimicrobial efficacy of 
AIC102827 between the 3 pathogens in a study with minimal variability of experimental parameters 
such as the health status of the mice and environmental conditions such as humidity and temperature 
(Figure 1D). An AIC102827 dose of 800 µg/gland was selected for the intra-experimental comparison 
study, because it showed reduction of the bacterial load virtually to the detection limit in most 
mammary glands in the separate dose-titration studies. For all 3 species, the mean bacterial counts 
(log10 cfu/g of gland) in the intra-experimental study (Figure 1D) closely approximated their respective 
means in the dose-titration study (Figure 1A to C), illustrating the reproducibility of our data. Together, 
our in vitro MIC and in vivo mouse data indicate adequate efficacy of AIC102827 against the 3 mouse 
mastitis challenge isolates. 
 III.2.5. Discussion 
The antimicrobial AIC102827 indicated similar in vitro MIC for Staph. aureus Newbould 305 and E. coli 
P4:O32. Consequently, analogous in vivo antimicrobial activity was expected against both pathogens. 
However, AIC102827 was less effective against E. coli than against Staph. aureus in the in vivo study. 
In contrast, efficacy against Strep. uberis in vivo was higher than expected based on the in vitro data. 
Together, these observations indicate that the mammary gland environment positively influences 
antimicrobial activity against the gram-positive bacteria and negatively affects activity against the 
gram-negative E. coli. A possible explanation for the increased in vivo activity against Staph. aureus 
and Strep. uberis could be that the concentration of AIC102827 in milk greatly exceeds the in vitro 
MIC required to inhibit bacterial growth. To assess this hypothesis, we evaluated the intramammary 
antimicrobial concentration in the bacterially infected mammary gland at 4 h postinfection; that is, at 
the time of compound treatment. On average, 52 µL (±19 µL) of secretory fluid was observed in the 
infected mammary gland, which had a mean weight of 635 mg (±163 mg) at the time of treatment 
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(Figure 2). Although substantial variability in gland volume was seen, these data indicate that the 
concentration of the compound suspension, which is injected in a volume of 100 µL, is reduced by 
approximately 30% after injection in the mammary gland. Treatment with the 8 mg/mL suspension led 
to a concentration of approximately 5 mg/mL in the mammary gland and is several-hundred-fold 
higher than the concentration that is used in in vitro experiments (in the µg/mL range) to determine the 
MIC values, corroborating this hypothesis. However, this does not explain the potentially lower in vivo 
antimicrobial efficacy against E. coli. The milk environment of the mammary gland is known to 
influence the in vivo efficacy of an antimicrobial agent. Critical aspects influenced by the milk matrix 
are local immune cell interactions, bacterial growth, and pharmacokinetic parameters (adsorption, 
distribution, metabolism, and excretion) of the antimicrobial (Brouillette and Malouin, 2005; Gehring 
and Smith, 2006; Van Bambeke et al., 2006). In this context, the extracellular residing E. coli has 
become better adapted to the milk environment than the typically intracellularly residing gram-positive 
pathogens Staph. aureus and Strep. uberis, at least partially clarifying the potentially lower than 
expected antimicrobial efficacy against E. coli observed in the current study. The observation that the 
in vitro antimicrobial activity of AIC102827 for Staph. aureus, Strep. uberis, or E. coli did not directly 
correlate with its in vivo efficacy corroborates previous reports by our group and others (Apparao et 
al., 2009; Pyörälä, 2009; Demon et al., 2012). Hence, our current data again highlight the importance 
of in vivo studies in addition to in vitro studies to screen antimicrobial candidates. 
Several studies in cows describe strain-specific associations for Staph. aureus, Strep. uberis, and E. 
coli with respect to clinical signs, persistence, and response to therapy (Saini et al., 2012; and 
reviewed by Zadoks, 2007; Zadoks et al., 2011). Therefore, systematic comparison of the efficacy of 
antimicrobials against mastitis induced by different clinically relevant bovine strains would greatly help 
to guide veterinary practitioners in combining the most efficacious therapeutics as a strategy to target, 
for example, particular cases involving either a single resistant pathogen strain or multiple strains. 
Strains of Staph. aureus and E. coli other than Newbould 305 and P4:O32, respectively, have been 
applied in the mouse mastitis model (reviewed by Brouillette and Malouin, 2005; and Notebaert and 
Meyer, 2006), highlighting the diversity of its possible applications. In contrast to labour-intensive and 
costly experimental mastitis studies in cows, an intra-experimental comparison of a panel of selected 
clinically relevant bovine pathogen isolates is easily achievable in mice and therefore of major added 
value. 
 
Figure 2. Volume of milky secretory fluid in the Staphylococcus 
aureus Newbould 305-infected mammary gland (n = 15) at 4 h 
postinfection. Volume is presented as microliters per 635 mg of 
mammary gland, because 635 mg is the average weight of an 
infected mammary gland at the moment of antimicrobial treatment. 
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The analysis in this in vivo mouse mastitis study showed the adequate antimicrobial efficacy of the 
novel biphenomycin compound AIC102827 against a reference strain of the 3 major bovine mastitis 
pathogens Staph. aureus, Strep. uberis, and E. coli. The field efficacy assessment of this promising 
compound in an appropriate formulation in dairy cattle is now required to validate these innovative 
intermediate data in the target species. 
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Mastitis in dairy cattle has deleterious effects on both animal welfare and the dairy industry. The 
ensuing inflammatory response, mastitis, leads to annual costs estimated to be upwards $35 billion 
US dollars and is a major concern worldwide (Modi, Patel et al. 2012). These overall economic losses 
consist of the decrease in milk production, discarded milk post-treatment, cost of animal replacement, 
labour and veterinarian costs (Hamadani, Khan et al. 2013). Extensive research indicates that mastitis 
is a very complex disease triggering multiple molecular mechanisms that have to be taken into 
account when developing preventive or curative strategies. Here, these are discussed in the context of 
the results obtained in this thesis. The following paragraphs focus on the inflammatory signaling 
induced by different bovine-associated isolates in a mouse mastitis model which could provide some 
clues as basis for innovative treatment and prevention. 
 
I. INFLAMMATORY CHANGES IN THE MAMMARY GLAND DEPEND ON THE BACTERIAL 
SPECIES: ROLE OF THE INFLAMMASOME AND LOCAL IL-1BETA LEVELS 
 
IL-1 beta is detectable in milk proteins during an udder infection caused by either E. coli or S. aureus. 
The release of IL-1beta is concomitant with an increase in the mammary glands’ vascular permeability 
which is necessary for the influx of somatic cells (Bannerman, Paape et al. 2004). This observation 
suggests that (vita)MAMPs of both pathogens trigger resident PRR-containing udder cells to produce, 
activate and secrete IL-1beta (Sander, Davis et al. 2011). Biologically active IL-1beta subsequently 
may trigger the IL-1R-containing endothelial cells so that neutrophils can be recruited at the site of 
infection. Based on other inflammatory models, a cellular apparatus responsible for proIL-1beta 
cleavage and secretion is the canonical inflammasome which engages and activates caspase-1 
(Lamkanfi and Dixit 2012). This canonical pathway was provisionally accepted as a basis for cleaved 
IL-1beta in milk, considering that an E. coli infection induces gene expression of procaspase-1 in 
udder tissue (Long, Capuco et al. 2001). However, in contrast to E. coli mastitis, canonical 
inflammasome activation upon S. aureus infection is less obvious: although S. aureus also induces IL-
1beta, caspase-1 activity is only limited or not at all present in bovine udder cells in vitro (Wesson, 
Deringer et al. 2000). 
To appropriately test the hypothesis for caspase-1 dependency of IL-1beta triggered by E. coli and 
analyze this seemingly different host-response pattern between Gram-negative versus -positive 
pathogen infections, mammary glands of mice were exposed to a bovine E. coli or S. aureus isolate 
(Chapter I.1.). Bannerman, Paape et al. (2004) demonstrated that IL-1beta protein levels increased in 
milk following experimental infection of dairy cows with E. coli as well as S. aureus. Furthermore, this 
increase was suggested to occur faster with E. coli compared to S. aureus corroborating the delay in 
mammary IL-1beta processing post-infection with S. aureus compared to E. coli in mice. Bannerman, 
Paape et al. (2004) established experimental mastitis in cows with the same isolates and also 
detected a slower influx of neutrophils into the S. aureus- compared to the E. coli-infected gland 
comparable as seen during our experiments. However, these authors did not check IL-1beta 
processing necessary for its biological activity. Quantitative methods that detect active IL-1beta 
predominantly focus on antibodies targeting p17. Our results based on the Cytometric Bead Array, 
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similar to the Enzyme-Linked ImmunoSorbent Assay (ELISA) method used in Bannerman, Paape et 
al. (2004) may be specific for IL-1beta, but can produce different results when studied in detail with a 
qualitative method such as Western Blot focusing on the IL-1beta cleavage patterns. Unfortunately, 
antibodies of ELISA methods are rarely usable for the Western blot technique probably due to the 
different kinds of epitopes that they recognize (structural epitope for ELISA vs linear epitope for 
Western Blot). Nevertheless, for both techniques the specificity of the antibodies was confirmed with 
samples of IL-1beta KO mice. Therefore, we aimed to emphasize the importance of validating IL-1beta 
data by complementary techniques in order to get a clear understanding of its activity in the mammary 
gland. In this respect, the differences between Fig. 2C and Figure 3A/B of Chapter I.1 can be 
tentatively attributed to method-based restrictions. Our hypothesis described below indicates that 
during a S. aureus infection, IL-1beta cleavage is more focused on processing pro-IL-1beta into p17, 
while E. coli-inflammation generates another fragmentation pattern of IL-1beta.  
In contrast to what was previously assumed (Figure 3 of the General Introduction), our results indicate 
that pro-IL-1beta cleavage does not require pro-inflammatory procaspase-1 activity - which reflects 
canonical inflammasome processing - for either of both pathogens. Notably, essential inflammatory 
pathways have backup mechanisms and this feature may also be true for proIL-1beta cleavage by 
caspases. Indeed, it is known that, besides caspase-1, also caspase-11 can induce IL-1beta secretion 
(Meunier, Dick et al. 2014; Shi, Zhao et al. 2014; Vigano and Mortellaro 2013). Although we did not 
selectively study caspase-11 during our experiments, it has been established that due to the way the 
transgenic mice were originally engineered, the caspase-1/-11 double KO mice are also deficient in 
caspase-11 (Kayagaki, Warming et al. 2011; Uchiyama and Tsutsui 2014). Furthermore, evidence has 
been published to suggest caspase-8 as an IL-1beta converting enzyme (Antonopoulos, El Sanadi et 
al. 2013; Man, Tourlomousis et al. 2013). Caspase-8 is activated during a S. aureus and an E. coli 
infection of bovine epithelia and believed to induce cell death in these cells (Aitken, Corl et al. 2011; 
Gilbert, Cunha et al. 2013; Hu, Cui et al. 2014). However, recombinant caspase-8 is able to cleave 
pro-IL-1beta in vitro at exactly the same site as caspase-1, an observation which does not correspond 
with our cleavage pattern data (Maelfait, Vercammen et al. 2008). Overall, caspases are very 
redundant and this is reflected by the many other caspases known to be enhanced during bovine 
mastitis (Wesson, Deringer et al. 2000; Long, Capuco et al. 2001; Hu, Cui et al. 2014). Of note, we 
detected that a known substrate of caspase-1, caspase-7 is also activated during an intramammary E. 
coli infection in mice (Lamkanfi, Kanneganti et al. 2008; Vanden Berghe, Demon et al. 2014). In a pilot 
experiment, IL-1beta levels in the mammary gland were higher in absence of caspase-7 than in the 
glands with capase-7 and this observation was concomitant with higher IL-6 and MCP-1. Nonetheless, 
single caspase-7 KO mice provided no significant difference in bacterial CFU post-infection, again 
indicating that IL-1beta is part of a redundant inflammatory process (Fig. 1, Breyne et al. unpublished 
data).   
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Figure 1. Minor differences in bacterial clearance could be observed during E. coli mastitis in 
caspase-7 (C7) knock-out (KO) mammary glands (n=6) compared to non-deficient mammary 
glands (C7wT, n=6) of C57BL/6 mice. (A) Cleavage of C7 was observed in infected C7wT 
C57BL/6 mammary glands and absent in C7KO mice. (B) No significant differences in bacterial 
loads seen between C7KO glands and C7wT glands. (C) Next to significant increases in IL-
1beta, les significant differences in IL-6 or MCP-1 levels could be detected in C7KO mammary 
glands compared to C7wT mammary glands. 
Despite the activation of several caspases during pathogen-induced mastitis, the different cleavage 
fragments of pro-IL1beta may indicate that processing occured rather following its secretion and 
through a multicellular mechanism (Fig. 2). Indeed, neutrophil proteases are the primary candidates 
for the suggested alternative IL-1 beta processing: these were already shown to contribute to proIL-
1beta processing in a caspase-1-independent way during experimental mouse models of arthritis and 
neutrophil-dominated inflammation (Guma, Ronacher et al. 2009; Joosten, Netea et al. 2009). 
Elastase and cathepsins are the predominant proteases identified in somatic cells and can be 
retrieved from mastitic cow milk where they presumably hydrolyze casein during an E. coli infection 
(Moussaoui, Laurent et al. 2003; Haddadi, Prin-Mathieu et al. 2006; Watanabe, Hirota et al. 2012). 
Moreover, S. aureus is also known to induces elastase activity in the udder. In secretions of a S. 
aureus mastitic cow, this enzyme cleaves the bovine lactoferrin in low activity fragments which 
increase NF-kappaB activity and cytokine production when incubated with bovine epithelia in vitro 
(Komine, Kuroishi et al. 2006). Whether the elastase activity is correlated to neutrophil elastase or 
bacterial elastase is a matter of debate. Still, S. aureus proteases are known to cleave pro-IL-1beta 
(Black, Kronheim et al. 1988). In contrast to S. aureus, elastase activity is rarely associated with the 
pathogenicity of bovine S. chromogenes isolates and may establish lower processing of inflammatory 
proteins (Watts, Naidu et al. 1990). Nevertheless, little is known about the production and the 
activation of IL-1beta induced during a CNS exposure. Our data indicates that intramammary S. 
chromogenes isolates induce active IL-1beta at a far lower level compared to S. aureus. Furthermore,  
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S. fleurettii, another CNS that is not associated with the udder, did not significantly enhance IL-1beta 
compared to the sham controls. Despite the lower levels of active IL-1beta, CNS still manifested 
neutrophil recruitment in the mammary alveoli.  
Moreover, a second candidate for IL-1beta cleavage are metalloproteinases (MMPs). MMPs are proIL-
1beta processing enzymes that produce small fragments which correspond to our fragmentation 
results (Fig. 2). After the processing of pro-IL-1 beta into biological active fragments, MMP members 
can further degrade mature IL-1beta into inactive or less active fragments (Schonbeck, Mach et al. 
1998). Unlike elastases, these proteolytic enzymes are not only expressed by neutrophils but also in 
the mammary epithelium where they are believed to degrade the extracellular matrix (Raulo, Sorsa et 
al. 2002; Gilbert, Cunha et al. 2013). This breakdown is accompanied by extensive remodelling of the 
mammary gland architecture while triggering detachment-induced cell death features (Green and Lund 
2005; Watson 2006). Our histopathological observation of marked cell detachment already early in the 
course of an E. coli infection, compared to the delayed process upon S. aureus in the mouse 
mammary gland infection, suggests that MMPs have a higher significance during Gram-negative than 
- positive pro-IL-1beta processing. Supporting our findings in mice, MMPs are not expressed in bovine 
epithelial cells infected with S. aureus but only during an E. coli exposure (Gunther, Esch et al. 2011; 
Gilbert, Cunha et al. 2013; Im, Lee et al. 2014). Therefore, these in vitro data can at least partly 
explain our concept of a pathogen-dependent pro-IL-1beta cleavage pattern by MMPs. Notably, 
proMMPs can still be increased in the milk during a long lasting chronic S. aureus infection. Probably 
this phenomenon is at that time rather due to the continuous influx of neutrophils which are known to 
secrete MMPs (Higuchi, Ishizaka et al. 2007; Nagahata, Kawai et al. 2011).  
What is the biological relevance of a local IL-1beta activation? During the innate immune response, 
bacterial growth is halted by recruited neutrophils that protect against lethal septic effects (Elazar, 
Gonen et al. 2010). The small and temporarily difference in pathogen loads between IL-1beta KO and 
wT animals observed in this PhD research indicates that the local production and processing of IL-
1beta is not so essential for bacterial clearance and therefore may also not be so critical for neutrophil 
recruitment (see below). In line with this hypothesis, another experiment from this thesis can be 
referred to where different bovine-associated CNS isolates were inoculated at a high inoculum dose of 
10
5
 CFU in wT mice: these all had low bacterial loads post-infection and induced a recruitment of 
neutrophils without needing to highly increase local IL-1beta levels. Furthermore, similar conclusions 
could be made when a LPS pretreatment was applied before S. aureus exposure in the mammary 
gland. The attenuation of IL-1beta was concomitant with high bacterial clearance next to neutrophil 
recruitment in the mammary glands. At last, local IL-1beta levels could also be decreased through the 
injection of bovine-associated CNS isolates prior to an infection with S. aureus (Fig. 3, unpublished 
data). Whether this also implies an effective drop in S. aureus CFU concomitant with a neutrophil 
influx is subject of ongoing research.  
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Figure 3. Local CNS pretreatment attenuates mammary levels of IL-1beta, IL-6 and TNF-alpha. 
(A) Schematic presentation of the experimental set-up. In short, 6h prior S. aureus infection, 
sham- , LPS- , S. chromogenes IM/TA and S. fleurettii were inoculated in mammary glands 
(ntreatment group = 12) of mice, two times sham inoculation in the mammary glands (n=6) was also 
implemented as control. (B) A pretreatment with CNS reduces the levels of TNF-alpha, IL-1beta 
and IL-6. Results are presented as mean ± standard deviation and DL; detection limit. 
Overall, these latter observations implicate that other cytokines are able to counter the function of IL-
1beta signaling when this cytokine is lacking. Indeed, an attractive alternative for neutrophil 
recruitment instead of IL-1beta would be IL-1alpha. Similarly as IL-1beta, IL-1alpha stimulates a 
common IL-1R (IL-1 receptor) and shares similar biological activities (Dinarello 1996). Despite their 
related structure and biological activity, both subtypes are prone to a markedly different production 
and processing. IL-1alpha only needs NF-kappaB transcription to become expressed as a ~31 kDa 
polypeptide and hence has a direct biological activity (Mosley, Urdal et al. 1987; Hazuda, Strickler et 
al. 1990; Fettelschoss, Kistowska et al. 2011). Indeed, this uncleaved pro-IL-1alpha form is already 
capable of binding to the IL-1 receptor, although it exhibits less biological activity than the cleaved 
form. A second major difference is that pro-IL-1alpha is not processed either by caspase-1 or by 
MMPs in contrast to IL-1beta (Ito, Mukaiyama et al. 1996). Nevertheless, it can be processed by 
elastase, calpains, chymase or granzymes, the former being a common protease with the hypothetical 
B 
A 
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cleavage of IL-1beta (Carruth, Demczuk et al. 1991; Schonbeck, Mach et al. 1998; Afonina, Tynan et 
al. 2011).  
As we observed in mastitic mice that the local NF-kappaB activity was lower after an S. aureus 
infection compared to an E. coli infection, the subsequent slower production of local IL-1alpha levels 
could explain the delay in neutrophils influx between both bovine pathogens. In line with this 
assumption, the high levels of IL-1alpha upon an E. coli infection may well compensate through IL-1R 
triggering even in the absence of IL-1beta. However, this is less plausible based on our of initial data 
of local IL-1Ra concentrations. This molecule is a naturally occurring inhibitor that prevents the 
interaction between IL-1alpha and IL-1beta and its cell-surface receptors (Burger, Dayer et al. 2006). 
We detected with a cytokine array that IL-1Ra was highly upregulated upon infection with E. coli 
compared to S. aureus which corroborate with reports in cows (Alluwaimi 2004). As IL-1Ra therapy 
failed in the latter study, It has been postulated that IL-1 has a marginal role in endotoxin-induced 
mastitis (Shuster and Kehrli Jr 1995). This assumption may be exaggerated. Neutrophils that are 
insensitive for IL-1 stimuli by the lack of the IL-1R, are unable to cross the mammary epithelium and 
get trapped in congested capillaries or interstitium upon LPS exposure (Elazar, Gonen et al. 2010; 
Elazar, Gonen et al. 2010). The phenotype is less pronounced with an E. coli infection, indicating that 
other MAMPs - PRR signaling may counter for the lack in IL-1R signaling and explain why IL-1beta KO 
or IL-1R KO mice in our model do not establish such an extreme phenotype (Porcherie, Cunha et al. 
2012; Mintz, Mintz et al. 2013).  
Next to the function of IL-1beta, the pathogen-dependent source of IL-1beta remains vague and is 
complicated in vivo by the fact that mastitis is a complex multi-factorial process with a continuous 
change in cell type mixture and cyto-/chemokine concentrations. MAMPs of bacteria can interact with 
different residential PRR-containing cells of the mammary stroma such as epithelial cells, 
macrophages, and neutrophils (Wellnitz, Reith et al. 2006). In addition to the translocation of NF-
kappaB subunits in the mammary epithelia, we also detected NF-kappaB activity in the neutrophils 
following pathogen infection. When stimulated with mastitic bacteria, bovine blood neutrophils, milk 
cells, or mammary epithelia confirmed this activation of NF-kappaB and/or the cleavage of caspases in 
in vitro studies performed by our group and by other authors both in mice and cows (Notebaert, 
Duchateau et al. 2005; Demeyere, Remijsen et al. 2013). Furthermore, it is suggested for the bovine 
species that professional immune cells such as macrophages are more easily stimulated than non-
professional bacterial sensing cells such as epithelia because they lack for example mCD14 (Sohn, 
Paape et al. 2004). The TLR4-NF-kappaB-IL-1beta signaling axis for E. coli is generally accepted, 
while TLR4-NF-kappaB activation by S. aureus does not seems to occur in the bovine cells in vitro 
(Yang, Zerbe et al. 2008; Fu, Zhou et al. 2013). However, TLR4 is not the only PRR expressed on 
bovine epithelial cells. Other PRRs such as TLR1/2/6 and NOD1/2 (Fig. 2 General Introduction) can 
be activated by both E. coli and S. aureus and have been shown to increase IL-8, a well-known 
chemokine responsible for neutrophil influx into the udder (Porcherie, Cunha et al. 2012). When 
bovine epithelial cells are exposed to MAMPs of S. aureus, IL-1beta is likely produced by other TFs 
such as AP-1 and CREB through the activation of MAP kinases (Kim, Im et al. 2011; Fig. 3 General 
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Introduction). Furthermore, interfering with MAPK signaling next to NF-kappaB pathways has also 
been effective attenuating the IL-1beta levels in LPS-induced mastitis (Gao, Guo et al. 2014). The 
pathogen-independent production of cytokines has been demonstrated in udder cells without MyD88 
or TRIF (Gunther, Esch et al. 2011). Although these cells can no longer induce NF-kappaB, they still 
express IL-6. In that respect we also detected a different response in mice for TNF-alpha and IL-
1alpha compared to IL-6 based on the comparison of E. coli- and S. aureus-infected mammary 
glands. Our experiments indicated that IL-6 was comparably enhanced in both E. coli- and S. aureus-
infected glands, while generally IL-6 is less induced following S. aureus compared to E. coli (Gunther, 
Esch et al 2011). This discrepancy may be due to the fact that these literature data are typically 
obtained from in vitro experiments using a single cell type (epithelial) based system without 
macrophages and/or to a strain-dependent phenomenon of the different S. aureus isolates used in 
these papers and/or due to the use of heat-killed versus viable bacteria. Nevertheless, even in 
mammary epithelial cells, LPS and LTA may enhance IL-6 to a similar extend (Fu, Zhou et al. 2013). 
Complementary to IL-1beta, IL-6 bind both with neutrophil as well as macrophage receptors and 
regulates neutrophil trafficking during the inflammatory response by orchestrating chemokine 
production and leukocyte apoptosis (Fielding, McLoughlin et al. 2008). Of note in this context, our 
proof-of-concept study with CNS suggests that IL-6 is unlikely sufficient to counter the IL-1R signaling 
(Chapter I.2.). Indeed, CNS contain teichoic and lipoteichoic acids, but do not induce IL-1beta or IL-6. 
Still, CNS strains clearly induced a mild neutrophil influx. This indicates that upon infection of the 
mouse mammary gland other - currently unknown - cytokine signaling could be important for the influx 
of neutrophils into the lumen following bacterial infection. 
At last we should mention that some of our observations concerning IL-1beta processing may be 
explained by the difference in the mouse strain used. In chapter I.1 we used C57BL/6 mice in 
accordance with the genetic background of the luc reporter and the IL-1beta KO and caspase-1/-11 
KO mice, while in the other chapters we experimented on CD-1 outbred mice. LPS exposure of 
peritoneal macrophages was suggested to induce a slightly faster production of TNF-alpha in C57BL/6 
background compared to the CD-1 mice (Wu, Vij et al. 2007). Next to the fact that different inocula 
were used (3000 CFU/ gland in chapter I.1 compared to 100 CFU/ gland in Chapter I.2); the genetic 
background of the used mice may also be a possible explanation why we could not detect TNF-alpha 
in Chapter I.2 at 28h post-infection with S. aureus with CD-1 mice while this was the case in Chapter 
I.1 (Fig 2 A 24h post-infection) with C57BL/6 mice. Furthermore, a similar concentration of TNF-alpha 
at 24h post-infection with C57BL/6 mice could only be reached at 48h post-infection with S. aureus in 
sham-pretreated CD-1 mice (Chapter II Fig. 2C). This seemingly different TNF-alpha response 
between CD-1 and C57BL/6 mice may also have consequences for an intramammary E. coli infection, 
as illustrated in our hypothesis (Fig. 2 General Discussion). Lower levels of TNF-alpha would imply 
less MMPs following an intramammary E. coli infection, less IL-1beta processing into less active 
fragments for E. coli compared to S. aureus and less histolopathological changes of the epithelial layer 
in the mammary gland following E. coli. Indeed, IL-1beta levels were higher in the E. col-infected 
mammary glands of CD-1 mice 18h post-infection compared to S. aureus (Add. Fig.3 Chapter II) and 
had an intact epithelial layer similar comparable to a S. aureus infection. It would therefore be very 
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relevant to compare the IL-1beta cleavage pattern in CD-1 mice with the IL-1beta processing in 
C57BL/6 mice next to the MMP and TNF-alpha levels.  
In conclusion, further research is mandatory to decipher the input of different cell types in the 
suggested multicellular proIL-1beta processing and neutrophil recruitment into the alveolar lumen. 
 
II. THE MOUSE MASTITIS MODEL, A BASIS FOR TESTING NOVEL CURATIVE AND 
PREVENTIVE STRATEGIES AGAINST MASTITIS 
 
Despite the in vitro susceptibility of bacterial isolates to antibacterial agents, mastitis remains difficult 
to fully eradicate with the current curative strategies (Erskine, Walker et al. 2002; Apparao, Oliveira et 
al. 2009). Two studies of this PhD thesis compared the in vitro and in vivo antimicrobial efficacy 
against a bovine mastitis-associated S. aureus isolate in mice of four first generation cephalosporins 
used as curative therapy in cows, respectively the susceptibility of three major bovine mastitis 
pathogens to a candidate novel antimicrobial compound from the biphenomycin class. 
In the first study (Chapter III.1.), the MIC data confirmed the previously reported efficacy of cefalonium 
(Groothuis and Frik 1982) over cefapirin (Owens, Ray et al. 1997), cefazolin (Brix 2007) and cefalexin 
(Guerin-Faublee, Carret et al. 2003), while the mouse mastitis data indicated that cefazolin had more 
antimicrobial efficacy in vivo than cefalonium, cephalexin or cefapirin. In favour of the latter model, the 
in vivo doses applied against bovine staphylococcal mastitis of the four cephalosporins are very 
similar as that in mice (BCFI 2011). In the second study (Chapter III.2.), the MIC data established a 
higher antimicrobial efficacy against E. coli and S. aureus compared to S. uberis, while in vivo the 
novel biphenomycin compound seemed less effective against E. coli than S. aureus and had a better 
efficacy against S. uberis than would be expected from the in vitro data. However, a pilot study with 
this compound on cows with mastitis would be of interest to demonstrate its antimicrobial efficacy in 
the target species (BAYER 2012). Overall, these discrepancies between in vitro and in vivo data 
applied on three bovine isolates indicate that the in vivo activity of a compound is influenced by factors 
that are not assessed by a simple MIC determination (Apparao, Ruegg et al. 2009). As reported, the 
used bacteria elicit different host response patterns and establish different absorption, distribution, 
half-life and metabolism of antimicrobials when they invade mammary cells compared to a laboratory 
growth medium (Craven and Anderson 1984; Sanchez, Ford et al. 1988; Gehring and Smith 2006; 
Schukken, Gunther et al. 2011). An additional intermediate step between MIC data with conventional 
growth media and in vivo data could be testing the efficacy of antimicrobials in milk. Indeed, different 
antibiotic activities have been observed between tryptone soy broth and delipidated milk in vitro 
(Amorena, Gracia et al. 1999). Nevertheless, a complete simulation of the in vivo situation that also 
includes a complex host-microbe interactions will not be attained. These arguments therefore argue 
against the extrapolation from these in vitro data to the in vivo situation in the cow (Apparao, Ruegg et 
al. 2009). Moreover, the mouse model has an additional advantage over the in vitro approach as it can 
improve existing curative treatment in the target species by modifying the delivery method (Brouillette, 
Grondin et al. 2004) or by optimizing the excipient formulation. As such, our data from the first curative 
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therapy study (Chapter III.1.) showed that the in vivo performance of an antibacterial compound such 
as cefazolin improved when formulated in an excipient with better solubility and absorption capacities 
(Sellers, Antman et al. 2005). As stated in the General Introduction, the studies of this PhD thesis 
confirm the conclusion drawn from previous studies on the advantage of the mouse model as a 
valuable intermediate step prior to evaluation of curative therapies in cows.  
In the past decade, an extensive effort has been made with regard to alternative preventive strategies 
than the classical antimicrobial curative therapies. Indeed, the standard use of antibiotics may 
introduce resistance, beneficial commensal bacteria may have unwanted susceptibility to these 
compounds and per definition it does not intercept a future infection (Owens, Donskey et al. 2008). 
Nevertheless, as stated in the General Introduction, these attempts have been relatively unsuccessful 
so far in the mastitis field, more specifically for S. aureus. 
Our studies with repeated challenge of the mammary glands in mice (Chapter II and Fig. 3) indicate a 
putative basis for an innovative preventive therapy. A proof-of-concept mouse study evaluated 
whether the immunomodulation of the innate immunity by LPS prior to a pathogenic mastitis infection 
is beneficial for the host or not. This strategy has been described by a handful of cow studies with at 
least partly contradictory results and fundamental mechanisms occurring at the molecular level remain 
to be fully elucidated (Rainard and Paape 1997; Kauf, Vinyard et al. 2007; Petzl, Gunther et al. 2012). 
While one report suggests that bacteria or MAMP exposure prior to another challenge in the udder 
attenuates excessive inflammation, enhances bacterial clearance and/or decreases bacterial 
colonization and reduces severity of clinical symptoms, another claims that such pretreatment on the 
contrary sensitizes the mammary gland (Rainard and Paape 1997; Petzl, Pfister et al. 2010; Gunther, 
Petzl et al. 2012; Hertl, Schukken et al. 2014). Elaborating on our previous findings, i.e. that a lack of 
IL-1beta as seen with KO mice did not induce a thorough change in the pathogenesis of mastitis, our 
alternative approach consisted of attenuating multiple cytokines through the injection of LPS prior to 
an intramammary infection with S. aureus. Indeed, when pretreating with the potent immunomodulator 
LPS - in addition to IL-1beta - other cytokines such as TNF-alpha, IL-6, or chemokines such as IL-8 
(i.e. IL-8 homologues in mice CXCL1/KC and CXCL2/MIP-2) and CLL3/MIP-1alpha also decreased 
upon subsequent experimental mastitis. Surprisingly, this decrease in cytokine levels was concomitant 
with significantly lower bacterial loads in the mammary gland and a decrease in severity of symptoms. 
Although a mere immunoparalysis can decrease the severity of the inflammatory symptoms, it does 
not guarantee bacterial resolution without appropriate curative antibiotic treatment (Aitken, Corl et al. 
2011; Guo, Zhang et al. 2013). Whether the observed lower number of CFU is the result of a reduced 
bacterial colonization and/or an increased bacterial clearance, is a matter of debate and should be 
studied in detail. Indeed the high LPS dose during the pretreatment given might induce a massive 
neutrophil influx in the mammary glands and thereby circumvent the bacterial colonization rather than 
influence the clearance of bacteria. Therefore, 6h after the LPS-injection we should verify whether 
neutrophils are present compared to sham-pretreated glands. Alternatively this could be checked with 
pretreatment of mammary glands with a low concentration of LPS that does not recruit neutrophils. 
Nevertheless, it should be emphasized that the observed number of CFU following LPS pretreatment 
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and S. aureus infection is rarely not detectable. Therefore, it can be suggested that if the pretreatment 
would only reduce the colonization and not their growth, the remaining bacteria would only reduce the 
colonization and not their growth, the remaining bacteria might still present grow in time. Although a 
time-growth experiment did not been conducted, we didn’t observe an increase in bacterial loads 
between bacterial loads determined at experiments 48h post-infection (Fig. 1A & Fig. 2B of Chapter II) 
and at 28h post-infection (Fig. 4B) but rather a small decrease. As such, the effect of the LPS 
pretreatment is possibly a combination of both a reduction of colonization as maybe also of bacterial 
clearance. Next to the bacterial and anti-inflammatory features, our results revealed that LPS 
pretreatment that the immunomodulation is a rather active process through the enhancement of 
specific cytokines such as CCL5/RANTES and IL-8 (i.e. the IL-8 homologue in mice CXCL5/LIX) as 
confirmed in vitro with udder epithelia (Petzl, Pfister et al. 2010; Gunther, Petzl et al. 2012). These 
authors suggested that LPS pretreatment induces a higher expression of the latter genes to promote 
the sentinel function of the mammary epithelia. However, we showed that CCL5/RANTES only has a 
mild immunomodulating function without a significant effect on the clearance and/or decrease in 
colonization of bacteria in the mammary gland. Based on findings concerning plant defense 
mechanisms and also on a variety sepsis models, the host defense against pathogens may be 
subdivided into two conceptually different components: targeting the ability to reduce bacterial loads 
(resistance) and the ability to limit the damage caused by a given pathogen burden (tolerance) 
(Raberg, Graham et al. 2009). In line with the second concept, the host may thus be strongly 
protected when subjected to severe infections without a negative effect on the performance of the 
pathogen. We can thus tentatively suggest that CCL5/RANTES may be implicated in the host 
tolerance rather than the resistance component of the mammary defense against mastitis pathogens, 
as we observed attenuation of inflammation and a suggestive possible amelioration of the lethality due 
to the S. aureus infection however without a concomitant reduction in bacterial loads. Of relevance, a 
recent study has demonstrated that a low non-lethal dose of anthracyclines reduces TNF-alpha, IL-
1beta and IL-6 and confer strong protection against severe sepsis (Figueiredo, Chora et al. 2013). 
This treatment was not able to lower the bacterial loads in absence of a supplementing an antibiotic 
treatment. The underlying mechanism of this effect is suggested to be a result of controlled Ataxia 
Telangiectasia Mutated-dependent autophagy induction. Therefore, it would be interesting to evaluate 
whether such tolerance-inducing pretreatments would also help to ameliorate the efficacy of classical 
therapeutic antibiotics in a mastitis set-up.  
Nevertheless, the concept of LPS pretreatment is very valuable as it seems not to be restricted to one 
infectious pathogen. Corroborating this literature, this strategy also reduced E. coli mastitis in cows 
while our in vivo study demonstrated protection against S. aureus mastitis (Lohuis, Van Leeuwen et al. 
1988; Lohuis, Kremer et al. 1990; Petzl, Pfister et al. 2010; Petzl, Gunther et al. 2012). Unfortunately, 
it should be stated that LPS pretreatment has also some major drawbacks as it has decreased yields 
and quality of the milk to some extend (Shuster and Harmon 1991) and the protective effect in cow 
has - until now - only been demonstrated for 10 days (Petzl, Pfister et al. 2010; Gunther, Petzl et al. 
2012).  
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As previously indicated, next to LPS, bacteria can also alter the immune system. Reports on dairy 
cows that have been infected twice with an E. coli isolate in the udder were accompanied by a drop in 
severity of the clinical signs for the second infection (Suojala, Orro et al. 2008). Although colonizing 
the udder with pathogenic bacteria to fight a possible next challenge is not really a desired option for 
treatment, probiotic bacteria create an attractive alternative. Probiotic bacteria can modulate the 
immune system in a host as they downregulate the inflammatory response in challenged subjects, 
while they obtain an immunostimulatory effect in healthy ones (Pelto, Isolauri et al. 1998). Ideally, for 
mastitis this would imply that cows with probiotic microorganisms are protected against pathogenic 
udder infections while they have beneficial effects for the milk production or quality. As far as known, 
the application of probiotic bacteria as a potential treatment shown to combat bacterial-induced 
mastitis is limited. It has been shown that Lactococcus lactis was able to treat natural occurring 
chronical or clinical mastitis cows in the field as efficacious as common antibiotic treatments 
(Klostermann, Crispie et al. 2008). Notably, this concept does not seems not to be host-related and 
was demonstrated in women with infectious mastitis. In the latter study, two orally given lactobacillus 
strains isolated from breast milk were shown to have more efficacy than conventional antibiotic 
therapy (Arroyo, Martin et al. 2010). Although, these studies did not colonize the gland with probiotic 
bacteria to induce immunomodulation, they clearly indicate an antimicrobial effect by the production of 
bacteriocins (Klostermann, Crispie et al. 2010; Ryan, Flynn et al. 1999; Šušković, Kos et al. 2010). In 
collaboration with the group of De Vliegher S. et al., we evaluated in another pilot study whether CNS 
are suitable to induce an altered immunity response prior to a challenge with a mastitis-associated S. 
aureus (Fig. 3). CNS are natural occurring udder bacteria that can inhibit major mastitis pathogens 
and also produce bacteriocins (De Vliegher, Opsomer et al. 2004; Braem, Stijlemans et al. 2014). 
Moreover, they are believed to induce higher milk production in the first lactation of heifers and do not 
show milk loss associated with occurrence of CNS (Piepers, Opsomer et al. 2010; Hertl, Schukken et 
al. 2014). These bovine isolates induced only a limited inflammatory response as suggested by the 
low local levels of IL-1beta and IL-6 in our mouse mastitis model (Chapter I.2). A colonization with S. 
chromogenes IM, S. chromogenes TA and S. fleurettii decreased local TNF-alpha, IL-1beta and IL-6 
levels upon bovine S. aureus (Fig. 3). Whether the pretreatment with CNS bacteria also lowers the 
bacterial load of S. aureus in the mammary gland, is a matter of ongoing research. 
The previously mentioned injection of cow with Lactococcus lactis cleared the chronic pathogenic 
infections but the SCC remained high unchanged regardless of treatment (Klostermann, Crispie et al. 
2008). These data raises the question whether a very low SCC and sterile milk are necessary features 
for a healthy cow? On one hand, too many active neutrophils may harm the udder tissue, but on the 
other hand our preconditioning experiments (Chapter II and Fig. 3) suggest that there is in se no 
detrimental effect associated with the mere enhanced alertness of the mammary gland. Moreover, an 
increased number of leukocytes in the mammary gland supports bacterial clearance and/or reduced 
colonization (Mehrzad, Duchateau et al. 2005; Elazar, Gonen et al. 2010). Unfortunately, the 
preventive use of antibiotics in the field of bovine mastitis makes it difficult to draw conclusions 
concerning this subject. However, there are some indications demonstrating a comparatively better 
health performance in organic husbandry (Weller and Bowling 2000). In contrast to conventional 
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herds, these cows are subjected to a lower degree of antibiotic pressure, which makes them prone to 
Gram-negative infections (KouřimsKá, LegaroVá et al. 2014). Although comprehensive information is 
scarce, these cows seem to have similar features as cows subjected to multiple challenges of 
endotoxin. These reports indicate that organic herds are associated with lower milk yield, higher SCC 
with increasing lactations, and lower incidence of mastitis compared to conventional farming (Hardeng 
and Edge 2001). 
In summary, a non-detrimental challenge seems to provoke an altered inflammation to a subsequent 
exposure of the mammary gland and the contribution of the induced cytokines during this process 
remains largely unknown and should be focused on in future research.  
 
III.  COMMENSAL AND PATHOGENIC BACTERIA OF THE UDDER 
 
Commensal bacteria have a mutually beneficial relationship with the host. On the one hand they 
prevent colonization by invasive pathogens that would induce inflammation in the host, on the other 
hand they thrive in a relative stable nutrient-rich environment provided by the host. This kind of benefit 
for the host is well-known for the gut, where non-pathogenic commensal bacteria exclude pathogens 
from the gut surface, enhance nutrient uptake and produce anti-pathogenic metabolites (Abt and 
Pamer 2014). Nevertheless, the answer to the question why commensals are beneficial and 
pathogens are detrimental while they both have similar MAMPs remains partly unknown till date. It is 
believed that a specific MAMP-TLR interaction can induce a dual response: (1) under normal steady-
state conditions, MAMPs are recognized by TLRs and may induce protective factors which are 
essential for epithelial homeostasis (Rakoff-Nahoum, Paglino et al. 2004), in contrast (2) excessive 
TLR-MAMP interaction may ignite a cytokine response as a consequence to uncontrolled inflammation 
and results in a variety of pathological conditions, including, at the extreme, septic shock (Michelsen 
and Arditi 2007).  
As milk is an important source to establish and maintain the probiotic gut microbiota of mammalian 
offspring, it is likely that a variety of commensal milk bacteria thrive and function in the mammary 
gland (Martín, Langa et al. 2003; Newburg and Walker 2007; Adlerberth and Wold 2009). Next to milk 
flora, the teat apex also contains a wide diversity of skin microbiota (Braem, De Vliegher et al. 2012) 
which are known to inhibit Gram-positive and/or -negative mastitis pathogens (Woodward, Besser et 
al. 1987). More specifically, CNS are natural colonizers of the bovine skin and other mucous 
membranes but they can also grow in the environment (Linhardt, Ziebuhr et al. 1992). Indeed, some 
CNS isolates harbor the teat apex of non-inflamed udders (Braem, De Vliegher et al. 2013), some the 
milk and others the stable (Piessens, De Vliegher et al. 2012; De Visscher, Supré et al. 2014). It is still 
a matter of debate whether CNS - generally considered as a group of minor mastitis pathogens - really 
contain harmless commensal isolates of importance for mastitis (Pyorala and Taponen 2009). The 
milk microbiota of healthy dairy cows is difficult to determine with standard culture techniques and 
culture conditions. A recent study revealed through pyrosequencing of 16S rRNA that even the 
culture-negative milk from cows with a SSC lower than 20,000 contained Staphylococcus spp. among 
S. epidermidis and S. equorum (Oikonomou, Bicalho et al. 2014). Although they are present in the 
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udder of dairy cows without inflammation symptoms, it is not demonstrated yet whether these isolates 
are commensals and not just pathobionts. A possible approach to identify commensal CNS isolates 
can be attempted based on IgA discrimination. In analogy with gut microbiota, potentially pathogenic 
bacteria are believed to have a higher affinity and specificity to IgA compared to commensals (Pabst 
2012). Highly IgA-coated bacteria from the gut were proven to induce detrimental effects when sterile 
colitis is induced compared to low IgA-coated bacteria (Palm, de Zoete et al. 2014). As such, low IgA-
binding CNS species from the milk of healthy cows could be injected in germ-free mice with our 
intraductal model (chapter I.2.). This experiment would enable us to profoundly evaluate the 
contribution of commensals to innate immunity of the mammary gland (Cash and Hooper 2005).  
Nevertheless, some bovine-associated CNS isolates may contain beneficial traits for the host. Based 
on a prevalence study, CNS colonization at the teat apex prepartum appears to be associated with 
lower SSC in the first few days of lactation compared to their non-colonized counterparts (De Vliegher, 
Laevens et al. 2003) and moreover are able to inhibit major mastitis pathogens in vitro (De Vliegher, 
Opsomer et al. 2004; Braem, Stijlemans et al. 2014). Interestingly, this likely is no species-specific 
feature as it is not restricted to cows, because as an S. epidermis isolated from breast milk of healthy 
women inhibited pathogenic S. aureus too (Heikkila and Saris 2003). Another remarkable observation 
is that heifers with CNS in their milk during early lactation have a significantly lower amount of clinical 
infections with mastitis-associated major pathogens, and seem to have a higher milk yield compared 
to CNS-negative heifers (Piepers, Opsomer et al. 2010; Piepers, Schukken et al. 2013).  
The fact that CNS species interact differently with their host implicates that conclusions based on 
epidemiological studies comprising several residential CNS is very challenging. Further complicating 
the interpretations of these studies, is that a marked intra-species heterogeneity among bovine S. 
chromogenes isolates was revealed in cows (Piessens, De Vliegher et al. 2012). In experimentally 
infected mice an intramammary isolated S. chromogenes IM showed a similar growth as one isolated 
from the teat apex (S. chromogenes TA), while inflammation with the latter strain was more severe in 
30% of the in our pilot study (Chapter I.2.). An explanation for these species-independent differences 
should likely be looked for in the ongoing process that started from the evolutionary precursors of S. 
chromogenes. Indeed, as CNS originate from skin bacteria and the mammary gland is derived from 
skin folds (see General Introduction, Section II), it is plausible that some CNS evolved along with the 
formation of this gland structure. This suggests that selection pressure and adaptation shaped the 
group of CNS and especially some S. chromogenes strains to acquire available nutrients and 
resources from the skin or teat apex, while other CNS members specialized into obtaining their 
advantage from nutrients typically available in the milk environment. Although this hypothesis has not 
been demonstrated for CNS, it has already been put forward for S. aureus. It is believed that this 
pathogen acquired its colonization potential of mammary epithelial cells by gene decay. By means of 
this latter evolutionary process, mastitis-associated S. aureus isolates probably evolved from a free-
living to an intracellular lifestyle, whereby biosynthetic components are lost in favour of parasitizing on 
nutrients obtained from the udder cells they reside in (Herron-Olson, Fitzgerald et al. 2007). 
169 
 
GENERAL DISCUSSION  
In this PhD thesis, CNS isolates obtained from different niches were compared for their capacity to 
induce a host immune response (Chapter I.2.). Furthermore, we compared the bacterial growth and 
cytokine profiles to these of a major S. aureus mastitis pathogen characterized by a high virulence in 
mice (Le Marechal, Jardin et al. 2011). It should be remarked that the mouse mastitis model has not 
yet been used to evaluate CNS mastitis but primarily to assess the pathophysiology of S. aureus and 
the role of its virulence factors (Bhakdi and Tranum-Jensen 1991; Dinges, Orwin et al. 2000; 
Brouillette, Grondin et al. 2004; Bouchard, Peton et al. 2012; Demon, Ludwig et al. 2012; Demon, 
Breyne et al. 2013). Mice have the physical disadvantage of a high surface area in relation to their 
body volume. Due to their difference in body volume, the used bovine S. aureus Newbould 305 - 
isolated from a clinical mastitis case (Bouchard, Peton et al. 2012) - typically causes already a more 
severe pathophysiological change in small ruminants than in cows (Noujaim, Lucca et al. 2004). For 
mice, this effect is even more pronounced with a severe systemic response to the S. aureus exotoxins 
characterized by a major drop in body temperature (Chapter I and II) (Bramley, Patel et al. 1989; 
Ragle and Bubeck Wardenburg 2009; Kebaier, Chamberland et al. 2012; Chinchali and Kaliwal 2014). 
This is probably due to alterations in the cardiovascular parameters i.e. a lower pulse distention and 
peripheral blood flow, which are inherent to topor in small animals (Cauwels, Janssen et al. 2006). Of 
relevance for the CNS findings described in this PhD thesis, it has been shown that lacking coagulase 
following mutagenesis decreased the virulence of S. aureus in the mouse mastitis model (Jonsson, 
Lindberg et al. 1985). However, other authors attributed this decrease as being due to the interference 
of multiple clotting factors (Phonimdaeng, O'reilly et al. 1990; Cheng, McAdow et al. 2010) present in 
CNS. In accordance with the former rather than the latter interpretation, it has been shown in a 
pioneer study that CNS virulence can be enhanced through the addition of coagulase activity (Ekstedt 
and Yotis 1960). Nontheless, before general conclusions concerning the virulence of CNS versus S. 
aureus can be drawn, more CNS species should be taken into account with the mouse mastitis model. 
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IV.  MAIN CONCLUSIONS 
 
 Differential inflammatory signaling of two major bovine-associated mastitis pathogens can be 
comparatively explored with the mouse mastitis model.  
 
 A mastitis-associated E. coli isolate induces an early influx of neutrophils in the mammary 
glands of mice compared to mastitis caused by a S. aureus isolate.  
 
 E. coli- and S. aureus-infections establish quantitative differences in NF-kappaB activity, 
inflammatory cytokine profiles, and IL-1beta processing in the mammary gland. The latter 
cytokine has negligible effect on the bacterial loads post-infection with E. coli or S. aureus and 
occurs independently of caspase-1/-11. 
 
 Bovine-associated CNS isolates can be compared in parallel with the mouse mastitis model. 
 
 A CNS-induced neutrophil influx in the mammary gland is characterized by low bacterial 
growth, as well as cytokine induction.  
 
 CNS-inflicted mastitis is mild compared to S. aureus mastitis. Small differences between CNS 
isolated from niches such as the saw bedding, the teat apex and milk can be observed based 
on cytokine response and bacterial growth. 
 
 Preventive LPS pretreatment modulates the mammary innate immune signaling beneficially 
during S. aureus-induced mastitis. 
 
 LPS pretreatment followed by a S. aureus infection is characterized with a reduction of 
bacterial loads, IL-1beta, TNF-alpha and IL-6 as well as an increase of CCL5/RANTES and 
CXCL5/LIX.  
 
 CCL5/RANTES in the mammary gland likely has only a limited tolerant and no resistance 
function during S. aureus-induced mastitis. 
 
 Curative antimicrobial compounds for bacterial-induced mastitis can be evaluated in the 
mouse mastitis model. 
 
 The intramammary efficacy of first generation cephalosporins against S. aureus-induced 
mastitis partly corroborates the MIC data obtained with this major bovine-associated isolate in 
vitro. 
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 The efficacy of cephazolin against S. aureus-induced mastitis can be increased through a 
change of excipient. 
 
 A novel biphenomycin compound can be assessed as candidate curative treatment against 
bovine-associated pathogens with the mouse mastitis model and holds promise as a broad-
spectrum antimicrobial drug 
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V. FUTURE PERSPECTIVES 
 
 The underlying working mechanism of pro-IL-1beta cleavage is hypothesized to be associated 
with neutrophil-associated proteases and MMP activity instead of caspase-1/-11 during S. 
aureus- and/or E. coli-induced mastitis (Fig. 2 of the General Discussion). It would be 
worthwhile to verify whether IL-1beta processing occurs in absence of MMPs and/or 
neutrophil-associated proteases during S. aureus- and/or E. coli-induced mastitis and whether 
other major mastitis pathogens may also elicit IL-1beta processing. Other cytokines such as 
IL-18, may be similarly processed as IL-1beta and are also worthwhile to investigate (Vanden 
Berghe, Demon et al. 2014). Nevertheless, caspase-1/-11 is activated during E. coli-induced 
mastitis and its function is not yet known in this pathology. It would be interesting to examine 
whether caspase-1/-11 restricts bacterial invasion. 
 
 Our hypothetic model indicates that mammary gland inflammation results from a multicellular 
process. Future research should focus on integrating effects of multiple sentinel cells (i.e. 
PRR-containing cells of the mammary such as mammary epithelia, macrophages and 
neutrophils) gland responding to different MAMPs of mastitis-causing pathogens. Notably, 
enzymes released by infiltrating neutrophils are known to be responsible for temporally 
elevated levels of inflammatory cytokines unrelated to the inflammasome (Bank and Ansorge 
2001). Identifying and altering the activity of neutrophil-associated proteases would unravel 
the essential signaling to control the local cytokine bioactivity and availability. 
 
 We observed that IL-6 production is activated by both E. coli and S. aureus and cannot be 
explained straightforwardly by NF-kappaB activity. This observation indicates that alternative 
signaling pathways triggered by MAMPs of both pathogens activate essential TFs other than 
NF-kappaB such as AP-1 or CREB (Wang, Song et al. 2014). Identifying genes that are 
controlled by these TFs during mastitis would help us to better understand the pathologenesis. 
 
 Our observations in the mouse mastitis model suggest that bovine-associated CNS isolates 
have low bacterial fitness compared to major mastitis pathogens. Correlation between 
bacterial loads, highly induced cytokines and neutrophil influx would help us to determine 
whether the fitness of the studied CNS isolates is lower than the S. aureus isolate. Cytokine 
profiling of CNS-infected mammary glands would help to determine which elevated cytokines 
are necessary for the influx of immune cells. Furthermore, CNS isolates from healthy dairy 
cows may be evaluated in germ-free mice to determine their pathogenicity (e.g. minor 
pathogenic vs commensal).  
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 Colonization of the mammary gland with beneficial CNS isolates can potentially be used as a 
novel long-term probiotic treatment. Preliminary data confirmed the advantages of CNS 
(Figure 3 of the General Discussion) but findings should be more exploited in the future. 
Moreover, different isolates should be validated in vivo to establish which CNS isolate is 
responsible for the beneficial traits suggested in dairy cows such as production of anti-major 
pathogenic bacteriocins (De Vliegher, Opsomer et al. 2004; Braem, Stijlemans et al. 2014). 
 
 LPS pretreatment suggests an increase in resistance and tolerance in the host against S. 
aureus-induced mastitis. Determining the anti-bacterial and protective parameters induced 
during this process would help to identify essential host signaling that could be exploited for 
preventive treatment. Alternatively, an increase in tolerance through low doses of 
chemotherapeutics prior to S. aureus-induced mastitis can be investigated to attenuate the 
severe damage induced by this major pathogen.  
 
 The mouse mastitis model opens perspectives for testing the in vivo efficacy of novel 
candidate antibiotics compared to those generally used. Nevertheless, validation in cows 
always is required. Parameters influencing the efficacy of curative antibiotic treatment should 
be determined in vivo as they may explain why antibiotics sometimes fail to do their 
assignment based on MIC data with conventional culture media. Furthermore, our data 
indicate that an elaborate comparison of the excipient formulation may offer more possibilities 
in increasing the efficacy of already available antibiotics. 
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SUMMARY 
Bacterial-induced mastitis is considered a major issue worldwide for both animal welfare and the dairy 
cow industry. The General Introduction explains how different pathogens cause mastitis in dairy 
cattle to a varying degree. For example, a limited number of colony forming units (CFU) of either a 
Gram-negative pathogen, such as Escherichia coli (E. coli), or a Gram-positive pathogen, such as 
Staphylococcus aureus (S. aureus), already cause mastitis, while a much larger number of CFU from 
a coagulase-negative staphylococcus (CNS), such as Staphylococcus chromogenes (S. 
chromogenes), induces only mild mastitis. The innate immune response in the host upon infection with 
bovine-associated isolates that display differences in their virulence is not well characterized. 
However, such mechanistical knowledge concerning host–microbe interactions is necessary to 
develop more efficient curative or preventive treatments for mastitis. Ideally, experimental mastitis is 
studied in dairy cows. However, those infection studies are very expensive and labour intensive. 
Therefore, an easily accessible mouse mastitis model was introduced in the 1970s. This validated in 
vivo model has since been used by several research groups to study the immune response induced 
by several bovine mastitis isolates, but not yet for CNS. Although results obtained in mice are 
undoubtedly valuable, they should always be confirmed in the target animal species, i.e. dairy cows. 
The Aims of the Thesis are threefold and always assessed using the mouse mastitis model with 
bovine-associated bacterial isolates to simulate the disease in dairy cows. The first objective is to 
compare the microbe-driven innate immune signaling triggered by E. coli, S. aureus or CNS isolated 
from different niches. It is then evaluated whether pretreatment with a membrane component of E. 
coli, lipopolysaccharide (LPS), may dampen a subsequent intramammary S. aureus infection as a 
basis for a potential preventative mastitis strategy. Finally, the efficacy of existing and novel candidate 
antibiotics against bovine mastitis isolates is compared in vitro and in vivo, as applications of a 
curative mastitis strategy. 
In Chapter I, the pathogen-dependent innate immune response was studied during mastitis. Until now 
it was accepted that microbe-associated molecular patterns (MAMPs), exposed by various bacteria, 
bind to pathogen-recognition receptors on udder cells to induce an influx of immune cells during 
mastitis. It was suggested that this influx results from cytokines secreted by these udder cells following 
activation of specific transcription factors, in particular Nuclear Factor (NF)-kappaB. Some pro-
inflammatory cytokines produced during this process, such as the inactive pro-form of interleukin (IL)-1 
beta, have to be processed post-translationally to obtain their biological activity. For proIL-1beta, this 
processing generally involves the inflammasome, a multiprotein complex that requires caspase-1 
and/or -11 proteolytic activity. In Chapter I.1, the inflammatory signaling in the mammary gland 
induced in parallel by an E. coli and a S. aureus infection was assessed. In comparison to the S. 
aureus-induced inflammation, E. coli induced a rapid influx of immune cells in the mammary gland, 
which was associated with histopathological changes. In addition, quantitative differences in NF-
kappaB activation and in local inflammatory cytokine profiles between infections with the Gram-
negative and -positive pathogens were also detected. More specifically, E. coli induced, both at 12 and 
24 hours after inoculation, a high NF-kappaB activity and substantial concentrations of IL-1alpha, 
tumor necrosis factor-alpha and monocyte chemotactic protein-1 in the mammary gland in comparison 
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to S. aureus. In contrast, IL-6 was upregulated equally for both types of infections, while IL-1beta 
concentrations were equally upregulated for both pathogens at 12 hours and significantly higher at 24 
hours for S. aureus. These intriguing differences in kinetics of IL-1beta between both infectious 
pathogens were studied in detail. Interestingly, proIL-1beta processing occurred in both E. coli- and S. 
aureus-infected glands. However, the cleavage pattern was pathogen dependent yet surprisingly 
independent of the inflammasome. This conclusion could be made based on similar infections in IL-
1beta knock-out and caspase-1/11 double knock-out mice, respectively. Pro-IL-1beta cleavage 
occurred for E. coli already at the early time-point, while for S. aureus it was observed only at the late 
time-point. To verify inflammasome dependency of this process, samples were taken at both time 
points in caspase-1/11 knock-out mice. Interestingly, the IL-1beta fragments were still present in the 
absence of caspase-1/11 activity. In Chapter I.2, the mouse model was validated for the first time to 
study CNS induced mastitis. The different CNS used in this study were isolated from various niches 
such as the udder of a dairy cow with chronic mastitis (IM), the teat tip of a heifer (TA) and the 
sawdust bedding. In contrast to the exponential growth of S. aureus after inoculation, S. chromogenes 
IM showed only very limited bacterial growth and this at several tested inoculum doses. This was also 
the case for S. chromogenes TA and S. fleurettii from the sawdust bedding. Although infection with 
each of the three bovine CNS isolates was accompanied with a local neutrophil influx, the 
corresponding innate immune response was characterized by much lower pro-inflammatory cytokine 
profiles (including IL-1beta) than that caused by S. aureus. 
It has previously been demonstrated that immunomodulation following pretreatment with LPS, a 
MAMP of E. coli, improves bacterial clearance and/or decreases bacterial colonization in various 
mouse infection models. There are indications that such an LPS injection in the udder can also be 
useful in the context of a preventive mastitis strategy in cows. Therefore, in Chapter II LPS was 
injected shortly before the induction of an intramammary S. aureus infection. This local pretreatment 
markedly reduced the severity of the symptoms, the local CFU and the pro-inflammatory cytokine 
response, compared with the non-pretreated animals. A comparative protein-array analysis between 
E. coli- and S. aureus-infected mammary glands identified that the chemokine CCL5/RANTES was 
induced by E. coli and not by S. aureus. However, in contrast to the LPS pretreatment, pretreatment 
with CCL5/RANTES was only associated with a minor immunomodulation in the mammary gland and 
could not reduce the local growth or decrease the colonization potential of bacteria. 
Antibiotics are frequently used as a curative therapy of bovine mastitis. Therefore, Chapter III 
compared the efficacy of antimicrobial agents against different mastitis pathogens in vitro, based on 
minimum inhibitory concentration (MIC) data, and in vivo, using the mouse mastitis model. In Chapter 
III.1, the antimicrobial activity of the first generation cephalosporins; cephalexin, cefalonium, 
cephapirin and cefazolin was analyzed. From the in vivo determination of the effective doses and the 
protective doses, cefazolin was shown to be the most efficacious antibiotic for the treatment of S. 
aureus mastitis while cefalonium and cephapirin were more active in vitro. Moreover, it was 
demonstrated in the mouse mastitis model that the antimicrobial efficacy of cefazolin could be 
enhanced by modifying the excipient. In Chapter III.2, the antimicrobial efficacy of a novel candidate 
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antibiotic was compared against different mastitis pathogens. As with the cephalosporins, the in vitro 
results with this biphenomycin class compound were not fully consistent with the in vivo data. Based 
on the effective and protective doses established in the mouse mastitis model, the screened 
compound shows potential as a broad-spectrum antibiotic against staphylococcal, streptococcal and 
coliform bovine mastitis pathogens. 
In the General Discussion, a hypothetical model is proposed based on the differences observed in 
proIL-1beta processing during intramammary infections with the major mastitis pathogens E. coli and 
S. aureus (Chapter I.1). This multicellular model demonstrates a prominent role for local cells such as 
macrophages or epithelial cells together with the infiltrating neutrophils. Local cells are believed to be 
activated by various MAMPs of both E. coli and S. aureus which secrete proIL-1beta into the interstitial 
space in an inflammasome-independent manner. Depending on the combination of MAMPs present 
on the bovine mastitis-associated bacterial isolate, the intensity and the kinetics of the innate immune 
response will differ in the mammary tissue. Indeed, MAMPs of E. coli will strongly activate NF-kappaB 
and induce a pathogen-dependent cytokine profile that allows rapid recruitment of circulating 
neutrophils in contrast to the MAMPs of S. aureus. The activated neutrophils may produce neutrophilic 
proteases that are supposed to cleave pro-IL-1beta into multiple fragments. Furthermore, the E. coli 
infection is associated with the loosening of mammary epithelial cells presumably as a result of matrix 
metalloproteinases. These host-derived cellular proteases may provide the additional cleavage of pro-
IL-1beta observed in an E. coli infection, whereas S. aureus-associated bacterial proteases may be 
responsible for the observed alternative pro-IL-1beta cleavage pattern. In conclusion, this molecular 
model shows that the inflammatory signaling during mastitis is strongly pathogen-dependent. In 
addition, alternative pathways can induce an immune cell influx, since bacterial isolates associated 
with mild mastitis, such as CNS, may lack the IL-1beta response characteristic for major mastitis 
pathogens, such as E. coli and S. aureus (Chapter I.2). Moreover, the local immune response 
following S. aureus mastitis can be dampened by pretreatment with LPS and thereby reduce the 
symptoms associated with high virulence of this pathogen. This observation provides prospects for 
alternative preventive strategies to favourably change the hosts‘ immune response. The comparison 
between data generated with MIC with conventional growth medium and the mouse mastitis model 
indicates that host-related factors may also influence the potential of antibiotics. As such, the efficacy 
of antimicrobial compounds can be screened with the mouse mastitis model in a fast and cost-
effective manner prior to in vivo confirmation in dairy cows. 
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Mastitis of uierontsteking bij melkvee vormt een wereldwijd probleem voor zowel het dierenwelzijn als 
voor de melkproductie. De Algemene Inleiding beschrijft hoe kiemen in verschillende mate mastitis 
kunnen veroorzaken bij melkvee. Zo kan een beperkt aantal kolonievormende eenheden (KVE) van 
hetzij een Gram-negatieve pathogeen zoals Escherichia coli (E. coli), hetzij een Gram-positieve 
pathogeen zoals Staphylococcus aureus (S. aureus) reeds mastitis veroorzaken, terwijl een veel 
groter aantal KVE vereist is om met mastitis ziekteverwekkers zoals de coagulase-negatieve 
stafylokok (CNS) Staphylococcus chromogenes (S. chromogenes) een uierontsteking te induceren. 
De reden waarom de immuunrespons van de gastheer tussen bacteriële isolaten uit koeien met 
mastitis in dergelijke mate verschilt, is onvoldoende gekend. Deze kennis is echter noodzakelijk om 
een efficiëntere curatieve of preventieve behandeling voor mastitis te ontwikkelen. Idealiter worden 
experimentele mastitis studies uitgevoerd bij melkkoeien. Echter, die infectiestudies zijn zeer duur, 
arbeidsintensief en kampen met een tekort aan onderzoeksinstrumenten. Om de moleculaire biologie 
van de aangeboren immuunrespons tijdens mastitis beter in kaart te brengen werd naar aanvullende 
onderzoeksmethoden gezocht. Zo introduceerde en karakteriseerde men in de jaren ‘70 het muis 
mastitis model dat sindsdien door verschillende onderzoeksgroepen werd gebruikt om de interactie 
van boviene bacteriële isolaten met de melkklier te bestuderen. Resultaten verkregen bij muizen zijn 
zeer waardevol, niettemin moeten ze steeds bevestigd worden in de melkkoe. 
De Doelstellingen van het proefschrift zijn drieledig en worden steeds benaderd met behulp 
het muis mastitis model dat gebruikt maakt van boviene-geassocieerde bacteriële isolaten om de 
situatie bij de melkkoe na te bootsen. De eerste doelstelling is om de immuunrespons te onderzoeken 
veroorzaakt door verschillende koe-geassocieerde kiemen namelijk E. coli, S. aureus en CNS 
geïsoleerd uit verschillende niches. Vervolgens wordt nagegaan of de voorbehandeling met een 
membraanfragment van E. coli, lipopolysaccharide (LPS), als een preventieve strategie kan fungeren 
om de daaropvolgende S. aureus mastitis te temperen. Ten slotte wordt de werking van zowel 
bestaande als kandidaat nieuwe antibiotica als curatieve behandeling tegen boviene mastitis 
vergeleken in vitro en in het muis mastitis model. 
In Hoofdstuk I werd de kiemafhankelijke immuunrespons in de melkklier bestudeerd. Tot op 
heden werd aanvaard dat microob-geassocieerde moleculaire patronen (MAMP), blootgesteld door 
verschillende mastitis kiemen, interageren met pathogeen herkennende receptoren op uiercellen wat 
een instroom van immuuncellen met zich meebrengt tijdens mastitis. Er werd gesuggereerd dat deze 
influx het gevolg is van de cytokines uitscheiden door lokale uiercellen na activatie van specifieke 
transcriptiefactoren met name Nuclear Factor (NF)-kappa B. Sommige pro-inflammatoire cytokines, 
zoals de inactieve pro-vorm van interleukine (IL)-1 beta, moeten post-translationeel worden verwerkt 
om hun activiteit te verkrijgen. Voor IL-1beta gebeurt dit in het inflammasoom, een complex dat 
caspase-1 en -11 omvat. In Hoofdstuk I.1 onderzochten we deze inflammatoire signalisatie in parallel 
bij een E. coli en een S. aureus infectie in de melkklier. In vergelijking met de S. aureus-geïnduceerde 
inflammatie, induceerde E. coli een snelle instroom van immuuncellen in de melkklier die gepaard ging 
met histopathologische veranderingen. Daarenboven waren tussen de Gram-negatieve en Gram-
positieve pathogenen ook kwantitatieve verschillen in NF-kappaB activatie en in lokale inflammatoire 
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cytokine- profielen. Meer specifiek induceerde E. coli zowel op 12 uur als op 24 uur na inoculatie een 
hoge NF-kappaB activiteit en hoge concentraties aan IL-1alpha, tumor necrosis factor-alfa en 
monocyte chemotactic protein-1 in de melkklier in vergelijking met S. aureus. De lokale IL-6 
concentraties stegen vergelijkbaar na beide infecties, terwijl dit voor IL-1beta enkel het geval was bij 
het vroege tijdspunt maar niet bij het latere tijdspunt. Na 24 uur inoculatie waren de IL-1beta 
concentraties significant hoger in de melkklier na een infectie met S. aureus. Deze intrigerende 
kiemafhankelijke kinetiek van IL-1beta werd in detail bestudeerd via Western blot analyse. Door 
middel van deze techniek observeerden we een pathogeen-afhankelijk verknippingspatroon, dat 
onafhankelijk tot stand kwam van het inflammasoom. Dit laatste werd duidelijk door het gebruik van 
IL-1beta knock-out muizen en caspase-1/-11 dubbel knock-out muizen. In Hoofdstuk I.2 werd het 
muismodel voor de eerste maal gebruikt om CNS infecties met elkaar te vergelijken. Deze CNS 
werden geïsoleerd uit verschillende niches zoals de uier van een melkkoe met chronische mastitis 
(IM), de speentop van een vaars (TA) en de stalbedding. In contrast met de exponentiële groei van S. 
aureus na inoculatie vertoonde S. chromogenes IM beperkte bacteriële groei en dit bij meerdere 
getestte inoculum dosissen. Dit was tevens het geval voor S. chromogenes TA en een S. fleurettii 
afkomstig uit de stalbedding. Alhoewel de drie boviene CNS isolaten een lokale neutrofiel-influx 
induceerden, was de corresponderende immuunrespons gekarakteriseerd door de pro-inflammatoire 
cytokine profielen (incl. IL-1beta) veel zwakker dan die veroorzaakt door S. aureus. 
Studies in diverse muis infectiemodellen toonden aan dat immunomodulatie door voorbehandeling 
met LPS, een MAMP van E. coli, geassocieerd is met een betere bacteriële opruiming en/of 
kolonisatie. Er zijn indicaties dat een dergelijke preventieve LPS injectie in de uier ook nuttig kan zijn 
in het kader van mastitis bij koeien. Daarom werd in Hoofdstuk II LPS geïnjecteerd kort voor een 
intramammaire S. aureus infectie. Deze lokale voorbehandeling verlaagde de pro-inflammatoire 
cytokine respons, de ernst van de symptomen en de lokale KVE in de melkklieren vergeleken met de 
niet voorbehandelde dieren. Een vergelijkende proteine-array tussen E. coli- en S. aureus-
geïnfecteerde melkklieren identificeerde o.a. het chemokines CCL5/RANTES dat werd geïnduceerd 
door E. coli en niet door S. aureus. In tegenstelling tot de LPS voorbehandeling ging een 
voorbehandeling met CCL5/RANTES slechts gepaard met een geringe immunomodulatie en kon deze 
de lokale groei en/of kolonisatie van bacteriën niet verminderen. 
Als curatieve therapie van boviene mastitis worden antibiotica nog steeds frequent gebruikt. Daarom 
vergeleek Hoofdstuk III de werkzaamheid van antimicrobiële middelen tegen verschillende mastitis 
ziekteverwekkers in vitro, gebaseerd op minimale inhibitorische concentratie (MIC) gegevens, ten 
opzichte van in vivo met het muis mastitis screening model. In Hoofdstuk III.1 werd de antimicrobiële 
werking van de eerste generatie cefalosporinen cefalexine, cefalonium, cefapirine en cefazoline 
geanalyseerd. Uit de in vivo bepaling van de effectieve en de beschermende dosissen blijkt dat 
cefazoline het meest werkzame antibioticum is voor de behandeling van S. aureus mastitis terwijl 
cefalonium en cefapirine actiever zijn in vitro. Bovendien kon in het muis mastitis model aangetoond 
worden dat de antimicrobiële werkzaamheid van cefazoline verhoogt door de hulpstof te wijzigen. In 
Hoofdstuk III.2 werd de antimicrobiële werkzaamheid van een nieuw kandidaat antibioticum uit de 
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biphenomycine klasse bestudeerd ten opzichte van verschillende mastitis ziekteverwekkers. Net als 
bij de cefalosporines, stemden de in vitro resultaten niet volledig overeen met de in vivo data. Onze 
gegevens op basis van het muis mastitis model, wijzen op het potentieel van het getestte 
biphenomycine als breedspectrum antibioticum.  
In de Algemene Discussie wordt een hypothetisch model voorgesteld dat de waargenomen 
verschillen in proIL-1beta verknippingspatronen tijdens een intramammaire infectie met mastitis 
ziekteverwekkers E. coli en S. aureus kan verklaren (Hoofdstuk I.1). In dit meercellige model is een 
prominente rol weggelegd voor lokale cellen zoals macrofagen of epitheliale cellen naast de 
infiltrerende neutrofielen. Deze cellen worden geactiveerd door verschillende MAMPs van zowel E. 
coli als S. aureus waardoor proIL-1beta wordt uitgescheiden in de interstitiële ruimte op een 
inflammasoom-onafhankelijke wijze. Afhankelijk van het MAMP zal de intensiteit en de kinetiek van de 
aangeboren afweer in het melkklierweefsel verschillen. Zo zullen de MAMPs van E. coli een sterke 
NF-kappaB activatie induceren en met een pathogeen-afhankelijk cytokineprofiel dat voor een snelle 
rekrutering van circulerende neutrofielen zorgt in tegenstelling tot de MAMP van S. aureus. Bij hun 
activatie, kunnen neutrofielen proteasen produceren die verondersteld worden proIL-1beta te klieven 
in meerdere fragmenten. Verder wordt een E. coli infectie geassocieerd met het loskomen van 
mammaire epitheelcellen vermoedelijk als gevolg van matrix metalloproteinasen. Deze proteasen 
zorgen voor de additionele verknipping van pro-IL-1beta tijdens een E. coli infectie, terwijl S. aureus 
geassocieerde bacteriële proteasen zouden instaan voor een alternatief pro-IL-1beta 
verknippingspatroon. In conclusie toont dit model aan dat de inflammatoire signalisatie tijdens mastitis 
op een kiemafhankelijke manier verloopt. Bovendien zijn er alternatieven voor het induceren van een 
immuuncel influx aangezien bacteriële isolaten geassocieerd met lage virulentie, zoals CNS, deze IL-
1beta respons karakteristiek voor hoog-virulente kiemen zoals E. coli en S. aureus ontbreken 
(Hoofdstuk I.2). Het preventief temperen van de lokale immuunrespons door een voorbehandeling met 
LPS kan bovendien de symptomen geassocieerd met hoge virulentie verminderen. Deze observatie 
biedt toekomstperspectieven waarbij alternatieve preventieve strategieën de gastheer-immuniteit 
gunstig wijzigen. De interactie tussen de immuunrespons van de gastheer en bacteriële mastitis 
isolaten blijkt ook de antimicrobiële activiteit van antibiotica te kunnen beïnvloeden. Om dit na te gaan 
kan men steeds op een snelle en kosteneffectieve manier de werkzaamheid van antibiotica screenen 
met het muis mastitis model voorafgaand aan in vivo bevestiging bij de melkkoe. 
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vertegenwoordigers een aardig procentje korting en een glimlachje verkrijgen. Je “koppel” talent, 
nieuwsgierigheid en lach is bewonderenswaardig en wordt van harte geapprecieerd. Mijn voorlopig 
enige bureaugenootje, Jorien, ook jou wil ik bedanken voor de leuke momenten op het werk. Je 
gigantische datasets en statistische verwerking spreken tot de verbeelding en ik ben ervan overtuigd 
dat je gauw je doctoraatstitel op zak zal hebben. Jonas, jij bent de laatste biochemische aanwinst. 
Hopelijk heb je veel plezier met de intraductale injecties en de bioluminescente kankercelletjes. Ik zal 
je zoveel mogelijk de weg tonen, maar ik weet zeker dat je voldoende capaciteiten bezit om het heft in 
eigen handen te nemen. 
De “mannen” van de farmacologie en toxicologie verdienen ook terechte dank. Eerst en vooral: 
Mathi/Matn/Mathias! Maatje, we hebben een “bère” tijd achter de rug: gaande van galabals, LAN-
party’s (die we dringend eens moeten herinvoeren) tot Canadese bull-rides. Merci voor alles! Alsook 
voor de tijd die je telkens maakte als ik eens plots aan je bureau verscheen. Ik weet dat er nog vele 
leuke momenten zullen volgen. Nathan, proficiat met je 30 jaartjes vandaag! Je talent om zaken te 
relativeren is fascinerend. Hetzelfde kan gezegd worden over je outfit keuze tijdens de sportdag waar 
Marlien direct voor bezwijmde. Je bent een zaligen kerel om op reis mee te gaan van het warme 
Guatemala, Belize en Mexico (+30°C) tot het ijskoude Chicago (-30°C). Voortaan heet je S.A.M. 
(Alsjeblieft mensen doe me een plezier en vraag aan Nathan waarvoor deze afkorting staat!). We 
hebben unieke avonturen beleefd waarvan vele mensen alleen maar kunnen dromen. Daarom terecht 
bedankt! Thomas, alhoewel je bij de start als een serieuze gast overkwam die klei met onevenaarbare 
precisie in zelfgemaakte enveloppes afwoog en je zelfs koffiebonen maalde om het authentieke 
koffiearoma te vrijwaren, zijde toch een geniepige drinkebroer. Ik stond versteld hoeveel gratis drank 
je in Amsterdam kon bemachtigen met zelfverzonnen smoesjes. Ook voor jou: merci voor de leuke 
momenten. Joren, alhoewel je nog maar net begonnen bent, ben ik blij dat je erbij bent en ik weet dat 
we met jou een leuke tijd tegemoet gaan. Ik hoop dat we het wekelijkse leed met z’n allen kunnen 
blijven doorspoelen in de Eluna en de jaarlijkse citytrips kunnen blijven in stand houden. 
Er kunnen geen mannen van de farmaco en toxico zijn, zonder een sterke vrouwelijke tegenpool. Elke 
G. , Sophie, Joske, Anneleen, Heidi en Elke P. ook jullie zijn bedankt voor de leuke werksfeer en ik 
wens jullie het beste toe voor jullie onderzoek en verdere carrière. Eveneens het GLP-team (Ann S., 
An M. en Jelle), KELA-team (Marc en Kris) en Sigried zorgen ervoor dat de werkstek een aangename 
plek blijft. Ook dank aan Nathalie om me te helpen bij alle praktische zaken, hopelijk stel je het goed 
bij de collega’s van de economie. Filip, welkom bij de vakgroep, je straalt positiviteit uit en 
enthousiasme uit wat altijd leuk is. 
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Mijn werk zou ik nooit kunnen hebben voltooid zonder de hulp van mensen van andere vakgroepen. 
Steven en Sofie, het was leuk om met jullie de talloze uren te doden aan de IVIS. Ook een speciaal 
dankwoordje voor het M-team. Sofie, je werkdrive is intrigerend, dikke merci voor de hulp in je al zo 
druk schema. Dankjewel Lars voor het verzamelen van stalen, prepareren van de CNS inocula en je 
praktisch inzicht. Anneleen, ook jij bedankt voor de genotypering van de CNS en je enthousiasme. 
Een mercike voor Lobke, Bart en Prof. Dr. Van den Broeck voor de hulp bij de histologie.  
Dankzij de flowcytometer had ons labo regelmatig vele bezoekers, ook die ik wil bedanken voor de 
aardige verstrooiing en de leuke gesprekken. Dank aan Ayse om het labo op orde te zetten en de 
meisjes (Seona, Elisabeth, Kim, Maité, Domenique, Isolde, Eva, Diede, Joyce, Caroline, Paulien en 
Sarah) om de muisjes te verzorgen. 
En dan nu de vriendjes van vroeger! OLO-team van weleer, wie had er gedacht dat we ooit in dit 
stadium zouden geraken? Maarten, hoe ver we ook van elkaar verwijderd zijn of hoe lang we elkaar 
niet gezien hebben, telkens als we elkaar terug zien, zal het aanvoelen alsof je nooit weggeweest 
bent. Je hielp me zware obstakels overwinnen en zelfs bergen van boven in plaats van beneden 
bewonderen. Ik kan in tal van superlatieven niet uitdrukken wat we samen hebben doorgemaakt. 
Reizen, duiken, tandjes rapen, feestjes bouwen en zelfs samenwonen … onvergetelijk prachtige 
avonturen… hebben we achter de rug en nog veel meer zullen er komen. Ik ben blij dat jij en Leen 
elkaar gevonden hebben. Jullie zijn een prachtpaar en het geluk straalt van jullie gezicht! Fréé’tje, ik 
vond het supertof dat je bij me kwam intrekken in Gent. Het was altijd leuk om te kletsen na het werk 
en ik ben er zeker van dat nu van hartenlust met Annelien kan kuieren. Zizi, nu zelfs papa Zizi, je bent 
je wilde haren verloren, je hebt ze op een paspop gezet, in de etalagekast gestoken en Effi heeft er 
een klein slotje op gezet. Maar ik ben blij dat er soms nog een klein Reinaert de vosje met een oranje 
broek van onder het stof komt gekropen tijdens een bendefeestje! Veel succes met je maalsteen 
onderzoek en ik zal duimen voor de goeie afloop ervan. (Papa) Pascie, je blijft me verbazen met je 
kook- en doe-het-zelf-talent. Je gereserveerde wijsheid is een ideale match met de speelse Ellen met 
wie je straks in het huwelijksbootje zal stappen. Ik hoop dat je kreet nog lang bij het volleybalteam kan 
doorgalmen en dat Lise je fakkel ooit zal kunnen overnemen. Tommie, dikke merci om samen met 
Melanie de vele Nieuwjaars(bende)feestjes bij jou thuis te organiseren. Super dat je in je drukke leven 
als business man altijd tijd hebt voor je vrienden. Pepijn(tje) en Carlo, het is lang geleden dat we 
elkaar nog eens gezien hebben. Bij de receptie gaan we er gauw eens werk van maken, wat zeggen 
jullie daarvan? Merci gasten, jullie zijn vrienden voor het leven. 
Klim-club vriendjes, ik kan jullie onmogelijk achterwege laten. Geen enkele klimroute is voor ons te 
lang of klimreis te ver. Elke, jij bent altijd de spring/loop/fietser int veld en je huppelt met een glimlach 
van de ene sportchallenge naar de andere. Je klimt vlugger dan een zekering het toelaat en deinst 
voor niks terug – zelfs niet voor een dutje in de gracht of naast het toilet na een avondje stappen. 
Polet(ski) a.k.a. “Tha Hulk”, nu jij waarschijnlijk aan het stressen bent, zit ik dit te schrijven. Je 
volwassen verantwoordelijkheid gaat resoluut met een glimlach aan de kant als je één druppel alcohol 
proeft. Laat staan als die druppels in de video’s vloeien, dan worden we nog eens getrakteerd op een 
legendarische one-and-only-Polet-move! 
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hebben geboden. Zonder jullie geduld en inspanningen was het me nooit gelukt. Het is ongelofelijk 
wat jullie allemaal hebben doorgemaakt en hoe jullie er altijd sterker uitkwamen. Jullie zijn een 
prachtkoppel en zijn een bron van inspiratie, waardoor ik de juiste weg vond en dit werk kon 
waarmaken.  
Lieve Nathalie, als er iets is waar ik terecht dankbaar voor ben, is het dat ik jou heb ontmoet tijdens 
mijn doctoraatsonderzoek. Zonder jou zou de eindspurt van dit werk niet half zo rustig verlopen zijn. 
Dank om m’n gedachten te verstrooien en een extra straaltje zon in huis te doen schijnen. Ik hoop dat 
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